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Executive Summary  
 
Background 
This review of the qualitative literature about needle and syringe programmes 
(NSPs) for injecting drug users (IDUs) complements the review of effectiveness 
and cost-effectiveness. It aims to provide a more situated narrative perspective on 
the overall guidance questions. 
 
Objectives 
The review sought qualitative evidence on six specific questions: 
 
1. What do IDUs and professionals working with IDUs,  including service 
commissioners, identify as suitable types of needle and syringe programmes, 
and what do they believe is the ideal level of coverage? 
2. What types of NSP (needle and syringe programmes) are valued (by IDUs, 
providers and stakeholders) and accessed by IDUs?  
3. Which additional harm reduction interventions offered by Needle and Syringe 
Programmes are valued (and accessed) by IDUs and professionals working 
with IDUs? 
4. How is opiate substitution therapy (OST) and NSPs (perceived to be) used 
together by IDUs and service providers?  
5. How do the general public (including the media) perceive the effectiveness 
and acceptability of NSPs?  
6. What are the views, experiences and attitudes of carers and families of IDUs 
to NSPs? 
 
Methods 
The methods for the review followed the National Institute for Clinical Excellence 
(NICE) protocols for the development of NICE public health guidance.  Ten 
electronic databases were searched for studies using qualitative or mixed 
methodology, published in English since 1990.  Websites of organisations and 
voluntary agencies were also searched. Two reviewers independently screened 
all titles and abstracts. Data extraction and quality assessment were undertaken 
by one reviewer and checked for accuracy by a second reviewer.  Each study 
was also graded (++, + or -) based on the extent to which the design and 
execution of the study facilitated a rich, credible, internally coherent and reliable 
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account. Results of the data extraction and quality assessment for each study 
were presented in structured tables and as a narrative summary.  
 
Results 
Forty studies are included in the review1. Of these, 10 were from the UK, 20 from 
the USA, five from Canada, two from Australia, and three from other European 
countries.  Thirty eight used interview or focus group methods and 17 used 
ethnographic or observation methods (some studies used both).   
 
Ten studies were assessed as good quality (rating ++); of these three were from 
the UK.  Twenty-five studies were assessed as being of moderate quality and five 
of poor quality.  Common barriers to validity included poor reporting of sampling 
strategy, data collection and analysis methods. Frequently the actual research 
process was either not described at all or so poorly reported that it was not 
possible to make any judgements about validity. In addition, the theoretical 
underpinning was rarely mentioned. There were several studies that, despite 
using qualitative methods to collect data, presented only quantitative data, and so 
were excluded from the review. In a substantial proportion of included studies, 
the data presented was not rich, lacking illustrative quotes and/ or context. Some 
of these issues may be due to editorial limitations on space or word count in 
journals, rather than due to poor conduct of the research.  However, without 
these details it is not possible to judge whether the omissions are due to poor 
reporting or poor quality research, and, without details of the included sample, it 
is difficult to decide whether the findings are generalisable. 
 
Ten UK studies received applicability grading A (most applicable); nine Canadian, 
Australian or European studies received grade B; 17 US studies and one 
Australian study received grade C; and three US studies that contained very little 
relevant data were ranked applicability grade D. 
 
There was insufficient qualitative evidence found to assess some of the research 
questions and sub-questions (see Table) 
 
 
                                                 
1 References to included studies can be found in the main report 
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Table: Availability of evidence for questions and subquestions 
Question/ subquestion 
 
Evidence?
1. What do injecting drug users (IDUs) and professionals working with IDUs,  
including service commissioners, identity as suitable types of needle and 
syringe programmes, and what do they believe is the ideal level of coverage?   
? 
Diversity of the population (e.g. age, gender and ethnicity); ? 
Whether or not users are homeless; ? 
Type of drugs injected; X 
Patterns of injecting, including who needle and syringe programme (NSP) users inject 
with;  
X 
Method and site of injection;  X 
Where IDUs acquire needles from (in addition to/in place of NSPs); ? 
Whether and how IDUs informally distribute needles, syringes and other paraphernalia 
with other users; 
? 
Whether and how users choose between multiple local NSPs; ? 
The ‘constellation’ or mix of services available; X 
The ‘constellation’ or mix of services desired. X 
IDUs’ involvement in service planning and/or evaluation ? 
2. What types of Needle and Syringe Programmes are valued and accessed by 
IDUs?  
? 
Providers (including personal characteristics, skill mix and level of training/competency 
of staff) site and size of setting, and commercial status of provider (including specialist 
providers, independent and multiple pharmacies); 
? 
Availability (opening times) and accessibility; ? 
Acceptability ? 
How able is target group to access services (not just how accessible are the services)? ? 
Type of injection equipment supplied; X 
Return policy on used equipment; ? 
Views on syringe pack components; X 
Beliefs about vulnerability to BBVs and wound site infections; ? 
How appropriate to meeting IDUs’ needs. ? 
3. Which additional harm reduction interventions offered by Needle and Syringe 
Programmes are valued (and accessed) by IDUs and professionals working 
with IDUs?  
? 
Provision of additional harm-reduction equipment such as filters, mixing containers, 
sterile water; 
?    
Availability of additional harm-reduction interventions such as advice and information on 
safer injecting practices, treatment for injection-site infections, onsite vaccination 
services, testing for hepatitis B and C and HIV, pre- and post-diagnostic counselling, 
general health advice, and primary health care; 
? 
Provision of spoken vs. printed advice and information; X 
Services which promote, or refer people to, a range of additional support services 
(including drug and alcohol treatment and support services, specialist support for those 
engaged in high-risk injecting methods, emergency referrals to secondary care. GP 
registration, dental care, safer sex/sexual health advice and condom distribution; 
referral to primary care services, and welfare, housing and legal advice); 
? 
Encouraging current (or employing former) IDUs to pass on sterile and unused injecting 
equipment to their peers. 
? 
4. How are opiate substitution therapy (OST) and NSPs (perceived to be) used 
together by IDUs?  
? 
Can users formally access OST and needles from the same NSP?  X 
Do users formally access OST and needles from the same NSP? X 
Do users informally access OST and needles from the same NSP? X 
What do care providers and users consider to be the advantages and disadvantages of 
integrated services? 
? 
5.   How do the general public perceive the effectiveness and acceptability of 
NSPs? 
? 
6.   What are the views, experiences and attitudes of carers and families of IDUs 
to NSPs? 
X 
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Question 1: Suitable types of programmes and ideal level of coverage 
Two US studies were found relating to key question 1. Both examined 
implementation of NSPs from the point of view of stakeholders and providers. 
 
Evidence statement 3.2a 
There is evidence from one moderate quality (+ rating) US study  that the features 
of a successful NSP include: flexibility in process and management models; 
knowledge; coalition building and community involvement; strong leadership; 
staging debate with sensitivity to political and cultural norms; access to 
resources; use of research; overcoming fear. 
 
 
Question 2: Types of NSPs valued and accessed by IDUs 
Thirty one studies were found relating to key question 2. Eight of these were from 
the UK (three ++ rating, four + rating and one – rating), 14 from the USA, five 
from Canada, one from Australia and two from other European countries. One 
compared people from the UK and the USA . 
 
Evidence statement 3.3a 
There is evidence from one good quality (++ rating) UK study and two moderate 
quality (+ rating) UK studies to suggest that immediate availability of injecting 
equipment is more important to injecting drug users than perceptions of risk 
associated with injecting behaviour. 
 
Evidence statement 3.3b 
There is evidence from two good quality (++ rating) UK studies and three 
moderate quality (+ rating) studies, two of which are from the UK, that pharmacy-
based needle and syringe programmes are popular with injecting drug users. 
Pharmacies were rated more highly than drug agency based NSPs for 
accessibility in 3 UK studies; although in another 2 UK studies, embarrassment, 
negative staff attitudes or fear of exposure led to negative feelings about 
pharmacy based NSPs, particularly in women. Agency based NSPs were rated 
more highly than pharmacies for advice and information. 
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Evidence statement 3.3c 
There is evidence from one good quality (++ rating) UK study, one good quality 
(++ rating) US study, one moderate quality (+ rating) UK study, two moderate 
quality (++ rating) US studies and one poor quality (- rating) UK study to suggest 
that convenience or otherwise (specifically opening hours, location and queues) 
of NSPs are very important to IDUs and can influence decisions on whether to 
obtain equipment from them or from street sellers or secondary exchange. 
 
Evidence statement 3.3d 
d. There is evidence from two good quality (++ rating) studies, one of which is 
from the UK, and seven moderate quality (+ rating) studies, two of which are from 
the UK, to suggest that IDUs are not a homogeneous group: there are different 
cultures, some of whom disapprove of others’ drug using behaviours and some of 
whom are more affluent than others.  Fear of being caught and publicly exposed 
as a drug user (to police (USA studies), neighbours or family (UK studies)) is a 
prominent theme and can impact upon use of NSPs and other services, with 
some IDUs preferring secondary syringe exchange for this reason. 
 
Evidence statement 3.3e 
There is evidence from one good quality (++) qualitative study that prison-based 
NSPs may find support but also opposition, both among IDUs and non-IDUs. 
There is evidence from one moderate (+) quality qualitative study that anonymity 
was seen as important by IDUs in relation to prison-based NSPs. 
 
 
Question 3: Additional harm reduction interventions valued and 
accessed by IDUs 
Nineteen studies were found relating to key question 3.  Three of these were from the 
UK (1 rating ++, 2 rating +), ten from the USA, one from Australia, two from Canada, 
one from the Netherlands and one from Ireland. One study compared people from 
the UK and the USA. 
 
Evidence statement 3.4a 
There is evidence from two moderate quality (+ rating) UK studies of gender 
differences in patterns of equipment sharing and use of services. Women are 
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less likely than men to share equipment with friends, preferring to share only with 
their sexual partner. Women are also more likely to have negative feelings about 
using pharmacy-based NSPs and to obtain equipment by secondary exchange, 
particularly with their sexual partner. 
 
Evidence statement 3.4b 
There is evidence from three good quality (++ rating) and one moderate quality (+ 
rating) study to suggest that a range of harm reduction interventions (referrals to drug 
treatment and other services; HIV testing; medical care) in addition to needle and 
syringe programmes were accessed  and valued by IDUs. 
 
Evidence statement 3.4c 
There is evidence from three good quality (++ rating) studies, one of which is 
from the UK, and six moderate quality (+ rating) studies, one of which is from the 
UK, that secondary syringe exchange2 is a valued method for obtaining clean 
syringes because it is convenient and relieves the fear of exposure. 
 
 
 
Question 4: Opiate substitution therapies and NSPs. 
Two UK studies (one rating ++, one rating +) were found relating to key question 4. 
However, there was very little data presented in either study about how OST and 
NSPs are used together. 
 
Evidence statement 3.5a 
In two UK studies (one good quality ++ rating, one moderate quality + rating), IDUs 
obtained oral methadone prescriptions from the same pharmacy they used for needle 
and syringe exchange. A need for privacy when collecting needles and taking oral 
methadone was expressed. 
 
 
Question 5: Perceptions of the general public 
Nine studies were found relating to key question 5. Two of these (++ rating) were 
from the UK, five from the USA, one from Australia and one from Canada. 
                                                 
2 where one person exchanges syringes at the NSP on behalf of others 
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Evidence statement 3.6a 
There was evidence from one good quality (++ rating) US study and two moderate 
quality (+ rating) studies, one of which was from the UK, that the general public, 
particularly religious groups, had concerns about the ethics or morality of providing 
syringes and needles to injecting drug users, with some stating that it was helping 
them (IDUs) to harm themselves; others were more concerned that it discouraged 
IDUs from taking personal responsibility for their drug use. 
 
Evidence statement 3.6b 
There was evidence from three moderate quality (+ rating) studies, one of which was 
from the UK, that the general public and IDUs themselves had some concerns about 
the environmental and health consequences (e.g. discarded needles, increased 
crime) of fixed site NSPs. In some cases direct opposition came from a vocal, more 
affluent, minority.  
 
 
 
Question 6: Perception of families and carers 
 
No qualitative studies were found that were conducted with families or carers of 
IDUs, therefore there was no evidence available that related to this question. 
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Main report  
 
1. Background  
 
For a background on health, policy and social implications of needle and syringe 
programmes for injecting drug users, readers should refer to the main effectiveness 
review. 
 
Research Questions 
This review is complementary to the reviews of the evidence of effectiveness and the 
evidence of cost-effectiveness. It aims to provide a more situated narrative 
perspective on the overall guidance questions. With this in mind, the questions in the 
scope were developed to make them more suited to a qualitative review:  
 
1. What do injecting drug users (IDUs) and professionals working with IDUs,  
including service commissioners, identity as suitable types of needle and 
syringe programmes, and what do they believe is the ideal level of coverage?   
Sub-questions considered the impact of the following components: 
• Diversity of the population (e.g. age, gender and ethnicity); 
• Whether or not users are homeless; 
• Type of drugs injected; 
• Patterns of injecting, including who needle and syringe programme (NSP) 
users inject with;  
• Method of injection;  
• Where IDUs acquire needles from (in addition to/in place of NSPs); 
• Whether and how IDUs informally distribute needles, syringes and other 
paraphernalia with other users; 
• Whether and how users choose between multiple local NSPs; 
• The ‘constellation’ or mix of services available; 
• The ‘constellation’ or mix of services desired. 
• IDUs’ involvement in service planning and/or evaluation 
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2. What types of Needle and Syringe Programmes are valued and accessed by 
IDUs?  
Sub-questions considered the impact of the following components on the 
opinions of the included participants outlined above.  
• Providers (including personal characteristics, skill mix and level of 
training/competency of staff) site and size of setting, and commercial 
status of provider (including specialist providers, independent and multiple 
pharmacies); 
• Availability (opening times) and accessibility; 
• Acceptability 
• How able is target group to access services (not just how accessible are 
the services)? 
• Type of injection equipment supplied; 
• Return policy on used equipment; 
• Views on syringe pack components; 
• Beliefs about vulnerability to BBVs and wound site infections; 
• How appropriate to meeting IDUs’ needs. 
 
3. Which additional harm reduction interventions offered by Needle and 
Syringe Programmes are valued (and accessed) by IDUs and professionals 
working with IDUs?  
Sub-questions considered the impact of the following components on the 
opinions of the included participants outlined above.  
• Provision of additional harm-reduction equipment such as filters, mixing 
containers, sterile water; 
• Availability of additional harm-reduction interventions such as advice and 
information on safer injecting practices, treatment for injection-site 
infections, onsite vaccination services, testing for hepatitis B and C and 
HIV, pre- and post-diagnostic counselling, general health advice, and 
primary health care; 
• Provision of spoken vs. printed advice and information; 
• Services which promote, or refer people to, a range of additional support 
services (including drug and alcohol treatment and support services, 
specialist support for those engaged in high-risk injecting methods, 
emergency referrals to secondary care. GP registration, dental care, safer 
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sex/sexual health advice and condom distribution; referral to primary care 
services, and welfare, housing and legal advice); 
• Encouraging current (or employing former) IDUs to pass on sterile and 
unused injecting equipment to their peers. 
 
4. How is opiate substitution therapy (OST) and NSPs (perceived to be) used 
together by IDUs?  
OST is defined as the prescription of substitute drugs for drug dependence, such as 
methadone and buprenorphine for a sustained period (maintenance therapy). Sub-
questions considered the impact of the following components on the opinions of the 
included participants outlined above.  
• Can users formally access OST and needles from the same NSP?  
• Do users formally access OST and needles from the same NSP? 
• Do users informally access OST and needles from the same NSP? 
• What do care providers and users consider to be the advantages and 
disadvantages of integrated services? 
 
5. How do the general public perceive the effectiveness and acceptability of 
NSPs?  
This question considered the perceptions of NSPs of groups including:  
• Local community representatives; 
• Schools; 
• Local councils and local councillors; 
• Local and national media; 
• Voluntary sector. 
 
6. What are the views, experiences and attitudes of carers and families of 
IDUs to NSPs? 
• Effectiveness of NSPs 
• Acceptability of NSPs 
• Information and advice needs (for themselves) 
 
Question six is an additional question, for the review of qualitative evidence only. 
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2. Methodology  
 
2.1 Literature Search  
 
A database of published and unpublished literature was compiled from systematic 
searches of electronic sources and websites and searching reference lists. Relevant 
articles, published since 1990, including literature from all OECD3/1st world countries 
were identified by searching the following sources (see Box 1). 
 
Box 1. Sources Searched 
• Sociological Abstracts 
• International Bibliography of the Social Sciences 
• Web of Knowledge (Social Science) 
• Social Care Online 
• SSCI 
• ASSIA 
• PsycLIT 
• CINAHL 
• MEDLINE 
• ERIC  
• World Health Organisation 
• Joseph Rowntree Foundation 
• King’s Fund 
• National Treatment Agency 
• Drug Organisations (drugs)  
                                  - Lifeline  
                      - HIT  
                      - ADFAM 
                      - Action on Addiction 
                      - Addaction 
                      - Black Poppy 
                      - Exchange Supplies 
                                                 
3 Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, 
Greece, Hungary, Iceland, Ireland, Italy, Japan, Korea, Luxembourg, Mexico, Netherlands, 
New Zealand, Norway, Poland, Portugal, Slovak Republic, Spain, Sweden, Switzerland, 
Turkey, United Kingdom, United States 
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                      - Hepatitis C Trust 
                      - Release 
                      - Drugs Futures 
                     - National Needle Exchange Forum 
                     - UK Harm Reduction Alliance 
                     - International Harm Reduction Association 
 
A search strategy was developed based on the following population and intervention 
keywords (see also Appendix D): 
 
Search keywords 
Population: Substance, drug, abuse, dependence, use, misuse, addict, addiction, 
injection, injecting, intravenous 
 
Interventions 
Needle exchange terms: needle exchange programs, syringe exchange, needle 
exchange, supply, provision, exchange, distribution, dispensing/vending machine, 
mobile, outreach, backpack, drug consumption rooms, safe injecting sites, shooting 
gallery, safe injecting facilities, prison, pharmacy, coverage, provision 
Additional injecting equipment terms: paraphernalia, (injection) equipment, bleach, 
disinfectant, sterile, citric acid 
Harm reduction terms: Harm reduction, preventive health services, referral, peer 
intervention, patient education, counselling, health promotion, safer sex advice, 
vaccination, testing, advice, information 
 
Qualitative terms: phenomeno$, grounded theory, constructionist, thematic 
analysis, observation study, survey, demonstration project, ethnograph$, evaluation, 
perception, experience, understanding, neighbourhood, family, carer, community, 
school, commissioner, commissioning, belief, network(s), distribution, attitudes, 
knowledge, values, motivation, behaviour, access, involvement, participation, 
collaboration, consultation, contribution, stakeholder, user 
 
It was not possible to combine all the search terms in all databases due to limitations 
of some of the search engines, for example, Social Care Online, WHO, Joseph 
Rowntree and Kings Fund only allowed for a limited number of keywords per query 
and as such keywords could not be combined appropriately. All databases were 
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searched from 1990 to March 2008. Search results were exported to an Endnote 
reference manager library for ease of handling. 
 
2.2 Selection of Studies for Inclusion  
 
Inclusion/exclusion criteria 
a. Participants 
Literature was selected that explored the views and perspectives of groups relating to 
the supply and use of injection equipment, including, but not limited to:  
 
• Current and former injecting drug users (IDUs); 
• The families and carers of IDUs; 
• Professionals working with IDUs, including pharmacists, drug workers, 
healthcare providers, GPs, A&E staff, prison staff; 
• Policy makers, service commissioners and budget holders 
 
‘Injecting drug users’ includes those who inject illicit substances, including non-
prescribed anabolic steroids and other performance and image enhancing drugs 
(PIED) and those who inject prescribed opiate substitutes such as methadone. For 
the purposes of this review, studies that include former injecting drug users are 
included. It does not include those people who inject drugs prescribed for a medical 
condition. 
 
For research question 5 we focused on literature that explored the views and 
perspectives of the general public including, but not limited to: 
 
• Local community representatives; 
• Schools; 
• Local councils and local councillors; 
• Local and national media; 
• Voluntary sector. 
 
For research question 6 we focused specifically on families and carers of IDUs. 
 
 16
NSP: Review of qualitative evidence – Full revised report  August 2008 
b. Study design 
Any qualitative design was considered as long as it was judged to be internally 
coherent4 in its methodology. The qualitative elements of mixed methods research 
were also included if they were of sufficient quality.  
c. Outcomes 
Although many qualitative studies are not intervention studies and therefore do not 
include outcomes per se, the following types of themes were of particular interest: 
 
• Beliefs, attitudes, knowledge and skills;  
• Preferred NSP structure, location and service provision;  
• Barriers to treatment; 
• Barriers to safe disposal; 
• Patterns of needle and syringe acquisition/disposal; 
• Injecting and related risk behaviours;  
• Views, attitudes and experiences of those using (or choosing not to use) 
needle and syringe programmes;   
• Views and attitudes of carers, families, drugs professionals and the 
general public; 
• Views on, and histories of, drug-related violence, crime, prosecutions, 
incarcerations and anti social behaviour; 
•   Drug-related hospitalisation 
 
Screening of electronic search results was carried out by two reviewers 
independently, with discussion over uncertainties.  If either reviewer was unsure 
about whether to obtain a full paper, it was obtained.  Selection of studies from full 
papers was carried out by two reviewers independently, with disagreements being 
resolved by consensus and, if necessary, consultation with a third reviewer. 
 
 
2.3 Quality Appraisal  
 
Data relating to both study design and quality were extracted by one reviewer into 
Word tables and independently checked for accuracy by a second reviewer.  
Disagreements were resolved through consensus and if necessary a third reviewer 
was consulted.  Time constraints did not allow us to contact authors for missing data.  
                                                 
2. Was it appropriate as a qualitative study design? Was the intended study design 
followed through i.e. was it conducted and analysed qualitatively? 
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The quality of the studies was assessed according to the NICE Centre for Public 
Health Excellence Methods Manual. Each of the studies was graded using a code, 
[++], [+] or [–] based on the extent to which the papers were judged to meet the 
validity criteria set out in the CPHE tool, where [++] represents the highest level of 
internal coherence and [–] is the least.   
It should be noted that validity cannot be measured or tested in qualitative research 
as in quantitative research. Validity and reliability are therefore addressed using a 
range of other tools, such as respondent validity, triangulation or ‘good research 
practice’ (Ritchie and Lewis 2003; Silverman 2006)5 
 
2.4 Study categorisation  
 
In this review, all included studies use qualitative methods. We have noted which 
studies used semi-structured or in-depth interviews or focus groups, and which 
studies used ethnographic or observation methods. Mixed methods studies (that 
used both quantitative and qualitative methods) were also included. Qualitative 
surveys that were analysed quantitatively were excluded on the grounds of lack 
of internal coherence.   
 
2.5 Assessing applicability  
 
The studies were graded for applicability to the population and settings defined 
above, using the existing grading from A to D, where A is the most applicable and D 
the least.  See table 1 below: 
 
Table 1: Applicability grading 
Applicability grade Description 
A Studies carried out with IDUs and related professionals or 
stakeholders in the UK 
B Studies carried out in non-UK countries that have similar 
legislation and policy to the UK (e.g. Canada);  
                                                 
5 Ritchie, J. and J. Lewis, Eds. (2003). Qualitative Research Practice. A Guide for 
Social Science Students and Researchers. London, Sage Ltd. 
Silverman, D. (2006). Interpreting Qualitative Data: Methods for Analyzing Talk, Text 
and Interaction. London, Sage. 
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C Studies with relevant data carried out in non-UK countries 
that do not have similar legislation and policy (e.g. USA) 
D Studies containing very little relevant data carried out in non-
similar non-UK countries (e.g. USA) 
 
2.6 Synthesis  
 
The results of the data extraction and quality assessment for each study are 
presented in structured tables (Appendix C) and summarised narratively and in short 
tables by key question.  Evidence statements are presented which take into account 
the strength and the applicability of the evidence for each key question and sub 
question. 
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3. Summary of Findings  
3.1 Overall summary of studies identified  
 
The electronic searches identified 3371 potentially relevant articles.  258 were 
ordered and 234 were obtained as full papers by the cut off date and screened 
for inclusion. Of these 194 were excluded: 133 did not use qualitative methods; 
46 did not pertain to needle and syringe programmes, 11 were from a non-first 
world country and four were non-English language.  A list of excluded studies 
with reasons for exclusion can be found in Appendix B.  We were unable to 
obtain 24 papers: these are listed in Appendix E.  
Figure 1: Flowchart showing process of study identification 
Results of 
literature 
Searches 
n=3371
Titles and abstract  
screening 
n=258 
Assessed for 
inclusion 
(full paper) 
n=234 
Not available 
n=24 
Excluded 
n=194 
Studies meeting 
inclusion criteria 
n=40 
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Forty studies were included in the review. Of these, 10 were from the UK, 20 from 
the USA, five from Canada, two from Australia, and three from other European 
countries.  38 used interview or focus group methods and 17 used ethnographic 
or observation methods (some studies used both).   
 
Ten studies were assessed of being as good quality (++ rating); of these three 
were from the UK.  Twenty-five studies were assessed as being of moderate 
quality (+ rating); five of these were from the UK and one included people from 
the UK and the USA. Five studies were of poor quality (- rating); one of these was 
from the UK.  Common barriers to validity included poor reporting of sampling 
strategy, data collection and analysis methods. Frequently the actual research 
process was either not described at all or so poorly reported that it was not 
possible to make any judgements about validity. In addition, the theoretical 
underpinning was rarely mentioned. There were several studies that, despite 
using qualitative methods to collect data, presented only quantitative data in their 
findings, and so were excluded from the review. In a substantial proportion (25%) 
of included studies, the data presented was not rich, lacking illustrative quotes 
and/ or context. Some of these issues may be due to editorial limitations on 
space or word count in journals, rather than poor conduct of the research, but 
without these details it is not possible to judge whether the omissions are due to 
poor reporting or poor quality research, and, without details of the included 
sample, it is difficult to decide whether the findings are generalisable. 
 
Many of the included studies addressed more than one of the key questions and 
there was considerable overlap between questions and subquestions as 
originally posed. In order to avoid repetition as much as possible we have tried to 
include information only once in the narrative summary and cross-reference to 
other questions where the same information is relevant. 
 
Ten UK studies received applicability grading A (most applicable), nine Canadian, 
Australian or European studies received grade B, 17 US studies and one 
Australian study received grade C and three US studies that contained very little 
relevant data were ranked grade D. 
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3.2 Key question (1)  
What do IDUs and professionals working with IDUs,  including service 
commissioners, identify as suitable types of needle and syringe programmes, 
and what do they believe is the ideal level of coverage?   
 
3.2.1 Narrative summary  
Two US studies were found relating to key question 1 (Downing 2005, Kelley 
2005).  Both examined implementation of NSPs from the point of view of 
stakeholders and providers. 
 
Quality assessment 
Both included studies were rated as being of moderate quality (+ rating).  Both 
were assessed as having a clear research objective for which a qualitative study 
design was appropriate.  Both presented rich data and findings that were judged 
to be credible and relevant, with plausible conclusions.  Details of the data 
collection and analysis processes and the role of the researcher(s) were poorly 
described in both studies. In Downing 2005, no details were given of sampling 
strategy at an individual level, and the context was not described, which limits the 
generalisability of the findings. In Kelley 2005, reporting of consent and ethics 
procedures was poor. 
 
Findings: implementation 
Two moderate quality (+ rating) US studies interviewed stakeholders and 
providers about the process of implementing NSPs (Downing 2005, Kelley 2005). 
Downing 2005 (C+) identified three models for formation of a NSP: community 
coalition, community activists or top down from government.  All had strengths 
and weaknesses and the strongest programmes were able to move from one 
model to another as required. Other features associated with successful 
programmes were: knowledge; staging the debate with sensitivity to political and 
cultural norms; coalition building and community involvement; strong leadership; 
access to resources; use of research; overcoming fear. 
 
In Kelley 2005 (D+) it was seen that when a programme moved from being illegal 
to having legal status, although access to resources and other physical issues 
were greatly improved, many motivating factors for providers, such as participant 
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management, personal responsibility to clients, and even deviant status, were 
removed, which reduced the sense of belonging among providers. This study 
was not very relevant to the UK, where historically NSPs are supported by 
government policy and specialist organisations (e.g. National Treatment Agency). 
 
The two studies included in key question (1) did not contain any information 
about the impact of: population diversity; whether or not users were homeless; 
type of drugs injected; patterns of injecting; method and site of injection; where 
else needles are acquired from; whether and how equipment is informally 
distributed; whether and how IDUs choose between multiple local NSPs; 
constellation or mix of services available or desired; involvement of IDUs in 
service planning and/ or evaluation.  However, some of the studies included in 
key question (2) did contain some information pertinent to these subquestions, 
and these are therefore discussed under key question (2). 
 
3.2.2 Evidence statement 3.2  
a. There is evidence from one moderate quality (C + rating) US studya  that 
features of a successful NSP include: flexibility in process and management 
models; knowledge; coalition building and community involvement; strong 
leadership; staging debate with sensitivity to political and cultural norms; access 
to resources; use of research; overcoming fear. 
a Downing 2005 
 
 
 
 
NSP: Review of qualitative evidence – Full revised report  August 2008 
Summary Table: Qualitative evidence for key question 1 
 
Author (Year) 
 
Design Population Outcomes Quality Applicability 
Downing 2005 Qualitative interviews 
with key informants.  
Extended interview  
Semi-structured 
interview  
 
US 
 
17 interviews with Public health 
officials, HIV prevention and drug 
treatment providers, researchers, 
policy makers, staff of community 
based organisations and activists 
 
Three implementation models were identified:  
1. NSPs established by community coalitions.  
2. NSPs established by community activists.  
3. NSPs established top down by govt. authorities.  
Successful implementation sometimes involved movement from 
one model to another as appropriate. 
Six strategies and resources were identified as characterising 
successful implementation of an NSP. 
 
+ C 
Kelley 2005 Survey 
Evaluation  
Case study  
Extended interview  
Observation 
(Participant)  
Appraisal of attitudes, 
beliefs and values 
 
San Francisco, US 
 
Needle and syringe programme 
 
56 Service providers at the needle 
and syringe programme 
 
The illegal nature of the operations was an attractive element of 
the experience for many and enhanced identification with the 
clients they were serving. The clandestine nature of the work also 
served to strengthen bonds among the providers. 
 
While the organisational transition fulfilled many of the positive 
practical expectations of the volunteers many of the motivating 
factors or ‘ideational rewards’ such as participant management, 
personal responsibility to the needs of the clients and even the 
deviant status of the group were removed. This reduced the 
volunteers’ sense of belonging. Many volunteers continued to 
participate however 
+ D 
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3.3  Key question (2)  
What types of Needle and Syringe Programmes are valued and accessed by 
IDUs?  
 
3.3.1 Narrative summary  
 
Thirty-one studies were found relating to key question 2. Eight of these were from 
the UK (Barnard 1993, Clarke 2001, Hay 2001, Matheson 1998, Matheson 1999, 
Neale 1998, Rhodes 2007, Power 1996), 14 from the USA (Buchanan 2003, 
Cooper 2005, Finlinson 2000, Junge 2000, Larkins 2000, Lewis 1996, Moore 
1995, Murphy 2004, Singer 1995, Somlai 1999, Springer 1999, Strenski 2000, 
Voytek 2003, Weiker 1999), five from Canada (Spittal 2003, Strike 2002a, Strike 
2002b, Strike 2004, Strike 2005), one from Germany (Jacob 2000), one from 
Australia (Miller 2001) and one from Ireland (Long 2004). One study compared 
service IDUs from the UK and the USA (Phillips 2007). 
 
Three UK studies (Barnard 1993, Neale 1998, Power 1996) examined IDUs’ beliefs 
and attitudes related to injecting behaviour and needle sharing. One US study 
reported NSP staffing as one of the issues covered in interview (Weiker 1999 D-); 
six studies (2 UK, 3 US, 1 Canadian) reported IDUs’ preferences for sources of 
needles and syringes. Six studies focused on the pharmacy as a means of 
needle exchange (5 UK). Barriers to using NSPs were discussed in 12 studies (4 
UK, 7 US, 1 Australian); in addition, two Canadian studies discussed location of 
NSPs and another two Canadian studies discussed exchange policy.  Two US 
studies mentioned IDUs’ sense of place in the community related to NSPs, and 
there were two studies of NSPs in prisons: one an evaluation of NSPs in prisons 
in Germany and one an examination of Irish prisoners’ attitudes towards NSP. 
 
Quality assessment 
Six (Finlinson 2000, Long 2004, Matheson 1998, Matheson 1999, Moore 1995, 
Power 1996) of the 31 included studies were rated ++ (good quality). Three of 
these (Matheson 1998, Matheson 1999 and Power 1996) were from the UK. The 
two Matheson (1998, 1999) studies were pharmacy-based. In five of the six ++ 
rated studies, all of the quality assessment criteria on the CPHE checklist were 
judged to have been adequately met. In Matheson 1999, details of ethics and 
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consent procedures and the role of the researcher were not clearly described, but 
these were thought unlikely to have a significant impact on the study findings. 
 
Of the remaining studies, five (Hay 2001, Junge 2000, Larkins 2000, Somlai 1999 
and Weiker 1999) were rated – (poor quality) and twenty were rated + (moderate 
quality).  Larkins 2000 was published only as an abstract therefore many details 
were missing. In the other four studies, very few details of methodology were 
provided. 
 
Reporting of consent and ethics procedures was poor in eight (Barnard 1993, 
Miller 2001, Neale 1998, Springer 1999, Strike 2002b, Strike 2004, Strike 2005, 
Voytek 2003) of the 20 + rated studies. In Strike (2002b) it was unclear to the 
reviewers whether the study’s conclusions were plausible (due to missing data). 
In one study (Murphy 2004) the research objectives were unclear. In ten studies 
(Clarke 2001, Cooper 2005, Lewis 1996, Murphy 2004, Neale 1998, Rhodes 
2007, Strike 2002b, Strike 2004, Strike 2005, Voytek 2003) insufficient detail of 
data collection was given or it was unclear whether the methods used were 
reliable; in fourteen studies insufficient detail of data analysis was given or it was 
unclear whether the methods used were reliable (Barnard 1993, Buchanan 2003, 
Clarke 2001, Jacob 2000, Lewis 1996, Miller 2001, Murphy 2004, Neale 1998, 
Singer 1995, Spittal 2003, Springer 1999, Strike 2002b, Strike 2004, Voytek 
2003).  Three studies did not report sufficient detail of context (Murphy 2004, 
Rhodes 2007, Strike 2005), in five studies the data reported was poor or unclear 
(Clarke 2001, Lewis 1996, Neale 1998, Phillips 2007, Strike 2002a) and in two 
studies the reviewers were not sure whether the data were credible (Clarke 2001, 
Strike 2002b). 
 
Reasons for sharing 
Situational factors i.e. the immediate availability of a syringe when drugs are 
available, was said to play a more important role than the availability of a NSP in 
three UK studies: even a short distance to walk can seem too far when someone 
is desperate to inject:  “I know it’s not a long walk, just a 15 minute walk… but I 
mean for a drug addict… when they’ve got their tack sitting right there, you would 
rather use somebody else’s needle than have to walk all the way to get it” (Neale 
1998 A+). Most often it was the case that drugs were immediately available when 
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clean equipment was not and IDUs would use the nearest available needle and 
syringe rather than risk losing the “hit”.  (Barnard 1993 A+, Power 1996 A++, 
Neale 1998 A+).  In one UK study male and female IDUs believed there was no 
additional risk if sharing syringes with a sexual partner (Power 1996 A++). In 
another UK study a difference between genders in sharing patterns was noted: 
women were more likely to share with sexual partners only than with others, while 
men were more likely to share with friends than women were (Barnard 1993 A+) 
 
In two UK studies (Power 1996, Neale 1998) the majority of IDUs did not realise that 
sharing other drug paraphernalia (e.g. filters, spoons and water) are also high risk 
activities. 
 
Preferences 
Staffing of NSPs 
In a US study, use of peers (IDUs) as staff on NSPs was found to increase 
engagement of clients with the NSPs although recruitment and training of peer 
staff was said to be time consuming (Weiker 1999 D-). 
 
Single versus multiple sources 
Preferences for obtaining syringes may be dependent on the social 
circumstances of the user: one US study found that IDUs from more affluent 
neighbourhoods were more likely to obtain syringes from a single source than 
multiple sources, more likely to inject alone in a private place than publicly, and 
more likely to dispose of syringes in a garbage can than in alleys or dumpsters 
(Buchanan 2003 C+). 
 
Buying equipment versus exchange 
In one US study IDUs reported that buying equipment from sellers (who may 
themselves have obtained it from a NSP) was quicker and easier than obtaining it 
from a fixed site NSP, although the cost may be prohibitive (Finlinson 2000 C++). 
A UK study similarly reported that IDUs would rather buy equipment from fellow 
users (who themselves obtain it from NSPs) than fixed site NSPs (Power 1996 
A++).  A Canadian study reported that some users preferred to obtain equipment 
from NSPs because it is free while others preferred to buy it over the counter for 
convenience and anonymity (Strike 2005 B+).  Three behaviours were noted in 
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obtaining equipment: stockpiling large quantities, often for secondary exchange 
(more common in those with stable living arrangements); maintaining 1-2 weeks 
supply; or obtaining equipment as needed (linked to less stable living 
arrangements, lack of planning, or fear of arrest for carrying used drug 
paraphernalia, Strike 2005 B+).  One UK study reported that IDUs obtained 
equipment from multiple sources (Hay 2001 A-).  In one US study where users 
were asked about syringe disposal methods, NSPs were preferred to other 
disposal methods, namely syringe collection programmes (accumulation of used 
syringes in a container which is then thrown away) or one way disposal boxes 
(Springer 1999 C++).  
 
Pharmacies 
Six studies focused on the pharmacy as a means of needle exchange (Clarke 
2001, Lewis 1996, Matheson 1999, Neale 1998, Power 1996, Rhodes 2007); five 
of these were from the UK.  Pharmacies were rated more highly than drug 
agency based NSPs by IDUs for accessibility (3 UK studies Power 1996 A++, 
Clarke 2001 A+ and Neale 1998 A+) although the opening hours could still be a 
problem (UK study Neale 1998 A+) but agency based NSPs were rated higher for 
receiving advice and information (UK study Clarke 2001 A+). From the point of 
view of pharmacists, those interviewed were largely willing and committed to 
providing NSPs (2 UK and 1 US studies Matheson 1998 A++, Clarke 2001 A+ 
and Lewis 1996 C+) and preferred the concept of exchanging rather than selling 
syringes (UK study Matheson 1998 A++, US study Lewis 1996 C+).  Pharmacists 
in South London, UK reported poor or non-existent links with local drug 
agencies6, although five of a sample of nine pharmacists in one study had 
received training from the local drug and alcohol team (Clarke 2001 A+).    
Pharmacists in the UK and the USA had business related concerns about running 
a NSP: they worried about negative effects on other customers (US study Lewis 
1996 C+; UK studies Clarke 2001 A+ and Matheson 1999 A++) and 
“encouragement” of other drug users to “indulge even more” (UK study Matheson 
1999 A++).  In the USA, pharmacists had additional concerns about legality of 
NSPs (Lewis 1996 C+) and some pharmacists (those who did not sell syringes) 
were also concerned about ‘supporting drug abuse’ (Lewis 1996 C+).  
                                                 
6 Each English DAAT/PCT should have a dedicated pharmacy lead that liaises with pharmacy 
NSP, and in some cases a pharmacy coordinator as well. 
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From the point of view of UK IDUs, a good pharmacy was stated to be one with 
good staff attitudes, although definitions of this varied, with some users preferring 
pharmacists to be ‘strict’ about dispensing equipment and others valuing discreet 
service, provision of advice or flexibility more (Matheson 1998 A++). Many did not 
want a prolonged conversation with staff and expressed a need for privacy 
(Matheson 1998 A++). In another UK study a dedicated NSP was preferred to 
pharmacy based NSPs due to fear of exposure, shaming and staff attitudes at the 
pharmacy (Rhodes 2007 A+). Female IDUs were more likely than male IDUs to 
have negative feelings about pharmacy based NSPs in one UK study (Neale 
1998 A+), this was thought to be due to embarrassment and a fear of being 
recognised and exposed.  IDUs identified a need for improved publicity about 
services offered in UK pharmacies (Neale 1998 A+). 
 
Barriers to use of NSPs 
In addition to, and building on, barriers mentioned above, fear of public exposure, 
either to police, co-workers, neighbours or family members and associated issues 
of shame was a barrier reported in one UK and three US studies (Rhodes 2007 
A+,  Strenski 2000 C++, Murphy 2004 C+, Voytek 2003 C+). Women and 
professionals were particularly concerned about exposure. In the USA, law 
enforcement issues presented a barrier to use of NSPs, with IDUs fearing arrest 
(Somlai 1999 C-, Strenski 2000 C++, Springer 1999 C++, Voytek 2003 C+) 
leading to an inhibition of their capacity to engage in harm reduction (Cooper 
2005 C++). Users were more willing to risk arrest by carrying used equipment for 
exchange rather than for disposal only (Voytek 2003 C+).   
 
Issues of personal safety were found to be a concern in one US study (Strenski 
2000 C++) as IDUs feared being robbed by non-NSP-using IDUs after visiting the 
NSP.  Another prominent theme was (in)convenience, either due to location  of 
the NSP (two UK and two US studies: Finlinson 2000 C++, Neale 1998 A+, 
Power 1996 A++, Voytek 2003 C+), queues (US study: Voytek 2003 C+) or 
opening hours (two UK, one US and one Australian studies: Finlinson 2000 C++, 
Hay 2001 A-, Miller 2001 C+, Neale 1998 A+).  In one US study, IDUs reported 
that for these reasons they preferred to use street sellers, although the price 
could then be prohibitive (Finlinson 2000 C++). 
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Location of NSP 
One Canadian study (Strike 2002a B+) reported that in fixed sites, location, adequate 
space and opening hours are seen as constraints that can negatively impact on client 
development and retention. Negative attitudes can reduce programme attendance. 
Fixed sites can also attract local opposition. Mobile NSP services on the other hand 
are believed to increase accessibility for clients who prefer to exchange in evening 
hours, do not have a vehicle or money to travel and/ or cannot travel, although 
mobile services are viewed as insufficient for incorporating other harm reduction 
interventions. There were perceived problems with using satellite sites including 
satellite agency staff not following NSP service guidelines, and refusal to act as 
satellite sites due to rejection of harm reduction principles. Perceived benefits of a 
home visit model included accessibility and credibility of the NSP. Workers who were 
former IDUs were more accepting and comfortable with this mode of delivery than 
other workers. 
 
Another study by the same authors (Strike 2004 B+) reported that where NSPs 
are housed in ‘parent’ organisations (e.g. public health units or AIDS service 
organisations) this can lead to negative effects: on the one hand the parent 
organisations may perceive the NSP and/ or IDUs as ‘non-core’ and 
‘undesirable’; on the other hand IDUs may be put off attending the NSP by stigma 
associated with the parent organisation (e.g. AIDS-related) or by a perception of 
the parent organisation as being too clinical. 
 
Exchange policy 
In the two Canadian studies that reported on exchange policy (Spittal 2003 B/C+, 
Strike 2002b B+) it was seen that the one-for-one exchange policy was dominant, 
particularly in more recently established programmes (Strike 2002b B+) but that 
policies became more lenient over time, as increased access to needles (needles 
as objects of ‘prevention’ rather than ‘risk’) became the main focus of the 
programme and as relationships were formed between providers and clients. 
 
Sense of community 
In two US studies, IDUs mentioned the place of NSPs in the community, either by 
expressing the hope that NSPs would lead to greater acceptance in the 
community of drug use as a medical issue (Somlai 1999 C-) or by expressing a 
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sense of ownership and of wanting to give something back (Moore 1995 C++), 
feelings that were not translated into broader action due to poor living and social 
conditions. 
 
Prisons 
One study examined two NSPs in two prisons in Germany (Jacob 2000 B+).  
Anonymity was seen as important by IDUs within the prisons, which was 
dependent on the mode of delivery: the NSP that used a vending machine was 
more popular than the one that used hand to hand exchange.  NSPs were more 
likely to be accepted by prison staff if they played an active part in planning and 
decision making processes. 
 
One study found support among prisoners (both IDUs and non-IDUs) for NSPs 
but also opposition, again from both IDUs and non-IDUs. Perceived benefits of 
NSPs were reduction in infection; perceived risks were safety and increased drug 
consumption (Long 2004 B++).   
 
Summary 
Prominent themes in key question (2) were: use of pharmacies; fear of exposure; 
fear of arrest (non-UK studies). In the UK, pharmacies were preferred to agency 
based NSPs for accessibility (opening hours and locations) while agency based 
NSPs were preferred for advice and information and, for some IDUs, there was 
felt to be less risk of shaming (due to negative staff attitudes and/ or 
embarrassment and exposure) at the agency based NSPs. Fear of exposure was 
particularly prominent for women and ‘professional’ IDUs and was lessened by 
using agency based rather than pharmacy based NSPs and by secondary 
syringe exchange or buying equipment from street sellers. 
 
Fixed site NSPs were found to be preferable (by providers) for providing a range of 
services in addition to NSP, but could attract local opposition or be viewed negatively 
by IDUs when based in parent organisations. Mobile NSPs were thought to increase 
accessibility for clients but could not offer the full range of services. Exchange 
policies became more lenient as NSPs became more established. Use of peers 
(IDUs) as staff on NSPs was found to increase engagement of clients with the NSPs 
although recruitment and training of peer staff was said to be time consuming 
(Weiker 1999 D-). In Singer 1995, an important product of the informal relationship 
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between NSP staff and clients was reported to be the significant level of program 
recruitment by satisfied users. Informal conversations provided a foundation for the 
collection of attitudinal and life history data on IDU for evaluation purposes. 
 
Accessibility of NSPs was related not just to opening hours, location and fixed versus 
mobile sites, but also to fear of exposure and shaming and to staff attitudes. 
 
There was no information in included studies about type of equipment supplied or 
views on syringe pack components. 
 
Not all the included studies reported even basic demographic details such as age, 
sex and ethnicity of study participants. Of those that did, women were more likely 
than men to use secondary exchange and to have negative feelings about using 
pharmacy-based needle and syringe programmes, due to fear of exposure as a drug 
user and more negative and stigmatised perceptions of female drug users by male 
drug users and the general population. 
 
Most included studies did not report on the living arrangements of participants.  Of 
those that did, two mentioned ways in which less stable living arrangements can 
have an impact on patterns of syringe acquisition and disposal and consequently 
increased levels of risk.   
 
Very little information was provided in the included studies about types of drug 
injected, methods or sites of injection, and almost none about what impact this would 
have on perceptions of suitable types of NSPs. 
 
3.3.2 Evidence statement 3.3  
 
a.  There is evidence from one good quality (++ rating) UK studya and two 
moderate quality (+ rating) UK studiesb to suggest that immediate availability 
of injecting equipment is more important to injecting drug users than 
perceptions of risk associated with injecting behaviour. 
 
b.  There is evidence from two good quality (++ rating) UK studies c and three 
moderate quality (+ rating) studies, two of which are from the UK,d that 
pharmacy-based needle and syringe programmes are popular with injecting 
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drug users. Pharmacies were rated more highly than drug agency based 
NSPs for accessibility in 3 UK studies, although in another 2 UK studies, 
embarrassment, negative staff attitudes and fear of exposure were associated 
with negative feelings about pharmacy based NSPs, particularly among 
women. Agency based NSPs were rated more highly than pharmacies for 
advice and information. 
 
c. There is evidence from one good quality (++ rating) UK study, one good 
quality (++ rating) US studye, one moderate quality (+ rating) UK study, two 
moderate quality (++ rating) US studiesf and one poor quality (- rating) UK 
studyg to suggest that convenience or otherwise (specifically opening hours, 
location and queues) of NSPs are very important to IDUs and can influence 
decisions on whether to obtain equipment from them or from street sellers or 
secondary exchange. 
 
d. There is evidence from two good quality (++ rating) studies, one of which is 
from the UKh, and seven moderate quality (+ rating) studies, two of which are 
from the UKi, to suggest that IDUs are not a homogeneous group: there are 
different cultures, some of whom disapprove of others’ drug using behaviours and 
some of whom are more affluent than others.  Fear of being caught and publicly 
exposed as a drug user (to police (USA studies), neighbours or family (UK 
studies)) is a prominent theme and can impact upon use of NSPs and other 
services, with some IDUs preferring secondary syringe exchange for this reason.  
 
e. There is evidence from one good quality (++) qualitative study that prison-
based NSPs may find support but also opposition, both among IDUs and non-
IDUsj. There is evidence from one moderate (+) quality qualitative study that 
anonymity was seen as important by IDUs in relation to prison-based NSPsk. 
 
a Power 1996 
b Barnard 1993, Neale 1998 
c Matheson 1999, Power 1996 
d Clarke 2001, Lewis 1996, Neale 1998 
e Power 1996, Finlinson 2000 
f Neale 1998, Voytek 2003, Miller 2001 
g Hay 2001 
h Matheson 1998, Strenski 2000 
i Buchanan 2003, Murphy 2004, Neale 1998, Spittal 2003, Strike 2005, Voytek 2003 
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j Long 2004 
k.Jacob 2000 
 
  
NSP: Review of qualitative evidence – Full revised report  August 2008 
Summary table: evidence for key question 2  
Author (Year) 
 
Design Population Outcomes Quality Applicability 
Barnard 1993 Qualitative:  
Ethnographic study 
Extended interview  
Observation 
 (Passive/Participant)  
Short standard  
schedule(structured) :  
variable depending on  
time and willingness of 
  participants 
 
Glasgow, Scotland. 
 
Drug injectors in two treatment 
centres, a needle and syringe 
programme centre 
and a  local pharmacy providing 
sterile injecting equipment. 
Injectors and non injectors around 
the streets (community) 
 
122 men and women 
 
Availability does not have an important part to play in the creation 
of some of the situations where needle sharing takes place, but it 
thus can only constitute a part of the explanation as instances of 
sharing was shown to be highly situationally  variable. 
 
Patterns of sharing between injectors highlighted sharing as 
rarely being an indiscriminate activity but one which frequently 
follows a pattern of sociability quite closely. So also author 
critically commented on gender distinct nature of the social 
activity which suggests that the risks of HIV infection are 
differently focussed for men and women 
+ A 
Clarke 2001 
 
Qualitative semi-
structured and 
structured interviews 
South London, UK 
 
155 needle and syringe 
programme clients and 9 
community pharmacists 
 
90% of IDUs had never asked pharmacists for advice 
about drug use. Clients rated pharmacies higher for being 
open when needed and easy to get to, but drug agencies 
were rated higher for receiving advice and information. . 
Most pharmacists reported poor or non-existent links with local 
drug agencies. Just over half had received training from the local 
drug and alcohol team 
+ A 
Matheson 1998 Descriptive study with 
evaluation (qualitative 
study) 
Semi-structured 
interview 
Observation 
(Passive/Participant)  
Appraisal of attitudes, 
beliefs and values 
 
Aberdeen, Dundee, Edinburgh, 
Glasgow and adjacent rural areas/ 
Scotland 
 
124 illicit drug users interviewed in 
23 pharmacies and 8 drug 
agencies 
 
Most frequently mentioned feature of a good pharmacy is the 
characteristics and attitude of the pharmacists or staff at the 
pharmacy. 
Many of the respondents did not want to enter a prolonged 
conversation with the staff. 
A good process was seen as one which was discreet, flexible, 
strict or if advice was offered. 
The need for privacy was mentioned by 6 respondents to reduce 
embarrassment faced by them and other customers, particularly 
w.r.t. supervised methadone. 
++ A 
Matheson 1999 
 
Descriptive study with 
evaluation (qualitative 
study) 
Extended interview  
Semi-structured 
interview  
Appraisal of attitudes, 
beliefs and values 
Scotland 
 
45 Pharmacists. 
Interviewed at work place through 
telephone interviews 
 
Two thirds of the participants sold or will sell needles and 
syringes. 
Among those not willing to sell, the reason often given was from 
concerns about the negative effect on other customers and the 
encouragement of other drug users. 
Several participants considered that NSP was an appropriate 
service and the reducing of injecting equipment sharing and 
communicable diseases was a motivating factor. 
++ A 
Neale 1998 Qualitative study Scotland, UK Broad support for increased availability of sterile injecting + A 
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 examining drug users 
attitudes and behaviour  
Descriptive study with 
evaluation (qualitative 
study) 
Semi-structured 
interview 
Appraisal of attitudes, 
beliefs and values 
Appraisal of knowledge, 
skills and behaviour 
 
Pharmacies and drug agencies 
124 illicit drug users 
 
 
equipment. Problems of accessibility in relation to geographical 
location of services and opening hours.  
A need for improved publicity about services offered in 
pharmacies. 
Motivations for sharing were mostly situational. 
Female respondents were disproportionately more likely to 
experience negative feelings regarding using a pharmacy to 
access/dispose of injecting equipment. 
Secondary syringe exchange was described by some 
respondents. 
No consensus regarding preference for pharmacy or dedicated 
needle and syringe programmes. 
 
Power 1996 Descriptive study with 
evaluation (qualitative 
study) 
Survey 
Semi-structured 
interview  
Observation 
(Participant)  
Ethnographic study 
 
London, semi-rural area and 
Midlands town /UK 
 
Field sites, research centres (work 
place), semi-public venues (pubs 
and cafes) and private homes. 
 
70 Injecting drug users 
 
IDUs adopted a variety of strategies to avoid risks associated 
with injecting. Respondents would rather buy a syringe from 
fellow colleagues who are in direct contact with NSPs over fixed 
site NSPs. Respondents preferred to use pharmacies than NSPs 
because of the distance  
The awareness of the risk of sharing needles was high. Re-used 
syringes are often stored in a secured place at home. Cleaning 
was another strategy mostly by flushing with water, if sharing 
more rigorous methods of cleaning such as bleaching will be 
used. 
Respondent believed that no additional risk was involved if you 
shared your needle with your sex partner, some were prepared to 
share the risk of HIV infection with their intimate partner, syringe 
availability was also a factor in determining risk management. 
 
++ A 
Rhodes 2007 Descriptive study with 
evaluation 
Semi-structured 
interview  
Appraisal of attitudes, 
beliefs and values 
South Wales, UK  
 
The interviews were conducted in 
six locations, This enabled data to 
be collected from urban, semi-rural 
and rural settings. 
 
49 active IDUs 
Respondents made a distinction between themselves as 
responsible, more hygienic drug users and irresponsible 
‘smackheads’, with responsible users safely disposing of not only 
their needles, but sometimes those discarded in public spaces as 
well. 
Accessing dedicated needle and syringe programmes was 
preferred to pharmacy based exchanges. Using pharmacy based 
services risked public exposure as an IDU and was also linked to 
shaming, both in being overheard when being served and in the 
way IDUs are treated by the staff. 
 
+ A 
Phillips 2007 Qualitative: Appraisal of 
attitudes, beliefs and 
values 
Structured interview with 
open ended questions 
 
Two samples: 
Nottingham, England; Northwest 
Ohio, USA. 
 
UK sample: Recruited from an 
outpatient drug clinic or inpatient 
Large proportion reported acceptance of various abstinence-
oriented treatments and harm reduction interventions. Only 15% 
of US sample found safer injection facilities acceptable 
 
Needle and syringe programme rated as acceptable by more 
than two thirds of both samples, the English sample had much 
- A 
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detoxification ward. 48 clients (35 
men / 13 women) 
 
US sample: Recruited from an 
inpatient residential program for 
women. 40 female clients 
 
greater experience of it). Most frequently reported advantage was 
disease prevention. Among the UK sample the most frequently 
reported disadvantage was harm to the larger community (from 
inappropriate disposal of syringes); also encouraging a shift from 
smoking to injecting. 
 
Hay 2001 Qualitative: 
Mixed methods: 
1. Descriptive study with 
evaluation (qualitative 
study) 
2. Survey 
(Questionnaire) 
3. Audit/Evaluation  
 
Scottish  city-centre needle and 
syringe programme which covers 
the whole of the city (limited 
needle exchange provision by 
retail pharmacies) 
 
10 clients of needle and syringe 
programme  
5 staff of needle and syringe 
programme  
 
Significant minority of clients only attend once or twice a year. 
Interviews explored potential reasons for this, including:  
Whether clients were providing false identifying details. This was 
thought by clients and staff to not be a problem. 
Injecting on an infrequent basis. Staff thought that this could be a 
potential explanation for infrequent attendance. 
Use of alternative sources of accessing sterile injecting 
equipment.  Staff and clients confirmed that alternative sources 
were used. 
Opening hours. It was noted that the needle and syringe 
programme normally closed at 5pm and was open until 8pm only 
one day per week. 
 
- A 
Jacob 2000 
 
Audit/Evaluation 
Local practice report  
Appraisal of knowledge, 
skills and behaviour 
Half standardized 
longitudinal examination 
Qualitative examination  
Lower Saxony/Germany 
Male and female prison 
 
224 male and female prison 
inmates, 153 staff of drug 
counselling service and health 
care unit, 75 members of external 
organizations (AIDS-Help-Groups) 
 The level of acceptance among prisoners largely depends on 
whether anonymity is maintained during needle exchange which 
can largely be affected by the mode of delivery. 
The level of acceptance among prison staff depends on whether 
staff members could identify with the goals of the project, whether 
they could actively participate in the planning and decision 
making processes and in setting the implementation modalities 
+ B 
Long 2004, Qualitative: Semi-
structured interview; 
Appraisal of attitudes, 
beliefs and values 
 
Dublin, Ireland: 
31 male prisoners. 16 were 
injecting drug users and 15 were 
non injectors 
Two key themes are identified: injectors take risks inside prison 
that they would not if they were outside; and there is support 
among prisoners for interventions to address drug misuse.  
 
Opinions on the provision of a needle and syringe programme in 
prison are divided, with some support coming from both injectors 
and non-injectors, and an equal number of each rejecting the 
idea. The potential to reduce infection is acknowledged and 
concerns relate to safety and the possibility of increased 
consumption.  
 
++ B 
Strike 2002a Descriptive study with 
evaluation (qualitative 
study) 
Semi-structured 
interview  
Ontario, Canada 
Needle and syringe programmes 
 
59 NSP staff and managers at all 
15 Ontario NSPs and government 
Fixed sites: Location, adequate space and opening hours are 
seen as constraints that can negatively impact on client 
development and retention. Negative attitudes can reduce 
program attendance. Fixed sites can also attract local opposition. 
Mobile NSP services: believed to increase accessibility for clients 
+ B 
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Observation 
(Passive/Participant)  
 
officials involved with the Ontario 
provincial needle and syringe 
programme. 
 
who prefer to exchange in evening hours, do not have a vehicle 
or money to travel and/ or cannot travel. Mobile service is viewed 
as insufficient for incorporating other harm reduction 
interventions. 
Satellite NSP site model: Perceived problems include satellite 
agency staff not following NSP service guidelines, and refusal to 
act as satellite sites due to rejection of harm reduction principles. 
Home visit model: Perceived benefits include accessibility and 
credibility of the NSP. Workers who are former IDUs are more 
accepting and comfortable with this mode of delivery than other 
workers.  
Strike 2002b 
 
A qualitative study using 
a modified ethnographic 
approach. 
Extended interview;  
Semi-structured  
interview 
 
Ontario, Canada 
 
Medical and Executive directors, 
Coordinators and workers at NSPs 
in Ontario, and Provincial 
government officials (n=59) from/ 
related to 15 Needle and Syringe 
Programme. 
Exchange policies within the NSPs vary from a one-for-one 
exchange to a distribution policy. The flexibility with which these 
are applied also varies. Exchange rate policies are more lenient 
as increased access to and distribution of needles is the main 
focus.  Younger programmes are more likely than older 
programmes to conceptualise needles as objects of risk and have 
strict exchange policies. 
 
+ B 
Strike 2004 
 
Qualitative: Local 
practice report ; 
Semi-structured 
interview 
 
Ontario, Canada 
 
59 Coordinators, managers and 
workers at 15 NSPs in Ontario 
Medical Officers of Health, 
Executive Directors and key 
informants from Ontario Ministry of 
Health and Long Term Care 
 
The operation of an NSP is likely to require delicate balancing of 
interests of the clients, workers, organisations overseeing the 
service and the wider community. Workers respond to the 
stigmatisation of their clients by contesting the differentness of 
their clients from the wider community. Approaches developed to 
contend with opposition are described including, the involvement 
of community partners in the planning process, keeping a low 
profile and locating to less contentious locations. 
 
+ B 
Strike 2005, Qualitative: 
Audit/Evaluation  
Brief interview  
Extended interview  
Semi-structured 
interview  
 
Toronto, Canada 
 
Some participants recruited / 
interviewed at Needle and Syringe 
Programme, others from the wider 
drug using community 
 
80 IDUs were interviewed.  
Other key informants were also 
interviewed as part of the 
evaluation of the NSP.  
 
IDUs are able to determine from where they get their injecting 
equipment and in what quantities. Some prefer the free syringes 
available from NSPs while others prefer to pay for OTC 
equipment for convenience and anonymity. Three behavioural 
patterns were identified related to syringe access: those who 
stockpile large numbers of sterile syringes (typically over 100), 
often for secondary distribution to friends and acquaintances as 
well as for personal use; those who plan ahead and maintain a 1-
2 week supply often from a range of sources, based on 
convenience; and IDUs who obtain equipment as needed, either 
through a conscious decision to not be in possession of syringes 
(for example for fear of police harassment) or through a lack of 
organisation.  
+ B 
Spittal 2003 
 
Ethnographic ‘ride 
along’/’walk along’ study 
Extended interview  
Vancouver, Canada 
 
Needle and Syringe Programme 
Discrepancies between policy and practice are described. While 
one-for-one exchange is still the dominant policy, evidence 
suggests that there is a large demand for needles from clients 
+ B/C 
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Observation 
(Passive/Participant) 
staff members – exchange agents. 
 
with none to exchange. As a result an informal ‘loaner’ system 
has developed based on agreements and relationships between 
exchange agents and their clients. The decision to ‘loan’ 
equipment is made on a client-by-client basis and the need for 
clients to return the equipment is stressed.  
 
Buchanan 2003 Quantitative and 
Qualitative 
Brief interview  
Document Analysis  
Observation 
(Participant)  
 
Springfield/USA 
Field sites 
332 Injecting drug users 
 
IDUs in more economically advantaged neighbourhood were 
more likely to obtain syringes from a single source rather than 
from multiple sources, were more likely to inject alone in their 
private residence rather than in public places, also are more likely 
to dispose of syringes in private garbage cans rather than alleys 
or dumpsters. 
 
+ C 
Cooper 2005 Open ended interviews 
plus a short survey.  
 
New York City, USA 
 
40 IDU participants took part in the 
research 
 
 
Overall, the analysis suggests that particular crackdown tactics, 
notably frequent police searches of participants’ bodies and 
elevated surveillance of the precinct's public spaces, 
reconfigured participants’ experiences of their bodies and the 
public spaces comprising the precinct in ways that adversely 
affected their capacity to engage in harm reduction. 
 
++ C 
Finlinson 2000 Qualitative and 
Quantitative study 
Survey 
Focus group(s)  
Extended interview  
Observation 
(Participant)  
Structured interview 
 
East Harlem New York/ USA, 
Bayamon/ Puerto Rico 
 
165 New York, 115 Bayamon 
94 Puerto Ricans (qualitative)  
 
men who have sex with men/Gay 
men IDUs, Male IDUs, Female 
crack users, Community Health 
promoters/outreach workers and 
drug users in recovery (qualitative) 
 
Clogging was a commonly encountered problem especially with 
re-used syringes. Can lead to borrowing of used syringe and use 
of discarded needles. 
Syringes obtained from gallery managers are obtained by them 
from NSPs and re-sold to gallery clients, or used syringes left by 
IDUs and rinsed with water and loaned out to clients.  
IDUs in NY obtain syringes from diabetics and colleagues who 
primarily use NSPs 
Ease of purchase of syringes from the syringe sellers: faster and 
always there for purchase. 
Price inhibits some IDUs from obtaining as many new syringes as 
needed. 
 
++ C 
Larkins 2000 Descriptive study with 
evaluation (qualitative 
study) 
Survey 
Extended interview  
Appraisal of attitudes, 
beliefs and values 
 
14 NSP workers 
29 NSP clients 
 
Additional 48 NSP clients 
completed survey 
 
Drugs professionals and IDUs 
 
Needle exchange contact provided significant physical and 
modest emotional health benefits to clients. All participants 
claimed to receive physical benefits beyond disease prevention: 
increased access to supplies, information and services was 
health promoting. 
 
- C 
Lewis 1996 Qualitative study Denver, Colorado/USA Concerns about disease transmission and increased drug use + C 
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 Semi-structured 
interview  
Appraisal of attitudes, 
beliefs and values 
 
 
Workplace (pharmacy), social 
place (coffee shop); interviews 
took place in a convenient location 
 
32 pharmacists at 24 pharmacies 
 
Business concerns 
Uncertainty about legality 
Views on Needle and Syringe programmes. 
 
Miller 2001 
 
Quantitative and 
qualitative study 
Before and after study  
Semi-structured 
interview  
 
Geelong, Australia 
Needle and Syringe Programme 
sites 
 
60 injecting drug users 
 
Females and younger heroin users were less likely to access 
NSPs directly, preferring to have an older friend (male or female) 
to get their needles for them (secondary exchange). 
Some respondents reported that the need to pay for needles and 
syringes after hours and at weekends when NSPs were closed 
often resulted into risky behaviour. The presence of needle 
disposal bins was highly welcomed by the respondents. The 
issue of discarded needles was identified as a major concern for 
majority of the respondents 
+ C 
Moore 1995 
 
Ethnographic Study 
Descriptive study with 
evaluation (qualitative 
study) 
Extended interview  
(open ended) 
Observation 
(Passive/Participant)  
Literature review 
 
San Francisco/ United States 
 
Needle and Syringe Programme 
site 
 
20 respondents (10 clients and 10 
providers of NSPs) 
 
Injecting drug users felt a sense of ownership and involvement in 
their participation in needle and syringe programme services as 
evidenced by out-reaches, education efforts and sourcing of sites 
for the programme. 
The injecting drug users also provided a source of information 
and encouragement to their friends and associates about the 
needle and syringe programme services, they were also a source 
of secondary needle exchange of syringes, condoms and bleach 
within their social networks. 
 
+ C 
Murphy 2004 A process evaluation of 
a large needle and 
syringe programme. 
Extended interview  
Observation 
(Participant)  
 
San Francisco, US 
Needle and Syringe Programme 
 
244 IDUs 
 
Three general routes of syringe distribution were identified 
between primary and secondary exchangers: exchanges took 
place between close friends and lovers; for people living nearby; 
and as part of a drug deal.  
Barriers to attendance at the NSP included fear of public 
exposure, including being seen by the police, co-workers and 
family members.  
Secondary exchange is able to respond to all barriers to 
attendance cited, except for those related to alternative sources 
of provision. 
 
+ C 
Singer 1995 Ethnographic study 
Descriptive study with 
evaluation (qualitative 
study) 
Survey 
Hartford/USA 
 
Injecting drug users of Hartford 
NSP 
 
With continuous use of NSP, the social interaction between the 
staffs and clients become more cordial and informal creating 
room for discussion of more personal topics such as emotional, 
health, family and money. 
NSP can come to be an important part of a client’s social network 
by providing a safe and friendly site for accessing needed social 
+ C 
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Brief interview  
Observation (Participant 
support. 
An important product of the relationship is the significant level of 
program recruitment by satisfied users. 
Informal conservations provide foundation for the collection of 
attitudinal and life history data on IDU which provides detailed 
answers provided in structured interviews. 
IDUs have special attitudes towards their needles and stylized 
ways of handling and referring to them. 
A fair number of needles are brought in by clients picked up from 
the streets. 
 
Snead 2003 A formative qualitative 
study to inform 
development of a peer 
HIV prevention initiative. 
Semi-structured 
interview  
 
Oakland and Richmond, California, 
US 
 
Needle and Syringe Programmes 
IDUs engaging in SSE as either 
provider or recipient 
 
n=47, providers = 26, recipients 
=21 
 
 
Secondary syringe exchange predominantly takes place within 
existing social networks, providers supplying their friends and 
family rather than strangers. In some cases new recipients may 
be introduced by a trusted friend. 
Many providers reported highly organised NSP operations, 
particularly among those who had a lot of recipients.   
Most NSP was conducted in the providers’ home. Nearly half of 
providers allowed recipients to inject in their home, in some 
cases the primary activity was drug use, in others it was syringe 
exchange. 
All providers reported distributing other harm reduction materials 
alongside syringes. None reported having difficulty accessing 
supplies from the NSP. 
 
+ C 
Somlai 1999 A case study of the 
implementation of an 
intervention based upon 
social science and 
community assessment 
research. 
Semi-structured 
interview  
Observation  
(Passive/Participant) 
 
Milwaukee, Wisconsin, US 
 
The following participated in the 
development of the NSP: 
IDUs 
Outreach workers 
Researchers 
Alcohol/drug treatment 
professionals  
Physicians 
and other key stakeholders 
 
300 individuals were recruited to 
the study. It is unclear whether the 
whole sample was interviewed 
In relation to NSPs, there was an ‘overwhelming’ amount of 
support from IDUs, with some hoping that it may lead to greater 
community acceptance of their drug use as a medical rather than 
criminal behaviour. However many of the respondents were 
sceptical about the amount of political/community support for the 
service. 
While possession of injecting equipment is not prohibited in the 
study area, IDUs were regularly arrested under drug possession 
laws if a syringe had a trace of illegal substances, it is suggested 
that this acts as a barrier to access to sterile equipment. The 
legal purchase of syringes from pharmacies was also shown to 
be problematic. 
Concerns were expressed at community meetings about a fixed 
site NSP encouraging violent and criminal behaviour. A mobile 
facility was more acceptable. 
 
- C 
Springer 1999 Qualitative study 
Extended interview  
Appraisal of attitudes, 
Atlanta/USA: area of high drug 
sales and drug use. 
 
The injecting drug users preferred using NSPs to the other 
disposal methods and community members’ opinion about NSPs 
were generally positive.  
++ C 
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beliefs and values 
 
Street outreach: interviews 
conducted in 2 offices centrally 
located in the community 
 
32 non injecting community 
members 
26 injecting drug user community 
members 
 
Both IDUs and community members believed that access to new 
syringes will be beneficial largely because it would reduce the 
reuse of syringes and thus reduce the risk of HIV transmission in 
the long run. 
IDUs major concern was the risk of getting arrested for 
possession of a syringe 
IDUs were more willing to take the risk of getting caught and 
arrested for syringe possession if they were receiving a new 
syringe for an old one disposed 
Disadvantages mentioned by community members centred on 
moral issues of providing new syringes to IDUs, it is believed that 
stopping drugs altogether is better than giving new syringes. 
 
Strenski 2000 
 
Ethnographic study 
Brief interview  
Extended interview  
Semi-structured 
interview  
Appraisal of attitudes, 
beliefs and values 
 
Chicago/USA 
 
Work place/Needle and Syringe 
Programme sites 
14 Injecting drug users using 
Needle and Syringe Programme 
services provided by Chicago 
Recovery Alliance. 
 
Impact of NSPs on Shooting Galleries 
Barriers to NSP use 
Concerns about privacy, fear of being seen exchanging and been 
exposed as a user, this is more popular amongst business 
professionals, health workers and bus drivers who send some 
else on their behalf.  
Problems with Law enforcement such as police harassments, 
confiscation of possessed needles and arrest. 
Personal safety issues and fear of being robbed by fellow addicts 
who don’t want to go to the sites themselves. 
 
++ C 
Voytek 2003 
 
Qualitative interviews 
exploring the 
motivations of 
participants 
Semi-structured  
interview 
 
Baltimore, US 
Needle and Syringe Programme 
Providers of secondary syringe 
exchange (n=20) 
Recipients of secondary syringe 
exchange who had never used the 
NSP in 1997 (n=10). 
 
Providers reported motivations centred around altruism and 
economic gain. The specific circumstances of the transaction 
often influenced whether the syringe was sold or given away. 
Influential factors included: relationship to recipient, current 
wealth, and desperation. Among those that regularly sold 
syringes a quarter reported collecting discarded needles from 
public places to exchange at the NSP. While recipients of SSE 
generally believed the NSP to be a valuable service, they felt it 
was not suitable for them for a range of reasons including; not 
convenient, location, not wanting to carry equipment, queues and 
lack of privacy. The most common sources of needles distributed 
through SSE were: NSP, diabetic, pharmacy, hospitals, clinics 
and street sales. 
 
+ C 
Weiker 1999 Survey 
Evaluation 
Focus group(s) 
Observation 
(Passive/Participant)  
Los Angeles, US 
 
A community based needle and 
syringe and harm reduction 
programme for young people. 
 
The focus of the article is the lessons to be learned from a 
collaborative evaluation.  
 
Some findings from the qualitative data are also presented. 
Engagement is seen as the primary aim for CNN/HRC. It was 
observed that youth who initially engaged with the service to use 
- D 
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Ethnographic interview 
 
N not reported 
 
the Needle and Syringe Programme  became more involved over 
time. Peer staff are also found to be important in encouraging 
engagement with many young people describing their 
relationship with peer staff as the source of their engagement. 
While the peer staff are seen as a crucial component of the 
service, training and supervision is time consuming. The 
CNN/HRC is portrayed by the clients as a safe, non-judgemental 
place to seek services related to drug use. 
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3.4 Key question (3)  
Which additional harm reduction interventions offered by Needle and Syringe 
Programmes are valued (and accessed) by IDUs and professionals working 
with IDUs?  
 
3.4.1 Narrative summary  
Nineteen studies were found relating to key question 3. Three of these were from the 
UK (Clarke 2001, Matheson 1998, Rhodes 2007), ten from the USA (Finlinson 2000, 
Junge 2000, Larkins 2000, Moore 1995, Murphy 2004, Porter 2002, Snead 2003, 
Somlai 1999, Springer 1999, Voytek 2003), one from Australia (Miller 2001), one 
form the Netherlands (Grund 1992), two from Canada (Spittal 2003, Strike 2002a), 
and one from Ireland (Long 2004). One study compared people from the UK and the 
USA (Phillips 2007). 
 
Quality assessment 
Four of the included studies were rated ++ (good quality), one of these was from 
the UK (Matheson 1998), two from the USA (Finlinson 2000, Moore 1995) and 
one set in an Irish prison (Long 2004).   In all four ++ rated studies, all of the 
quality assessment criteria on the CPHE checklist were judged to have been 
adequately met. 
 
Three of the included studies (Junge 2000, Larkins 2000, Somlai 1999) were 
judged to be poor quality (- rating), all were from the US. Larkins 2000 was 
published only as an abstract so many methodological details were missing. In 
the other two studies, many of the quality assessment criteria were not met either 
due to poor reporting or poor conduct of the study. 
 
In six of the + rated studies (Grund 1992, Miller 2001, Porter 2002, Snead 2003, 
Springer 1999, Voytek 2003), consent and ethics procedures were poorly 
reported.  In two of the + rated studies (Grund 1992, Murphy 2004) the research 
objective was unclear. In six + rating studies (Clarke 2001 (UK), Grund 1992, 
Murphy 2004, Rhodes 2007 (UK), Snead 2003, Voytek 2003) methods of data 
collection were poorly described or it was unclear whether the methods used 
were reliable.  In eight + rated studies methods of data analysis were poorly 
described or it was unclear whether they were reliable (Clarke 2001 (UK), Grund 
 44
NSP: Review of qualitative evidence – Full revised report  August 2008 
1992, Miller 2001, Murphy 2004, Snead 2003, Spittal 2003, Springer 1999, 
Voytek 2003).   In three studies the role of the researcher was unclear (Clarke 
2001 (UK), Miller 2001, Spittal 2003) and in three studies context was not clearly 
described (Clarke 2001 (UK), Murphy 2004, Rhodes 2007 (UK)).  Two studies 
presented data that was not rich (Clarke 2001 (UK), Grund 1992) and in both of 
these studies reviewers were not sure whether the findings were credible. 
 
Awareness of and attitudes towards harm reduction services were examined in four 
studies (Phillips 2007, Porter 2002, Strike 2002a, Long 2004). One Australian study 
mentioned needle disposal bins (Miller 2001), while in two UK studies harm reduction 
advice at pharmacies was discussed (Matheson 1998, Clarke 2001).  Five studies 
mentioned beneficial aspects of NSPs and other harm reduction interventions 
(Springer 1999, Larkins 2000, Phillips 2007, Moore 1995, Junge 2000), and a further 
nine studies (2 UK, 6 US, 1 Netherlands) mentioned secondary syringe 
exchange. Perceptions of harmful aspects of NSPs were looked at in three studies 
(Philllips 2007, Rhodes 2007, Spittal 2003). 
 
The included studies did not address the question of which additional harm reduction 
interventions were valued, only whether they were valued.  
 
In one US/UK study, a large proportion of former IDUs undergoing treatment reported 
acceptance of various harm reduction interventions, however the majority of the US 
sample found safer injection facilities unacceptable (Phillips 2007 A-).  The main 
reasons given for this were “encouragement” of drug use and fears that crime would 
increase in the immediate vicinity. In a US study around two thirds of those 
interviewed either used NSPs for services other than needle exchange (specifically: 
HIV testing, medical care, drug-user treatment referrals, referrals to other services) or 
were aware of these services (Porter 2002 C++).  A Canadian study looking at 
different service models found that, in contrast to a parent site, satellite sites may 
reject harm reduction principles (Strike 2002a B+). 
 
In one US study, increased access to additional services, advice and information was 
health promoting and led to physical and emotional benefits beyond disease 
prevention (Larkins 2000 C-).   Benefits may also have derived from increased social 
contact in this study.  In an Irish study, there was support for harm reduction 
services, including methadone maintenance, needle and syringe programmes, 
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individual counselling and support, and a regular routine of activities among injectors 
and non-injectors in prison (Long 2004 B++). In a Canadian study, mobile NSPs were 
viewed by providers as insufficient for providing other harm reduction interventions 
(Strike 2002a B+).  
 
Needle disposal bins were a popular concept among IDUs in one Australian study 
(Miller 2001 C+) 
 
Within UK pharmacies, while most IDUs did not want to engage in a long 
conversation with pharmacy staff, some did or would value advice from them, 
although not specifically about drug misuse “somebody that’s pleasant and willing to 
speak to you about your medication and if you’ve got any problems” (Matheson 1998 
A++). Some interviewees suggested that pharmacies should keep leaflets on drug 
misuse or give advice on safer injecting, while others felt that their information needs 
were met elsewhere by GPs, drug workers and other drug users. There was 
insufficient detail of respondents given to determine whether attitudes to receiving 
information were associated with any IDU or staff characteristics (Matheson 1998 
A++). In another UK study, when questioned, 90% of IDUs said they had never 
asked the pharmacist for advice regarding their drug use (Clarke 2001 A+) 
 
Harm reduction materials, advice and information were also provided in the context 
of secondary exchange. 
 
Secondary syringe exchange (SSE) 
This was mentioned in nine studies (two UK studies, five US studies, 1 Australian 
study, 1 Netherlands study: Finlinson 2000 C++, Grund 1992 B/C +, Miller 2001 
C+, Moore 1995 C++, Murphy 2004 C+, Neale 1998 A+, Power 1996 A++, Snead 
2003 C+, Voytek 2003 C+) and seemed to be a popular method for obtaining 
clean syringes.  Secondary exchange (where one person exchanges syringes at 
the NSP on behalf of others) relieves the fear of exposure (US study Murphy 
2004 C+, Australian study Miller 2001 C+) and was mentioned in one UK study 
as being preferred to direct NSP use by IDUs (Power 1996 A++) and, in an 
Australian study, by women (Miller 2001 C+).  Secondary exchange can involve 
giving away clean needles or selling them, this can depend on the situation (US 
studies Finlinson 2000 C++, Voytek 2003 C+).  Motivations for becoming a 
secondary exchanger are either altruism or economic gain (US studies Finlinson 
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2000 C++, Voytek 2003 C+). Secondary exchangers obtain clean needles from a 
variety of sources including NSPs (US study Voytek 2003 C+) and these 
exchanges tend to take place within existing social networks (US studies Moore 
1995 C++, Snead 2003 C+).  Collective exchangers were found in one study from 
the Netherlands to be more aware of high risk behaviours such as sharing 
needles and to make more effort to maintain health and injection-related hygiene 
than individual exchangers (Grund 1992 B/C+). They were found in one US study 
to be more highly organised (Snead 2003 C+), and in two US studies to distribute 
other harm reduction materials (e.g. bleach and condoms) as well as needles and 
syringes (Moore 1995 C++, Snead 2003 C+). In one study secondary exchange 
coordinators were involved with the NSP’s outreach, fundraising and education 
efforts (Moore 1995 C++). In the other study (Snead 2003 C+) that presented 
some demographic details of participants, no differences were seen between 
secondary exchangers and recipients. In Snead 2003 (C+), although most 
secondary exchange coordinators provided associated equipment such as filters, 
some reused this equipment due to lack of awareness of associated risks. 
 
Perceived benefits of NSPs 
NSPs were perceived by both IDUs and non-IDUs to reduce the risk of reuse of 
injecting equipment and of HIV transmission (US study: Springer 1999 C++) and 
to facilitate disease prevention (US study Larkins 2000 C-, US/ UK study Phillips 
2007 A-). Social contact was also mentioned as a benefit associated with NSPs 
in two US studies (Junge 2000 D-, Larkins 2000 C-), providing modest emotional 
health benefits and significant physical health benefits (Larkins 2000 C-).  
Increased access to supplies, information and services and consequent physical 
health benefits beyond disease prevention were mentioned in one US study 
(Larkins 2000 C-), and a sense of ownership and involvement with the NSP was 
also noted as a positive feature in another US study (Moore 1995 C+). 
 
Perceived harms of NSPs 
In one study with former IDUs, most of whom described themselves as “addicted 
users”, in the US and the UK undergoing drug treatment, potential harms 
mentioned were harm to the community through inappropriate disposal of 
syringes and encouragement of a shift from smoking to injecting drugs (Phillips 
2007 A-). Irresponsible disposal of needles was also mentioned as a perceived 
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harm in a UK study with ‘responsible’ IDUs disapproving of the behaviour of 
irresponsible ‘smackheads’ (interpreted as being chaotic heroin users)  (Rhodes 
2007 A+). In a Canadian study (Spittal 2003 B/C+) ‘responsible’ IDUs collected 
used needles discarded in public places by ‘irresponsible’ IDUs, saying that it was 
their civic duty as ‘junkies’ to prevent the needles from causing harm to others.  
 
Summary 
Several studies examined IDUs’ perceptions of risk in injecting behaviour: themes 
were lower perception of risk if sharing with a sexual partner and gender differences 
in sharing behaviour. Additional harm reduction interventions were valued, 
specifically, increased access to drug treatment and other services, HIV testing and 
medical care, advice and information.  A Canadian study with stakeholders and 
providers concluded that mobile sites, while increasing accessibility, were not 
appropriate for providing additional harm reduction interventions.  Secondary syringe 
exchange was important for provision of additional equipment (e.g. filters) particularly 
as many IDUs do not realise that sharing these items is a high risk activity.  None of 
the included studies reported preferences for spoken or written information. 
 
3.4.2 Evidence statement 3.4  
 
a. There is evidence from two moderate quality (+ rating) UK studiesa of 
gender differences in patterns of equipment sharing and use of services. 
Women are less likely than men to share equipment with friends, preferring to 
share only with their sexual partner. Women are also more likely to have 
negative feelings about using pharmacy-based NSPs and to obtain equipment 
by secondary exchange, particularly with their sexual partner.  
 
b. There is evidence from three good quality (++ rating)b and one moderate 
quality (+ rating)c qualitative studies to suggest that a range of harm reduction 
interventions (referrals to drug treatment and other services; HIV testing; medical 
care) in addition to needle and syringe programmes were accessed  and valued 
by injecting drug users. 
 
c. There is evidence from three good quality (++ rating) studies, one of which 
is from the UKd, and six moderate quality (+ rating) studies, one of which is 
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from the UKe, that secondary syringe exchange is a valued method for 
obtaining clean syringes because it is convenient and relieves the fear of 
exposure. 
 
a Barnard 1993, Neale 1998 
b Long 2004, Power 1996, Porter 2002 
c Phillips 2007 
d Finlinson 2000, Power 1996, Moore 1995 
e Voytek 2003, Grund 1992, Miller 2001,  Murphy 2004, Neale 1998, Snead 2003 
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Summary table: Evidence for key question 3 
Author (Year) 
 
Design Population Outcomes Quality Applicability 
Clarke 2001 
 
Qualitative semi-
structured and 
structured interviews 
South London, UK 
 
155 needle and syringe 
programme clients and 9 
community pharmacists 
 
90% of IDUs had never asked pharmacists for advice 
about drug use. Clients rated pharmacies higher for being 
open when needed and easy to get to, but drug agencies 
were rated higher for receiving advice and information. . 
Most pharmacists reported poor or non-existent links with local 
drug agencies. Just over half had received training from the local 
drug and alcohol team 
+ A 
Matheson 1998 Descriptive study with 
evaluation (qualitative 
study) 
Semi-structured 
interview 
Observation 
(Passive/Participant)  
Appraisal of attitudes, 
beliefs and values 
 
Aberdeen, Dundee, Edinburgh, 
Glasgow and adjacent rural areas/ 
Scotland 
 
124 illicit drug users interviewed in 
23 pharmacies and 8 drug 
agencies 
 
Most frequently mentioned feature of a good pharmacy is the 
characteristics and attitude of the pharmacists or staff at the 
pharmacy. 
Many of the respondents did not want to enter a prolonged 
conversation with the staff. 
A good process was seen as one which was discreet, flexible, 
strict or if advice was offered. 
The need for privacy was mentioned by 6 respondents to reduce 
embarrassment faced by them and other customers, particularly 
with regards to supervised methadone. 
++ A 
Rhodes 2007 Descriptive study with 
evaluation 
Semi-structured 
interview  
Appraisal of attitudes, 
beliefs and values 
South Wales, UK  
 
The interviews were conducted in 
six locations, This enabled data to 
be collected from urban, semi-rural 
and rural settings. 
 
49 active IDUs 
Respondents made a distinction between themselves as 
responsible, more hygienic drug users and irresponsible 
‘smackheads’, with responsible users safely disposing of not only 
their needles, but sometimes those discarded in public spaces as 
well. 
Accessing dedicated needle and syringe programmes was 
preferred to pharmacy based exchanges. Using pharmacy based 
services risked public exposure as an IDU and was also linked to 
shaming, both in being overheard when being served and in the 
way IDUs are treated by the staff. 
 
+ A- 
Phillips 2007 Qualitative: Appraisal of 
attitudes, beliefs and 
values 
Structured interview with 
open ended questions 
 
Two samples: 
Nottingham, England; Northwest 
Ohio, USA. 
 
UK sample: Recruited from an 
outpatient drug clinic or inpatient 
detoxification ward. 48 clients (35 
men / 13 women) 
 
US sample: Recruited from an 
inpatient residential program for 
Large proportion reported acceptance of various abstinence-
oriented treatments and harm reduction interventions. Only 15% 
of US sample found safer injection facilities acceptable 
 
Needle and syringe programme rated as acceptable by more 
than two thirds of both samples, the English sample had much 
greater experience of it). Most frequently reported advantage was 
disease prevention. Among the UK sample the most frequently 
reported disadvantage was harm to the larger community (from 
inappropriate disposal of syringes); also encouraging a shift from 
smoking to injecting. 
+ A/B 
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women. 40 female clients 
 
 
Strike 2002a Descriptive study with 
evaluation (qualitative 
study) 
Semi-structured 
interview  
Observation 
(Passive/Participant)  
 
Ontario, Canada 
Needle and syringe programmes 
 
59 NSP staff and managers at all 
15 Ontario NSPs and government 
officials involved with the Ontario 
provincial needle and syringe 
programme. 
 
Fixed sites: Location, adequate space and opening hours are 
seen as constraints that can negatively impact on client 
development and retention. Negative attitudes can reduce 
programme attendance. Fixed sites can also attract local 
opposition. 
Mobile NSP services: believed to increase accessibility for clients 
who prefer to exchange in evening hours, do not have a vehicle 
or money to travel and/ or cannot travel. Mobile service is viewed 
as insufficient for incorporating other harm reduction 
interventions. 
Satellite NSP site model: Perceived problems include satellite 
agency staff not following NSP service guidelines, and refusal to 
act as satellite sites due to rejection of harm reduction principles. 
Home visit model: Perceived benefits include accessibility and 
credibility of the NSP. Workers who are former IDUs are more 
accepting and comfortable with this mode of delivery than other 
workers.  
+ B 
Long 2004, Qualitative: Semi-
structured interview; 
Appraisal of attitudes, 
beliefs and values 
 
Dublin, Ireland: 
31 male prisoners. 16 were 
injecting drug users and 15 were 
non injectors 
Two key themes are identified: injectors take risks inside prison 
that they would not if they were outside; and there is support 
among prisoners for interventions to address drug misuse.  
 
Opinions on the provision of needle and syringe programmes in 
prison are divided, with some support coming from both injectors 
and non-injectors, and an equal number of each rejecting the 
idea. The potential to reduce infection is acknowledged and 
concerns relate to safety and the possibility of increased 
consumption.  
 
++ B 
Grund 1992 Audit/Evaluation  
Semi-structured 
interview  
Observation 
(Passive/Participant)  
Appraisal of knowledge, 
skills and behaviour 
Ethnographic fieldwork 
 
Rotterdam, The Netherlands 
 
HADON: community based 
information programme providing 
outreach, prevention and referral 
services to active out of treatment 
IDUs  
104 exchangers in quantitative 
part of research (25 collective and 
79 individual exchangers). The 
authors do not report how many 
people took part in the qualitative 
part of the research. 
 
Findings from fieldwork: Users who engaged in collective 
exchange seemed more aware of high risk behaviours and made 
more effort to maintain health and hygiene than individual 
exchangers. Needles distributed through collective exchange 
have an impact beyond the user collective (e.g. friends who visit 
a collective exchanger’s house to inject).  Nonetheless, there is 
often pressure on IDUs to share needles.  
 
+ B/C 
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Spittal 2003 
 
Ethnographic ‘ride 
along’/’walk along’ study 
Extended interview  
Observation 
(Passive/Participant) 
Vancouver, Canada 
 
Needle and Syringe Programme 
staff members – exchange agents. 
 
Discrepancies between policy and practice are described. While 
one-for-one exchange is still the dominant policy, evidence 
suggests that there is a large demand for needles from clients 
with none to exchange. As a result an informal ‘loaner’ system 
has developed based on agreements and relationships between 
exchange agents and their clients. The decision to ‘loan’ 
equipment is made on a client-by-client basis and the need for 
clients to return the equipment is stressed.  
 
+ B/C 
Finlinson 2000 Qualitative and 
Quantitative study 
Survey 
Focus group(s)  
Extended interview  
Observation 
(Participant)  
Structured interview 
 
East Harlem New York/ USA, 
Bayamon/ Puerto Rico 
 
165 New York, 115 Bayamon 
94 Puerto Ricans (qualitative)  
 
men who have sex with men/Gay 
men IDUs, Male IDUs, Female 
crack users, Community Health 
promoters/outreach workers and 
drug users in recovery (qualitative) 
 
Clogging was a commonly encountered problem especially with 
re-used syringes. Can lead to borrowing of used syringe and use 
of discarded needles. 
Syringes obtained from gallery managers are obtained by them 
from NSPs and re-sold to gallery clients, or used syringes left by 
IDUs and rinsed with water and loaned out to clients.  
IDUs in NY obtain syringes from diabetics and colleagues who 
primarily use NSPs 
Ease of purchase of syringes from the syringe sellers: faster and 
always there for purchase. 
Price inhibits some IDUs from obtaining as many new syringes as 
needed. 
 
++ C 
Larkins 2000 Descriptive study with 
evaluation (qualitative 
study) 
Survey 
Extended interview  
Appraisal of attitudes, 
beliefs and values 
 
14 NSP workers 
29 NSP clients 
 
Additional 48 NSP clients 
completed survey 
 
Drugs professionals and IDUs 
 
Needle exchange contact provided significant physical and 
modest emotional health benefits to clients. All participants 
claimed to receive physical benefits beyond disease prevention: 
increased access to supplies, information and services was 
health promoting. 
 
- C 
Miller 2001 
 
Quantitative and 
qualitative study 
Before and after study  
Semi-structured 
interview  
 
Geelong, Australia 
Needle and syringe programme 
sites 
 
60 injecting drug users 
 
Females and younger heroin users were less likely to access 
NSPs directly, preferring to have an older friend (male or female) 
to get their needles for them (secondary exchange). 
Some respondents reported that the need to pay for needles and 
syringes after hours and at weekends when NSPs were closed 
often resulted into risky behaviour. The presence of needle 
disposal bins were highly welcomed by the respondents. The 
issue of discarded needles was identified as a major concern for 
majority of the respondents 
+ C 
Moore 1995 
 
Ethnographic Study 
Descriptive study with 
evaluation (qualitative 
San Francisco/ United States 
 
Needle and syringe programme 
site 
 Injecting drug users felt a sense of ownership and involvement in 
their participation in needle and syringe programme as evidenced 
by out-reaches, education efforts and sourcing of sites for the 
programme. 
+ C 
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study) 
Extended interview  
(open ended) 
Observation 
(Passive/Participant)  
Literature review 
 
 
20 respondents (10 clients and 10 
providers of NSPs) 
 
The injecting drug users also provided a source of information 
and encouragement to their friends and associates about the 
needle and syringe programme, they were also a source of 
secondary needle exchange of syringes, condoms and bleach 
within their social networks. 
 
Murphy 2004 A process evaluation of 
a large needle and 
syringe programme. 
Extended interview  
Observation 
(Participant)  
 
San Francisco, US 
Needle and Syringe Programme 
 
244 IDUs 
 
Three general routes of syringe distribution were identified 
between primary and secondary exchangers: exchanges took 
place between close friends and lovers; for people living nearby; 
and as part of a drug deal.  
Barriers to attendance at the NSP included fear of public 
exposure, including being seen by the police, co-workers and 
family members.  
Secondary exchange is able to respond to all barriers to 
attendance cited, except for those related to alternative sources 
of provision. 
 
+ C 
Porter 2002 Qualitative: Semi-
structured interview;  
Appraisal of attitudes, 
beliefs and values; 
Appraisal of knowledge, 
skills and behaviour 
 
Philadelphia/United States 
 
46 IDUs: 20 exchangers, 26 non-
exchangers 
 
Four category codes from statements made by respondents were 
created.  
Category 1 (active involvement – personal use and experience of 
service; used NSPs for services other than needle exchange, 
39% of sample; 
Category 2 (Stepping stone – specific knowledge of services 
other than needle and syringe programmes but use only of 
needle and syringe programme, 28% of sample in this category); 
Category 3: Vague awareness; Category 4: Unaware (13% of 
sample in this category) 
 
++ C 
Snead 2003 A formative qualitative 
study to inform 
development of a peer 
HIV prevention initiative. 
Semi-structured 
interview  
 
Oakland and Richmond, California, 
US 
 
Needle and Syringe Programmes 
IDUs engaging in SSE as either 
provider or recipient 
 
n=47, providers = 26, recipients 
=21 
 
 
Secondary syringe exchange predominantly takes place within 
existing social networks, providers supplying their friends and 
family rather than strangers. In some cases new recipients may 
be introduced by a trusted friend. 
Many providers reported highly organised NSP operations, 
particularly among those who had a lot of recipients.   
Most NSP was conducted in the providers’ home. Nearly half of 
providers allowed recipients to inject in their home, in some 
cases the primary activity was drug use, in others it was syringe 
exchange. 
All providers reported distributing other harm reduction materials 
alongside syringes. None reported having difficulty accessing 
supplies from the NSP. 
 
+ C 
Somlai 1999 A case study of the Milwaukee, Wisconsin, US In relation to NSPs, there was an ‘overwhelming’ amount of - C 
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implementation of an 
intervention based upon 
social science and 
community assessment 
research. 
Semi-structured 
interview  
Observation  
(Passive/Participant) 
 
 
The following participated in the 
development of the NSP: 
IDUs 
Outreach workers 
Researchers 
Alcohol/drug treatment 
professionals  
Physicians 
and other key stakeholders 
 
300 individuals were recruited to 
the study. It is unclear whether the 
whole sample was interviewed 
support from IDUs, with some hoping that it may lead to greater 
community acceptance of their drug use as a medical rather than 
criminal behaviour. However many of the respondents were 
sceptical about the amount of political/community support for the 
service. 
While possession of injecting equipment is not prohibited in the 
study area, IDUs were regularly arrested under drug possession 
laws if a syringe had a trace of illegal substances, it is suggested 
that this acts as a barrier to access to sterile equipment. The 
legal purchase of syringes from pharmacies was also shown to 
be problematic. 
Concerns were expressed at community meetings about a fixed 
site NSP encouraging violent and criminal behaviour. A mobile 
facility was more acceptable. 
 
Springer 1999 Qualitative study 
Extended interview  
Appraisal of attitudes, 
beliefs and values 
 
Atlanta/USA: area of high drug 
sales and drug use. 
 
Street outreach: interviews 
conducted in 2 offices centrally 
located in the community 
 
32 non injecting community 
members 
26 injecting drug user community 
members 
 
The injecting drug users preferred using NSPs to the other 
disposal methods and community members’ opinion about NSPs 
were generally positive.  
Both IDUs and community members believed that access to new 
syringes will be beneficial largely because it would reduce the 
reuse of syringes and thus reduce the risk of HIV transmission in 
the long run. 
IDUs major concern was the risk of getting arrested for 
possession of a syringe 
IDUs were more willing to take the risk of getting caught and 
arrested for syringe possession if they were receiving a new 
syringe for an old one disposed 
Disadvantages mentioned by community members centred on 
moral issues of providing new syringes to IDUs, it is believed that 
stopping drugs altogether is better than giving new syringes. 
 
++ C 
Voytek 2003 
 
Qualitative interviews 
exploring the 
motivations of 
participants 
Semi-structured  
interview 
 
Baltimore, US 
Needle and Syringe Programme 
Providers of secondary syringe 
exchange (n=20) 
Recipients of secondary syringe 
exchange who had never used the 
NSP in 1997 (n=10). 
 
Providers reported motivations centred around altruism and 
economic gain. The specific circumstances of the transaction 
often influenced whether the syringe was sold or given away. 
Influential factors included: relationship to recipient, current 
wealth, and desperation. Among those that regularly sold 
syringes a quarter reported collecting discarded needles from 
public places to exchange at the NSP. While recipients of SSE 
generally believed the NSP to be a valuable service, they felt it 
was not suitable for them for a range of reasons including; not 
convenient, location, not wanting to carry equipment, queues and 
lack of privacy. The most common sources of needles distributed 
through SSE were: NSP, diabetic, pharmacy, hospitals, clinics 
and street sales. 
+ C 
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Junge 2000 Evaluation Cohort study 
 
Baltimore, Maryland/USA 
 
Field sites 
 
413 Injecting drug users and 
previous injecting drug users 
 
21.9% reported sharing one’s own equipments with others, while 
9.1% said they used other injectors used syringes. 
7.7% reported having met at least 1 person at the NSP van site 
since enrolment and mean number of contact was 3.3. 
People who met at least 1 person were more likely to trade sex 
for drug or money during the previous 2 weeks. 
People who met someone were less likely to have injected at 
least daily (70.4 versus 85.2%, P=0.047) and more likely to have 
used other used injection syringes (22.2 versus 8%, P=0.026).  
 
- D 
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3.5 Key question (4)  
How are opiate substitution therapy (OST) and NSPs (perceived to be) used 
together by IDUs?  
 
OST is defined as the prescription of substitute drugs for drug dependence, such as 
methadone and buprenorphine7 for a sustained period (maintenance therapy). 
 
3.5.1 Narrative summary  
Two UK studies were found relating to key question 4 (Clarke 2001, Matheson 1998). 
  
Quality assessment 
Matheson 1998 was graded ++ (good quality) because a good account was given of 
sampling strategy, how data were collected and analysed, the role of the researcher, 
consent and ethics procedures, and the data presented were rich and in context.  
Clarke 2001 was graded + (moderate quality) because details of sampling strategy, 
data collection and analysis methods, the role of the researcher were poorly 
reported, and the sources for the data presented  could not be traced in all cases, 
which will limit the generalisability of the findings. 
 
There was very little information reported in either study about how OST and NSPs 
are used together. In Clarke 2001 A+ of those receiving a methadone prescription 
approximately half collected it from the same NSP pharmacy in which they were 
interviewed and from which they had collected injecting equipment for their own use.  
Just over two thirds collected the methadone daily. Details of current drug use of the 
sample were not reported. Both studies mentioned the need for privacy and one 
study also mentioned not being kept waiting when taking supervised oral methadone. 
There were also preferences expressed for different types of methadone (Matheson 
1998 A++).  IDUs reported that a “total service” from the pharmacy would include 
both dispensing methadone and providing needles (Matheson 1998 A++).  
 
3.5.2 Evidence statement 3.5 
a. In two UK studies (one good quality ++ rating, one moderate quality + rating), IDUs 
obtained oral methadone prescriptions from the same pharmacy they used for needle 
                                                 
7 See NICE technology assessment 114 
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and syringe exchange. A need for privacy when collecting needles and taking oral 
methadone was expressed. 
Clarke 2001; Matheson 1998 
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Summary table: evidence for key question 4 
 
Author (Year) 
 
Design Population Outcomes Quality Applicability 
Clarke 2001 
 
Qualitative semi-
structured and 
structured interviews 
South London, UK 
 
155 needle and syringe 
programme clients and 9 
community pharmacists 
 
90% of IDUs had never asked pharmacists for advice 
about drug use. Clients rated pharmacies higher for being 
open when needed and easy to get to, but drug agencies 
were rated higher for receiving advice and information. . 
Most pharmacists reported poor or non-existent links with local 
drug agencies. Just over half had received training from the local 
drug and alcohol team 
+ A 
Matheson 1998 Descriptive study with 
evaluation (qualitative 
study) 
Semi-structured 
interview 
Observation 
(Passive/Participant)  
Appraisal of attitudes, 
beliefs and values 
 
Aberdeen, Dundee, Edinburgh, 
Glasgow and adjacent rural areas/ 
Scotland 
 
124 illicit drug users interviewed in 
23 pharmacies and 8 drug 
agencies 
 
Most frequently mentioned feature of a good pharmacy is the 
characteristics and attitude of the pharmacists or staff at the 
pharmacy. 
Many of the respondents did not want to enter a prolonged 
conversation with the staff. 
A good process was seen as one which was discreet, flexible, 
strict or if advice was offered. 
The need for privacy was mentioned by 6 respondents to reduce 
embarrassment faced by them and other customers, particularly 
with regards to supervised methadone. 
++ A 
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3.6 Key question (5)  
How do the general public perceive the effectiveness and acceptability of 
NSPs?  
This question considers the perceptions of NSPs of groups including local community 
representatives; schools; local councils and local councillors; local and national 
media; voluntary sector. 
 
3.6.1 Narrative summary  
Nine studies were found relating to key question 5 (Barnard 1993, Downing 2005, 
Korner 2003, Lawrie 2003, Shaw 2006, Somlai 1999, Springer 1999, Strike 2004, 
Tempalski 2007).  Two of these were from the UK (Barnard 1993, Lawrie 2003), five 
from the USA (Downing 2005, Shaw 2006, Somlai 1999, Springer 1999, Tempalski 
2007), one from Australia (Korner 2003) and one from Canada (Strike 2004). 
 
Two US and one Canadian study interviewed stakeholders and providers (Downing 
2005, Tempalski 2007, Strike 2004), one UK study interviewed IDUs (Barnard 1993), 
one UK study and 3 US studies interviewed or observed community members 
(Lawrie 2003, Shaw 2006, Somlai 1999, Springer 1999) and one Australian study 
documented newspaper reporting of the closure of a NSP (Körner 2003). 
 
Quality assessment 
Eight of the nine included studies were rated + (moderate quality) and one (Somlai 
1999) was rated – (poor quality).  In all nine the research objective was clear, but in 
five (Downing 2005, Shaw 2006, Somlai 1999, Strike 2004, Tempalski 2007), 
methods of data collection were poorly described or it was unclear whether the 
methods used were reliable.  In all nine, details of data analysis were poorly 
described.  The role of the researcher was unclear in all except Tempalski 2007, 
where it was clearly described, and Körner 2003, where it was not applicable.  The 
data reported was rich in all but one study (Somlai 1999) although context was poorly 
described in three studies (Downing 2005, Shaw 2006, Somlai 1999).  In seven of 
the included studies the findings were judged to be credible but in Somlai 1999 they 
were judged to be not credible and in Shaw 2006 the reviewers could not decide due 
to missing data. Conclusions were judged to be plausible in all but Somlai 1999. 
 
One US study (Downing 2005 C+) identified three models of NSP implementation: 
community coalitions; community activists and top down from government 
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authorities.  A strong NSP would move from one model to another as required.  The 
community coalition model was most likely to lead to broad based support while the 
top down model was vulnerable to community criticism. A strong model would also 
include research, strong leadership, coalition and community building. A need was 
identified to stage debate with sensitivity to political and cultural norms. 
 
Körner 2003 B+ analysed Australian media reporting of the closure of a NSP.  The 
analysis showed alignment of newspapers with positive or negative positions relating 
to NSPs, although there was an absence of overt judgments and sensationalist 
reporting. There were however no descriptions of the benefits of NSPs or public 
health messages in any of the newspaper reports. 
 
Customers in UK pharmacies (non-IDUs) were interviewed in Lawrie 2003 A+. Most 
were supportive of pharmacies offering NSPs and believed they would lead to a 
reduction in risk of discarded needles and reduction in risk of disease transmission.  
A small minority were not supportive, these interviewees did not want the service to 
be visible to non-IDU customers or saw the service as condoning drug injection.  
 
Shaw 2006 C+ (USA) documents community opposition from diverse quarters in 
response to a proposed NSP. Arguments were advanced about addiction, personal 
responsibility, HIV and community.  The first protests came from a predominantly 
white neighbourhood far from areas of high drug prevalence. It was felt by some 
interviewees that these community members were better at using the political system 
to initiate change and also had high representation on the council and as voters, so 
were more likely to be listened to. Non-white citizens were less likely to vote and felt 
marginalised from governmental decisions, including decisions about whether and 
how to implement NSPs. Also mentioned was the stigma of drug use and HIV in the 
African-American Muslim population, and the tendency of the community to exclude 
‘deviants’ from public spaces. 
 
In Somlai1999 C- (USA) concerns were expressed at community meetings that a 
fixed site NSP would encourage violent and criminal behaviour; mobile sites were felt 
to be more acceptable.  
 
Tempalski 2007 C+ (USA) reported that critics of NSPs frequently use language 
about the immorality of drug use. There were two main sources of opposition: 
political and institutional; and neighbours and businesses. Political and institutional 
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opposition included drug paraphernalia laws, harassment of IDUs and NSP providers 
by politicians and police, state and local government (in)action or opposition (this can 
be the strongest factor).  Local opposition by neighbours and businesses can include 
stigmatisation of IDUs and resistance to NSPs. Resistance does not exist in isolation 
and different players can generate opposition, e.g. by putting pressure on politicians 
and service providers to relocate.  
 
Strike 2004 B+ (Canada) reported that the operation of NSPs requires a delicate 
balance of the interests of clients, workers, service organisations and the wider 
community. Approaches to dealing with opposition include involving community 
partners in planning, keeping a low profile and relocating. 
 
In Springer 1999 C++ (USA) community members were generally positive about 
NSPs, believing that access to new syringes would be beneficial due to reducing the 
reuse of syringes and transmission of HIV.  There was some concern however over 
moral issues of providing new syringes to IDUs, with some community members 
favouring an abstinence rather than a harm reduction approach. 
 
Barnard 1993 A+ (UK study) points to a perceived negative connotation and 
stigmatisation towards female IDUs by the general public and by male IDU 
counterparts, which in turn inhibits female IDUs from accessing services. 
 
3.6.2 Evidence statement 3.6  
 
 
a. There is evidence from one good quality (++ rating) US study a and two moderate 
quality (+ rating)b studies, one of which was from the UK that the general public, 
particularly religious groups, had concerns about the ethics or morality of providing 
syringes and needles to injecting drug users, with some stating that it was helping 
them (IDUs) to harm themselves; others were more concerned that it discouraged 
IDUs from taking personal responsibility for their drug use. 
 
b. There is evidence from three moderate quality (+ rating) c studies, one of which 
was from the UK, that the general public and IDUs themselves had some concerns 
about the environmental and health consequences (e.g. discarded needles, 
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increased crime) of fixed site NSPs. In some cases direct opposition came from a 
vocal, more affluent, minority.  
a Springer 1999 
b Lawrie 2005, Shaw 2006 
c Lawrie 2005, Shaw 2006, Tempalski 2007 
NSP: Review of qualitative evidence – Full revised report  August 2008 
Summary table: Evidence for key question 5 
 
Author (Year) 
 
Design Population Outcomes Quality Applicability 
Barnard 1993 Qualitative:  
Ethnographic study 
Extended interview  
Observation 
 (Passive/Participant)  
Short standard  
schedule(structured) :  
variable depending on  
time and willingness of 
  participants 
 
Glasgow, Scotland. 
 
Drug injectors in two treatment 
centres, a needle and syringe 
programme centre 
and a  local pharmacy providing 
sterile injecting equipment. 
Injectors and non injectors around 
the streets (community) 
 
122 men and women 
 
Availability does not have an important part to play in the creation 
of some of the situations where needle sharing takes place, but it 
thus can only constitute a part of the explanation as instances of 
sharing was shown to be highly situationally  variable. 
 
Patterns of sharing between injectors highlighted sharing as 
rarely being an indiscriminate activity but one which frequently 
follows a pattern of sociability quite closely. So also author 
critically commented on gender distinct nature of the social 
activity which suggests that the risks of HIV infection are 
differently focussed for men and women 
+ A 
Lawrie 2005 
 
Semi-structured 
interview;  
Appraisal of attitudes, 
beliefs and values 
 
80 (non-IDU) customers in 
pharmacies in Aberdeen and 
Glasgow (Scotland) 
 
8 Pharmacies in city centre, 
suburban and rural locations. Only 
2 of the pharmacies ran a NSP. 
 
General public 
Most were supportive of pharmacies offering NSPs. 
Two main reasons: reduction in risk of finding discarded needles 
in public places especially by children and the reduction in 
transmission of diseases. 
 
A small minority was not supportive either because they did not 
want such services to be too visible or because it was seen to 
condone drug injecting. 
 
+ A 
Korner 2003 Document analysis 
founded in Critical 
Discourse Analysis and 
Systemic Functional 
Linguistics. 
Case study  
Document Analysis 
 
Sydney, Australia 
 
Case study was selected as a 
‘critical case sample’. 
 
Four newspapers were examined:  
 
Seven texts in three newspapers dealt with the NSP closure, 
including four news reports and one editorial. While there is an 
absence of overt judgements and sensationalist reporting the 
texts are not value free. The intertextual analysis shows an 
alignment of the papers with positive or negative positions 
relating to NSPs and this case in particular. Reporters are able to 
choose which speaking subjects are included and which are 
foregrounded/backgrounded. Politicians and their media officers 
are the most privileged, while drug educators are the least 
represented. No comments from staff or clients at the service 
involved are included in any of the texts. Also absent are any 
public health messages or descriptions of the benefits of NSPs.  
 
+ B 
Strike 2004 
 
Qualitative: Local 
practice report ; 
Semi-structured 
interview 
 
Ontario, Canada 
 
59 Coordinators, managers and 
workers at 15 NSPs in Ontario 
Medical Officers of Health, 
The operation of an NSP is likely to require delicate balancing of 
interests of the clients, workers, organisations overseeing the 
service and the wider community. Workers respond to the 
stigmatisation of their clients by contesting the differentness of 
their clients from the wider community. Approaches developed to 
+ B 
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Executive Directors and key 
informants from Ontario Ministry of 
Health and Long Term Care 
 
contend with opposition are described including, the involvement 
of community partners in the planning process, keeping a low 
profile and locating to less contentious locations. 
 
Downing 2005 Qualitative interviews 
with key informants.  
Extended interview  
Semi-structured 
interview  
 
US 
 
17 interviews with Public health 
officials, HIV prevention and drug 
treatment providers, researchers, 
policy makers, staff of community 
based organisations and activists 
 
Three implementation models were identified:  
1. NSPs established by community coalitions.  
2. NSPs established by community activists.  
3. NSPs established top down by govt. authorities.  
Successful implementation sometimes involved movement from 
one model to another as appropriate. 
Six strategies and resources were identified as characterising 
successful implementation of an NSP. 
 
+ C 
Shaw 2006 participant-observation, 
public records and in-
depth interviews, 
ethnographic interviews  
 
Springfield, Massachusetts. 
 
The number of participants in the 
research was not made explicit. 
 
Local opinion leaders and front-
line harm-reduction workers plus 
needle and syringe programme 
opponents and African-American 
citizens. 
 
The paper outlines the debate of a needle and syringe 
programme in Springfield.  It highlights the marginalization of 
African-Americans in the political system.  The paper shows the 
divergent views of various stakeholders and demonstrates how 
these views impact on the implementation of the programme. 
 
+ C 
Somlai 1999 A case study of the 
implementation of an 
intervention based upon 
social science and 
community assessment 
research. 
Semi-structured 
interview  
Observation  
(Passive/Participant) 
 
Milwaukee, Wisconsin, US 
 
The following participated in the 
development of the NSP: 
IDUs 
Outreach workers 
Researchers 
Alcohol/drug treatment 
professionals  
Physicians 
and other key stakeholders 
 
300 individuals were recruited to 
the study. It is unclear whether the 
whole sample was interviewed 
In relation to NSPs, there was an ‘overwhelming’ amount of 
support from IDUs, with some hoping that it may lead to greater 
community acceptance of their drug use as a medical rather than 
criminal behaviour. However many of the respondents were 
sceptical about the amount of political/community support for the 
service. 
While possession of injecting equipment is not prohibited in the 
study area, IDUs were regularly arrested under drug possession 
laws if a syringe had a trace of illegal substances, it is suggested 
that this acts as a barrier to access to sterile equipment. The 
legal purchase of syringes from pharmacies was also shown to 
be problematic. 
Concerns were expressed at community meetings about a fixed 
site NSP encouraging violent and criminal behaviour. A mobile 
facility was more acceptable. 
 
- C 
Springer 1999 Qualitative study 
Extended interview  
Appraisal of attitudes, 
beliefs and values 
Atlanta/USA: area of high drug 
sales and drug use. 
 
Street outreach: interviews 
The injecting drug users preferred using NSPs to the other 
disposal methods and community members’ opinion about NSPs 
were generally positive.  
Both IDUs and community members believed that access to new 
++ C 
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 conducted in 2 offices centrally 
located in the community 
 
32 non injecting community 
members 
26 injecting drug user community 
members 
 
syringes will be beneficial largely because it would reduce the 
reuse of syringes and thus reduce the risk of HIV transmission in 
the long run. 
IDUs major concern was the risk of getting arrested for 
possession of a syringe 
IDUs were more willing to take the risk of getting caught and 
arrested for syringe possession if they were receiving a new 
syringe for an old one disposed 
Disadvantages mentioned by community members centred on 
moral issues of providing new syringes to IDUs, it is believed that 
stopping drugs altogether is better than giving new syringes. 
 
Tempalski 2007 
 
Descriptive study with 
evaluation (qualitative 
study) 
Semi-structured 
interview  
Appraisal of attitudes, 
beliefs and values 
 
32 metropolitan statistical areas in 
the USA 
 
93 interviewees in 32 MSAs 
 
24 NSP directors 
14 drug treatment providers 
13 outreach workers 
28 researchers 
14 public health administrators 
 
Themes were:  
1. institutional and/ or political opposition based on 
    (a) political and law enforcement issues associated with state 
drug paraphernalia laws and local syringe laws; 
   (b) harassment of drug users and resistance to services for 
drug users by local politicians and police; and 
   (c) state and local government (in)action or opposition; and 
 
2. Stigmatisation of drug users and NSP resistance from 
neighbours and businesses. 
 
+ C 
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3.7 Key question (6)  
What are the views, experiences and attitudes of carers and families of IDUs to 
NSPs? 
This question considers the views of families and carers with regard to effectiveness 
of NSPs, acceptability of NSPs; and information and advice needs (for themselves). 
 
 
No qualitative studies were found that contained information relating to this 
question.  None of the studies retrieved after title and abstract screening had 
sought the views of families and carers of IDUs, so there was no evidence 
available to answer this question. 
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Discussion 
 
Forty qualitative studies were included in this review, covering a diverse range of 
participants, settings, countries and themes. There was strong representation from 
the UK, where NSPs have been established for many years, with many included UK 
studies interviewing and observing IDUs.  Despite this, we did not find any evidence 
pertaining to key question 6, about the views of families and carers.  This is perhaps 
not surprising given that a prominent theme across the other key questions was the 
IDU’s fear of being publicly exposed to families and neighbours, as well as to the 
police, which suggests that families and carers may not know about the drug use and 
therefore would not know about the use of related services. There was also very little 
qualitative information about combined use of NSPs and oral methadone.   
 
IDUs are a hidden population that is hard to reach for the purposes of providing 
services and undertaking research, so it is again not very surprising that the majority 
of the included qualitative studies lacked detail of the sample demographics, as it is 
understandable that many IDUs, while willing to take part in interviews, do not want 
to provide any potentially identifying details about themselves.   It was surprising, 
however,  that included studies often did not report details of qualitative research 
methodology such as data collection, sampling strategy, data analysis, consent and 
ethics procedures and the roles of the researchers in collecting and analysing data. 
This could be due in part, as for quantitative research, to word limits in journal 
publications, but may also reflect a more general tendency for qualitative research 
methodology to be poorly understood and reported in the scientific literature.  These 
methodological flaws combine to limit the generalisability of the findings of this 
review, as we cannot tell how representative the samples in the included studies are 
of the IDU population as a whole. 
 
This review included only qualitative studies that were internally coherent in their 
methodology, therefore questionnaire-based surveys, whether administered verbally 
or not, were excluded, as there was no provision for recording responses other than 
yes/ no, and furthermore the analysis of such surveys tended to be quantitative.  It is 
possible however that the excluded surveys may still contain useful data that could 
add to what was found in the qualitative studies.  
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Despite the above caveats, some strong themes emerged, namely:  
• embarrassment and fear of public exposure,  
• preferences for secondary syringe exchange and (in some cases) pharmacy 
based NSPs due to fear of exposure, convenience of opening hours and 
location 
• gender differences in injecting risk behaviour and syringe acquisition 
• heterogeneity of IDUs as a group, largely related to socioeconomic status/ 
stability of living arrangements 
• awareness and use of a range of additional harm reduction interventions 
(though little detail of what these were) 
• objections from the general public were based on morality (not wanting to 
help IDUs harm themselves, or concepts of personal responsibility) or fear of 
increased crime or injury from discarded needles 
 
Conclusions 
 
The qualitative literature on NSPs for IDUs lacks methodological detail, which limits 
its generalisability. 
 
There was no qualitative literature on the attitudes of families and carers of IDUs to 
NSPs, and very little on combined use of NSP and oral methadone services. 
 
A strong theme among IDUs in the included studies was fear of public exposure, 
which influenced their choices over where to obtain injecting equipment from.  
Secondary syringe exchange was popular for this reason. 
 
Convenience was important to IDUs. Pharmacies were rated higher than drug 
agency based NSPs for accessibility due to opening hours and location. Secondary 
syringe exchange and buying syringes were also felt to be more convenient than 
using a fixed site NSP. Beyond convenience, however, agency based NSPs were 
rated more highly than pharmacies for the advice and information they provided. 
 
Women were more vulnerable than men to unsafe injecting practices, due to 
incorrect beliefs about risk of sharing with a sexual partner, and increased fear of 
exposure. 
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APPENDIX C: Evidence tables 
Data extraction tables 
 
PROGRESS: Place of residence (e.g. homeless); Race/ ethnicity; Occupation; Gender; Religion; Education; Socioeconomic status; Social capital 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Barnard 1993 
 
Country: UK 
 
Research question: 
What are the social 
contexts within which 
needle sharing takes 
place amongst injecting 
drug users in Glasgow. 
 
 
 
Design: Qualitative:  
Ethnographic study 
Extended interview  
Observation 
 (Passive/Participant)  
Short standard  
schedule(structured) :  
variable depending on time 
willingness of the  
participants 
 
Quality: + 
Data analysis methods poorly 
reported 
 
Glasgow, Scotland. 
 
Drug injectors in two treatment 
centres, a needle exchange 
centre 
and a  local pharmacy providing 
sterile injecting equipment. 
Injectors and non injectors 
around the streets (community) 
 
122 men and women 
 
PROGRESS data: None 
reported 
 
General awareness of HIV associated risks of needle 
sharing. 
 
Majority had shared within one month of the interview 
despite knowledge of associated risk factors 
 
Barriers noted to use of NEP or reasons given for sharing 
were opening hours of the programme or pharmacy and the 
distance to the services (access was judged to be difficult). 
 
Sharing behaviour was brought about as a result of the 
desire to inject as soon as a hit was available and most IDU 
prioritized injecting drugs ASAP, even if it meant sharing 
equipment, over sterility irrespective of if an NEP was open 
or not. 
 
Sharing as a social behaviour was implied as an expression 
of social ties between people. Difficulties in refusal to share 
equipment. 
 
There was gender imbalance to access of NEP, reasons 
being that more women than men found it very 
embarrassing to use the services for fear of revealing their 
drug use to the shop assistants and other customers, being 
seen entering or leaving such services led to an obvious 
interpretation. 
 
Mothers were particularly sceptical because of official 
notification which may identify them as been unfit to parent 
their child properly. 
Men by contrast rarely claimed such difficulties and would 
collect injection equipment for women who cannot attend. 
Overall women are more socially inhibited from securing 
independent access to NEP (rather acquisition is through a 
sexual partner or an acquaintance… a third party) 
Giving the context of reliance by women on a third party the 
A 
 
Why:  
The concepts of 
stigma, NIMBY 
and place and 
the legal basis 
of the NEP are 
comparable in 
the UK. 
 
Generally, the 
research has 
shown strong 
evidence that 
needle sharing 
is clearly an 
activity 
differentiated by 
gender.   
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concept of sharing becomes likely.  
Reinforcements by perceived negative connotation and 
stigmatization towards female IDU by public and male 
counterparts. 
 
Incidence of sharing with friends was most marked among 
male injectors. 
 
Environmental, personal, financial and social factors all play 
a role in the motivation of risky behaviour despite the 
availability of NEP. 
 
Conclusions: 
The author clearly pointed out that availability does not have 
an important part to play in the creation of some of the 
situations where needle sharing takes place, but it thus can 
only constitute a part of the explanation as instances of 
sharing was shown to be highly situationally  variable. 
 
Patterns of sharing between injectors highlighted sharing as 
rarely being an indiscriminate activity but one which 
frequently follows a pattern of sociability quite closely. So 
also author critically commented on gender distinct nature 
of the social activity which suggests that the risks of HIV 
infection are differently focussed for men and women.   
 
 
Study details Study design and quality Study population Main results Applicability to UK populations 
and settings 
Comments 
Buchanan 2003 
 
Country: USA 
 
Research question:  
What factors affect 
syringe access, use and 
discard in different 
neighbourhoods in 
Springfield USA? 
Are there differences in 
the micro-contextual 
factors influencing syringe 
access, use and discard 
that are associated with 
distinct socio-
demographic 
characteristics of different 
neighbourhoods in 
Design: Quantitative and 
Qualitative 
Brief interview  
Document Analysis  
Observation (Participant)  
 
 
 
Quality: + 
Sampling criteria and details 
of data analysis not reported 
 
Springfield/USA 
Field sites 
332 Injecting drug users 
 
Place of residence: Mason 
Square: Property owner (40%), 
relative’s place (33.8%), renting 
(6.3%), others (17.5%) 
North End: Property owner 
(47.6%), relative’s place (8.3%), 
renting (25%), others (16.7%) 
Race/ ethnicity: 
North End: 94% Latino, 5% 
African American, 1% white 
Mason Square: 64% African 
American, 31% Latino, 4% 
whites 
Occupation: 
Mason Square: full time worker 
IDUs in more economically advantaged 
neighbourhood were more likely to 
obtain syringes from a single source 
rather than from multiple sources, were 
more likely to inject alone in their private 
residence rather than in public places, 
also are more likely to dispose of 
syringes in private garbage cans rather 
than alleys or dumpsters. 
 
C  
 
Why:  
While clearly not representative of 
the full range of neighbourhood, the 
neighbourhoods selected are 
largely representative of those poor 
and largely minority 
neighbourhoods most severely 
affected, similar sorts of differences 
between neighbourhoods and racial 
segregation and relatively 
homogenous in their demographic 
composition which can be found in 
most cities in the States, but 
unlikely in the UK, however data 
collected from the different socio-
economic background can reflect 
similar scenario/context in UK. 
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Springfield? 
 
Date of study (to/from): 
2.5 years ending May 
2002 
 
 
(21.3%) 
North End: full time worker 
(8.3%) 
Gender: Mason Square< 
34years (20%), 35-44 years 
(40%), >45 (40%); North End: 
<34 (26.7%), 35-44 (67.9%), 
>45 (6%). 
Socioeconomic status: 
Mason square: <1000$/month 
(66.7%), >1000$/month 
(33.8%) 
North End: <1000$/mth 
(89.3%), >1000$/mth (8.3%) 
 
 
 
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Clarke 2001  
 
Country: UK 
 
Research question: To 
assess client’s use and 
perceptions of pharmacy 
needle and syringe 
exchange services and to 
see how well they 
matched the perceptions, 
experiences and attitudes 
of community pharmacists 
operating needle 
exchanges. 
 
All interviews were 
conducted in 1996 
 
 
 
 
 
 
 
 
 
Design: 
Qualitative: semi-structured 
interview; Appraisal of  
attitudes, beliefs and values; 
Appraisal of knowledge, skills 
  behaviour; Structured  
Interview 
 
Quality: + 
Data collection with IDUs was 
very structured; few details of 
analysis reported; data 
presented are mostly 
quantitative. 
 
One health authority area in 
inner city south London, UK 
 
Sample of 9 pharmacies 
selected from the 19 in the area 
offering NEPs 
 
155 needle exchange clients 
and 9 community pharmacists 
 
For the vast majority of IDUs, 
the pharmacy in which they 
were interviewed was their 
primary source of clean 
injecting equipment. 
 
Age  (range or mean):  mean 
31, range 19-52 
 
Place of residence: 59% lived in 
rented accommodation and 
25% were in temporary 
accommodation or were 
homeless 
Race/ ethnicity: 96% white 
Occupation: Not reported 
Gender: 67% male 
90% had never asked pharmacist for advice regarding their 
drug use. 
 
Just under half of the client sample “always” picked up 
clean syringes for themselves, just over one third reported 
usually collecting equipment for partners, and one fifth 
reported collecting equipment for friends. For the vast 
majority, the pharmacy in which they were interviewed was 
their primary source of clean injecting equipment. Given the 
choice of collecting equipment from a pharmacy or a drug 
agency exchange, just under half preferred pharmacy, just 
over half had no preference and a small proportion 
preferred the drug agency exchange. 
 
Positive features about pharmacy NEP were reported to be 
that it was “easy”, “good staff”, “free works”, “close by”, 
“convenient” and “new clean works”. 
 
When asked about the worst features of the pharmacy NEP, 
over half of the clients reported there were no worst 
features.  One fifth of responses indicated that “other people 
in the pharmacy” (lack of privacy?) was the worst feature, 
along with associated concerns such as being embarrassed 
and meeting people they knew.  
 
The overwhelming majority were satisfied or very satisfied 
with the scheme. 
A 
 
Why: Pharmacy 
based NEPs 
operate 
throughout the 
UK and this 
sample was 
randomly 
selected, with a 
93.4% 
response rate, 
so should be 
representative 
of the UK IDU 
population 
(those who use 
pharmacy 
based NEPs) 
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 Religion: Not reported 
Education: Not reported 
Socioeconomic status: Not 
reported 
Social capital: Not reported 
 
91% had been in drug 
treatment in the past and 60% 
were currently part of a drug 
treatment programme. 56% 
currently receiving methadone 
prescription. 
 
 
Most knew which drug agencies ran a NEP and over half 
had used a drug agency based NEP. The main reason 
given for not using drug agency NEPs was that there was 
no need.  Clients rated pharmacies higher for being open 
when needed and easy to get to, but drug agencies were 
rated higher for receiving advice and information. 
 
Pharmacists: 
Mean length of time they had been involved with NEPs was 
2.8 years. Most encouraged clients to return used needles 
and syringes.  Just over half had received training from the 
local drug and alcohol team. Most reported poor or non-
existent links with local drug agencies. 
 
Most were fully committed to operating the scheme. 
 
Pharmacists were asked about positive and negative 
features of pharmacy based NEPs. In positive aspects, they 
largely agreed with client sample: top two answers were 
“good rapport/ easy going staff” and “convenient/ easy to 
access”. Just under half did not report any negative 
attributes, other responses were “it puts off non-drug using 
customers”, users “may have to wait to be served” and 
“registering of clients”. 
 
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Cooper 2005 
 
Country: USA 
 
Research question:  
To explore the 
interrelationships of a 
police drug crackdown, 
participants’ sense of their 
bodies’ geography and 
the precincts’ public 
spaces, and their ability to 
practice harm reduction.    
 
Date of study: 
August – December 2000  
 
Design: 
 
Open ended interviews plus a 
short survey.  
 
Quality: ++ 
Very well conducted study 
 
New York City, USA 
 
The study was conducted in the 
46th precinct of New York City.  
This was located in the Bronx 
area and used in this study 
because the Deputy Inspector 
of Narcotics at the NY police 
department noted that the 
crackdown in this area was 
particularly active when the 
study commenced. 
 
40 participants took part in the 
research 
 
Injecting drug users aged over 
Overall, the analysis suggests that particular crackdown 
tactics, notably frequent police searches of participants’ 
bodies and elevated surveillance of the precinct's public 
spaces, reconfigured participants’ experiences of their 
bodies and the public spaces comprising the precinct in 
ways that adversely affected their capacity to engage in 
harm reduction. Frequent police searches, for example, 
discouraged participants from carrying the injection 
equipment they needed to ensure that they could inject with 
a sterile syringe. Constant monitoring of local public spaces 
made it difficult for homeless women and men to inject 
safely. Simultaneously, participants expressed support for 
police actions that reduced public drug activity. 
 
C 
 
Why:  
 
Drug 
crackdowns 
also take place 
in the UK, these 
methods could 
feasibly be 
replicated in 
densely urban 
areas of the UK 
and are likely to 
mirror the 
findings from 
this study.  
All data was 
collected a 
number of 
months (even 
years) after the 
police 
crackdowns.  
The study did 
not interview 
individuals with 
less frequent 
drug injecting 
patterns and 
also did not 
speak to those 
who may have 
been 
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18 years residing in the 46th 
precinct for at least 1 year prior 
to interview, able to speak 
English and reported injecting 
illicit drugs at least three times a 
week during the past year.  
 
Age  (range or mean):  
Median: 41 
Range: 24-59 
 
Place of residence:  
One-third were homeless   
Race/ ethnicity:  
Hispanic/Latino n=24 (60%),  
Hispanic/Latino (Black) n=4 
(10%)  
Hispanic/Latino (other) n=20 
(50%) 
Non-Hispanic/Latino n=16 
(40%) 
Non-Hispanic/Latino (Black) 
n=14 (35%) 
Non-Hispanic/Latino (White) 
n=2 (5%) 
Non-Hispanic/Latino (Other) 
n=0 (0%) 
Gender: Men n=21 (53%), 
Women  n=19 (48%) 
Education 
< High-school graduate n=24 
(60%) 
High-school graduate n=9 
(23%) 
>High-school graduate n=7 
(18%) 
Social capital: Most participants 
had deep roots in the 
community, reporting that they 
had resided in the area for 12 
years on average.  
 incarcerated 
from dug 
offences at this 
period of time.  
 
 
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Downing 2005 Design: Qualitative US Three implementation models were identified:  C  inability to 
 92 
NSP: Review of qualitative evidence – Full revised report  August 2008 
 
Country: USA 
 
Research question:  
To identify factors and 
conditions that facilitated 
or deterred the adoption 
of SEPs. 
 
Date of study June 2000-
Sep 2001 
 
 
 
 
 
 
 
 
 
 
interviews with key 
informants.  
Extended interview  
Semi-structured interview  
 
Quality: + 
Limited detail provided on 
sampling, data collection or 
analysis 
 
 
17 interviews with Public health 
officials, HIV prevention and 
drug treatment providers, 
researchers, policy makers, 
staff of community based 
organisations and activists 
 
Nine cities were selected from 
thirteen involved in a larger IDU 
study, a lack of SEP data 
prevented all thirteen being 
used. Selected cities were: 
Baltimore, Boston, Detroit, 
Honolulu, Nashville, Oakland, 
Seattle, Miami and Newark. 
The first seven cities listed here 
had successfully implemented 
SEP, the latter two had not. 
 
 
Method of 
recruitment/enrolment and 
response rate:  
Selection criteria:  
No selection criteria for 
individuals is reported. 
 
Of 49 interviews conducted as 
part of a larger study, 17 
interviews were analysed for 
this study as they focused 
substantively on syringe 
exchange. 
 
 
 
 
 
1. SEPs established by community coalitions. Strengths 
identified as broad based support leading to community 
approval and improved sustainability. Weaknesses – 
original plans may be diluted by compromises needed to 
established coalition. 
2. SEPs established by community activists. Strengths – 
willing to take action when no-one else will. Weaknesses – 
Lack of resources, power and legitimacy. 
3. SEPs established top down by govt. authorities. 
Strengths – access to political power and financial 
resources. Weaknesses – slow to react due to bureaucracy 
and vulnerability to community criticism. 
Successful implementation sometimes involved movement 
from one model to another as appropriate. 
Six strategies and resources were identified as 
characterising successful implementation of an SEP. 
Knowledge and effective use of these in combination with 
an ability to move between models contributed to 
successful implantation of the SEPs investigated. 
Staging the debate with sensitivity to political and cultural 
norms 
Coalition building and community involvement 
Leadership – strong leadership with access to local power 
and resources. 
Access to resources 
Researchers and research findings – used to gain support 
and defend the service. 
Overcoming fear of repercussions and political hostility 
 
 
Why: The 
different legal 
basis for needle 
exchange in the 
UK compared 
to US 
 
identify key 
informants 
roles/professions 
and how they 
were selected 
may limit 
usefulness of 
paper 
 
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Finlinson 2000 
 
Country: USA 
Design: Qualitative and 
Quantitative study 
Descriptive study with 
East Harlem New York/ USA, 
Bayamon/ Puerto Rico 
Participant Observation 
Clogging was a commonly encountered problem especially 
with re-used syringes. 
C 
 
Why:  
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Research question:  
Are there any differences 
in drug related HIV risk 
behaviour of Puerto Rican 
IDUs living in New York 
and Puerto Rico? 
What alternative sources 
are there for the 
acquisition of syringes 
including SEPs 
 
Date of study: January to 
August 1998 
 
 
 
 
 
 
 
 
 
evaluation (qualitative study) 
Survey 
Focus group(s)  
Extended interview  
Observation (Participant)  
Structured interview 
 
 
 
Quality: ++ 
Well conducted mixed 
methods study 
 
 
Project study sites 
280 Puerto Ricans (quantitative 
study)  
165 New York, 115 Bayamon 
94 Puerto Ricans (qualitative)  
 
Injecting drug users, Crack 
cocaine users (quantitative) 
 
men who have sex with 
men/Gay men IDUs, Male 
IDUs, Female crack users, 
Community Health 
promoters/outreach workers 
and drug users in recovery 
(qualitative) 
 
Sex (%): Female 21.7% (Puerto 
Rico); 20.6% (New York) 
Male 78.3 (PR); Male 79.4% 
(NY)  
 
Age  - (range or mean): PR 
34.2 years: NY 38.8 years 
 
Group  
All Puerto Ricans. 42.6% and 
43% had completed high school 
in Puerto Rico and New York 
respectively. Similar proportions 
are homeless in both groups. 
IDUs in NY were more likely to 
inject Heroin or cocaine only 
than PR. The majority of PR 
injects a combination of drugs. 
 
 
Clogging of needles is usually caused by adulterants used 
to cut drugs and remnants of blood in improperly cleaned 
syringes. 
Clogging is usually identified when injecting or preparing 
drugs 
This is particularly distressing (clogging) to the severely 
addicted. 
Can lead to borrowing of used syringe and use of discarded 
needles. 
Strategies to deal with clogging by the Puerto Ricans are 
heating and insertion of thin plant materials into needles. 
Syringes obtained form gallery managers are obtained by 
them from SEP and re-sold to gallery clients, or used 
syringes left by IDUs and rinsed with water and loaned out 
to clients.  
Varieties of individuals are in the business of sale of 
syringes. 
IDUs in NY obtain syringes from diabetics and colleagues 
who primarily use SEPs 
Focus Groups 
Connection between clogging of syringes and risky injection 
practices. 
Ease of purchase of syringes from the syringe sellers which 
are the single most important source of syringes in PR 
because it is faster and always there for purchase. 
Price inhibits some IDUs from obtaining as many new 
syringes as needed. 
Quantitative survey 
Puerto Ricans in PR inject twice as much many times a day 
than Puerto Ricans in New York. 
IDUs in PR use each syringe 5.9 times on average while 
IDUs in NY do so 2.9 times. 
Clogging more reported by IDUs in PR (67.5%), NY (31.5%) 
(P<.001) 
Sources of syringe:  
Drug dealer: No significant differences in proportion of 
obtained syringes in both sites. <5% use. 
Shooting Gallery manager: <5% syringes obtained  
Syringe sellers: Single most important source of syringes in 
PR, considerable source 22.9% in NY. 
Pharmacy: IDUs in PR more likely to obtain Needles from 
this source. 
SEPs: Single most important source in NY, only 17.6% IDU 
obtain fro this source in PR  
 
Good evidence 
and study well 
carried out but 
not same 
context as UK.  
 
 
 
Study details Study design and quality Study population Main results Applicability Comments 
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to UK 
populations 
and settings 
Grund 1992 
 
Country: Netherlands 
 
Research question:  
To evaluate needle 
exchange patterns of 
IDUs participating in a 
collective exchange 
scheme (to target 
unknown IDUs) and 
compare them to needle 
exchange patterns on 
IDUs exchanging on an 
individual basis. 
 
Date of study: May 1998 
to June 1999 
 
 
 
Design: Audit/Evaluation  
Semi-structured interview  
Observation 
(Passive/Participant)  
Appraisal of knowledge, skills 
and behaviour 
Ethnographic fieldwork 
 
 
 
Quality: + 
Limited details of methods 
provided in this report 
 
Rotterdam, The Netherlands 
 
HADON: community based 
information program providing 
outreach, prevention and 
referral services to active out of 
treatment IDUs  
Program started before 
implications of AIDS epidemic 
among IDUs were known; 
priorities have shifted towards 
prevention of HIV transmission, 
including needle exchange. 
 
104 exchangers in quantitative 
part of research (25 collective 
and 79 individual exchangers). 
The authors do not report how 
many people took part in the 
qualitative part of the research. 
 
PROGRESS data: none 
reported 
 
Findings from fieldwork: Users who engaged in collective 
exchange seemed more aware of high risk behaviours and 
made more effort to maintain health and hygiene than 
individual exchangers. Needles distributed through 
collective exchange have an impact beyond the user 
collective (e.g. friends who visit a collective exchanger’s 
house to inject).  Nonetheless, there is often pressure on 
IDUs to share needles.  
 
There is some evidence that results were negatively 
influenced by increased police activity during the study. 
 
B/C  
 
Why: I’m not 
sure how 
similar policy is 
to the UK 
 
The conclusion 
about effects of 
police activity 
did not come 
from the 
research 
findings but was 
part of the 
discussion.   
 
Data presented 
are largely 
quantitative; 
details of 
qualitative 
methods are in 
another paper. 
 
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Hay 2001 
 
Country: UK 
 
Research question: How 
good are needle and 
syringe exchange 
services at maintaining 
contact with their clients? 
 
Date of study (to/from): 
1995-1998 
 
 
 
Design: Qualitative: 
Mixed methods: 
1. Descriptive study with 
evaluation (qualitative study) 
Semi-structured interview 
(‘interview’ is all that is stated 
in the paper) 
 
2. Survey (Questionnaire) 
Appraisal of knowledge, skills 
and behaviour: aspects of 
drug use and risk behaviour 
 
Scottish  
city-centre needle exchange 
which covers the whole of the 
city (limited needle exchange 
provision by retail pharmacies) 
 
10 clients of needle exchange 
clinic 
5 staff of needle exchange clinic 
 
Sex (%): 77% male (in whole 
study, n=1556). Not given for 
interviewees 
 
Age (range or mean): “Average” 
Attendance pattern audit found that a significant minority of 
clients only attend once or twice a year. Interviews explored 
potential reasons for this, including:  
 
Whether clients were providing false identifying details. This 
was thought by clients and staff to not be a problem “at first 
you worry a bit but once you get to know them you know it’s 
confidential and nobody can trace you”, although clients 
who did have concerns about confidentiality were probably 
unlikely to agree to be interviewed, those who were 
interviewed did believe that their details were confidential. 
The lengthy questionnaire that first time attendees were 
required to fill in was also thought to be a barrier to 
providing multiple false identifiers.  
 
A 
 
Why: no other 
UK data from 
needle 
exchanges to 
compare with 
this one. Poor 
reporting of 
qualitative part 
of study. 
However, 
similar research 
in a US needle 
exchange 
The qualitative 
element of the 
study was very 
small and no 
details are given 
of methodology, 
however the 
authors do not 
draw 
conclusions 
from the 
interviews, other 
than to point out 
that currently we 
lack data on 
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3. Audit/Evaluation  
Case study  
Local practice report  
Attendance pattern of needle 
exchange clients over one 
calendar year 
 
Quality: - 
Very little detail given of data 
collection, analysis or findings 
from qualitative part of 
research.  Data that are 
reported are not rich. 
 
= 25 years (in whole study, 
n=1556). Not given for 
interviewees. 
 
 
 
Injecting on an infrequent basis. Staff thought that this could 
be a potential explanation for infrequent attendance, either 
because people only used drugs occasionally on a 
recreational basis, or because they are using prescription 
replacements and do not need needles very often. There 
was also a suggestion that not needing to use the needle 
exchange would be seen as a positive thing by clients who 
did not use needles very often, and that perhaps they would 
prefer to use the pharmacy.  These views were from staff, 
not clients. 
 
Use of alternative sources of accessing sterile injecting 
equipment.  Staff mentioned that they routinely provided 
clients with information on pharmacies that supplied 
injecting equipment in that area. Each of the five clients 
interviewed confirmed that they did obtain sterile injecting 
equipment on occasions from pharmacists. 
 
Opening hours. Staff noted that they would be concerned if 
the reason for clients not returning to the needle exchange 
after an initial visit was to do with failure to meet their 
needs. It was noted that the needle exchange normally 
closed at 5pm and was open until 8pm only one day per 
week. 
 
indicated 34% 
of injectors 
attending only 
once (similar to 
this study) 
 
staff-client 
relationships 
within needle 
exchanges and 
about factors 
that may 
facilitate or 
hamper the 
retention of 
clients within 
needle 
exchange 
clinics. 
 
 
 
 
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Jacob 2000 
 
Country: Germany 
 
Research question:  
How feasible, useful and 
efficacious is the provision 
of needle exchange for 
the provision of sterile 
injection equipment and 
the provision of 
communicative methods 
of prevention to drug 
addicted inmates of a 
Design: Audit/Evaluation 
Local practice report  
Appraisal of knowledge, skills 
and behaviour 
Half standardized longitudinal 
examination 
Qualitative examination  
 
Quality: + 
Mixed methods approach; 
details of sampling and data 
analysis not reported. 
 
Lower Saxony/Germany 
 
Male and female prison 
 
224 male and female prison 
inmates, 153 staff of drug 
counselling service and health 
care unit, 75 members of 
external organizations (AIDS-
Help-Groups) 
 
Female prison project: 169 
women took part out of 183 
prisoners 
1. The level of acceptance among prisoners largely depends 
on whether anonymity is maintained during needle 
exchange which can largely be affected by the mode of 
delivery. 
2. The level of acceptance among prison staff depends on 
whether staff members could identify with the goals of the 
project, whether they could actively participate in the 
planning and decision making processes and in setting the 
implementation modalities. 
3. Needle exchange programmes are feasible, i.e. 
organizationally they can be incorporated into everyday 
routine prison work. The project may cause some changes 
in the social structures in the prison: initially, the inter-
relationships can be affected. 
B 
 
Why:  
The positive 
experiences 
gained from 2 
similar pilot 
projects in 
Switzerland 
informed the 
decision by 
policy makers 
in Germany to 
implement such 
The Author 
pointed out that 
there is no 
official rules 
regulating 
NEPs, they are 
usually 
institution 
specific. Not 
every prison 
NEP need a 
dispensing 
machine for 
exchanging, 
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male and female prison in 
Germany? 
How acceptable are the 
above measures by the 
staffs, medical service 
and management? 
Are there changes in the 
drug user’s behaviour and 
knowledge (development 
of needle sharing, 
changes in drug use 
patterns)?  
Are there changes in 
inmates’ knowledge of 
health and health-related 
behaviour (including harm 
prevention measure)? 
 
Female prison project 
from 15/04/1996 to 
14/04/1998 
Male prison project from 
15/07/1996 to 14/07/1998 
 
 
 Male prison project: 83 men 
took part out of 267 prisoners 
 
Age  (range or mean): not 
reported 
 
 
 
4. Threats such as attacks on fellow inmates and staff with 
un-sterile syringes did not occur and the implementation of 
NEP as part of the general health service did not have a 
negative effect on the onward referral of drug users to 
follow-up treatment, on the contrary there was an increase 
in referral treatments. 
5. Needle sharing was not of ritual importance to drug-
addicted inmates, but rather a spontaneous response to 
the non-availability of sterile injecting equipment. 
6. Needle exchange brought to light the discrepancies in the 
drug-users because drug use although officially prohibited 
is accepted as a fact; hence the contrast between a 
prison’s control function and the need to health oriented 
help becomes clear. 
7. There was no increase in drug consumption observed. 
8. Accompanying preventive measures and educational 
programmes for prison staff and information meetings for 
prisoners helped to achieve the overall goal of the 
projects. 
9. The health-related knowledge of hepatitis infection was 
very limited compared to that on HIV and AIDS where NE 
projects were set up.   
 
 
measures, this 
was drawn from 
the similarity of 
the context of 
which the UK is 
no exception, 
where the 
number of 
prisoners using 
illegal drugs 
continues to 
rise and where 
drug users 
make up a 
large proportion 
of the prison 
population.  
 
however, every 
prison should 
have 
discussions on 
the risks 
involved in drug-
use taking 
place. 
 
 
 
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Junge 2000 
 
Country: USA 
 
Research question:  
To examine possible 
formation of new social 
contacts at Baltimore 
syringe Exchange 
program. 
Are there possible 
associations between 
network formation and 
demographic and 
behavioural variables? 
Design: 
Evaluation Cohort study 
 
 
Quality:  - 
Analysis mainly quantitative 
 
Baltimore, Maryland/USA 
 
Field sites 
 
413 Injecting drug users and 
previous injecting drug users 
 
Race/ ethnicity 
African-Americans 91.5%, 
Caucasians 1%, Asian/Pacific 
Islander 0.2%, others 7.3% 
 
Occupation 90.3% unemployed 
 
Gender 67% Male  
Return rate of 51.8%, 29.8% of whom were HIV+ and 85% 
active injectors. 
Amongst active injectors, 84% reported injection at least 
daily during the previous 6months with mean daily injection 
frequency of 4.4 times. 
21.9% reported sharing one’s own equipments with others, 
while 9.1% said they used other injectors used syringes. 
7.7% reported having met at least 1 person at the SEP van 
site since enrolment and mean number of contact was 3.3. 
People who met at least 1 person were more likely to trade 
sex for drug or money during the previous 2 weeks. 
People who met someone were less likely to have injected 
at least daily (70.4 versus 85.2%, P=0.047) and more likely 
to have used other used injection syringes (22.2 versus 8%, 
P=0.026).  
D 
 
Not clear  
 
Why:  
Different 
context, not 
much relevant 
data 
Quantitative 
analysis. 
 
 97 
NSP: Review of qualitative evidence – Full revised report  August 2008 
 
Date of study: February 
1995- February 1997 
 
 
 
 
Age  - (range or mean): 39.1 
average 
 
68.5% are single  
 
 
 
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Kelley 2005 
 
Country: USA 
 
Research question: To 
examine the role of 
volunteers and volunteer 
commitment in relation to 
the organisational 
transition of a syringe 
exchange programme 
from underground to 
legitimate modes of 
operation. 
 
Date of study: 1993-1995 
 
 
 
 
 
 
 
 
 
 
 
 
Design: Descriptive study 
with evaluation (qualitative 
study) 
Survey 
Evaluation  
Case study  
Extended interview  
Observation (Participant)  
Appraisal of attitudes, beliefs 
and values 
 
 
 
Quality: + 
Limited detail provided about 
data collection and analysis 
 
San Francisco, US 
 
Needle Exchange Programme 
 
56 Service providers at the 
syringe exchange 
 
At time of interview only 
seven(13%) respondents had 
been with the programme for 
less than a year, sixteen (28%) 
had been with the organisation 
for 10 years or more. 
 
Race/ ethnicity 
White   68% 
African American 14% 
Latino  13% 
Pacific Islander  4% 
 
Occupation 
Gender 
Religion 
 
Education 
<High school    4% 
High school    7% 
Some college 18% 
College   41% 
More than college  30% 
 
Socioeconomic status 
Social capital 
 
IDU status 
Prevention Point’s founders were researchers and public 
health employees. Several volunteer providers were 
community health outreach workers, others had 
employment in advocacy or community organisation and 
some were in school. 
 
Reasons cited for volunteering in the organisation were 
most commonly the desire to participate in AIDS politics, 
requirements of a class/programme and relationships with 
other volunteers.  
 
Continuing involvement with the programme was related to 
a range of factors including an underlying commitment to 
the harm reduction philosophy and solidarity with other 
providers and service clients. Decisions related to the 
programme were made by consensus and providers 
operated with a level of autonomy this resulted in them 
feeling an active part of the programme 
 
The illegal nature of the operations was an attractive 
element of the experience for many and enhanced 
identification with the clients they were serving. The 
clandestine nature of the work also served to strengthen 
bonds among the providers. 
 
Volunteers’ expectations of the transition to legal status 
mostly related to increased effectiveness of existing 
operations. A reliable source of supplies, development of 
ancillary services i.e. on-site medical care, expansion of 
programme services and training for providers were all 
desired outcomes. 
 
Institutionalised funding prompted both positive and 
negative responses from volunteers. While some felt this 
would legitimise the programme, ensure adequate supplies 
and increase organisation, others feared an increase in 
D  
 
Why:  The very 
different 
political and 
legal contexts 
within which 
programmes 
operate in the 
UK, data 
generated 
thirteen years 
ago and may 
now be out of 
date, little 
methodological 
detail 
presented. 
 
As syringe 
exchange 
operations in the 
UK do not face 
the same legal 
problems as this 
case study, 
there is perhaps 
little of 
relevance to the 
review 
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Never injected  75% 
Active user   18% 
Ex-user  21% 
 
 
 
bureaucracy, a loss of autonomy and less emphasis on the 
political ideology of the programme. 
 
While the organisational transition fulfilled many of the 
positive practical expectations of the volunteers many of the 
motivating factors or ‘ideational rewards’ such as participant 
management, personal responsibility to the needs of the 
clients and even the deviant status of the group were 
removed. This reduced the volunteers’ sense of belonging. 
Many volunteers continued to participate however. 
 
 
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Korner 2003 
 
Country: Australia 
 
Research question: To 
examine the reporting, in 
local print media, of 
syringes found near a 
primary school in Sydney, 
within the context of 
Australian National 
Council on Drugs (ANCD)  
recommendations of 
“balance and accuracy” in 
reporting. 
 
Date of study: Feb-March 
2002 
 
 
Design: Document analysis 
founded in Critical Discourse 
Analysis and Systemic 
Functional Linguistics. 
Case study  
Document Analysis 
 
 
Quality: + 
The study was well 
conducted, but the focus was 
local media reporting rather 
than NSPs as such 
 
Sydney, Australia 
 
Case study was selected as a 
‘critical case sample’. 
 
Four newspapers were 
examined:  
Northern District Times and The 
Weekly Times were selected as 
they are the weekly papers that 
cover the local area. The 
Sydney Morning Herald is the 
metropolitan broadsheet and 
the Daily Telegraph is a 
national tabloid. 
Seven texts in three newspapers dealt with the NSP 
closure, including four news reports and one editorial. While 
there is an absence of overt judgements and sensationalist 
reporting the texts are not value free. The intertextual 
analysis shows an alignment of the papers with positive or 
negative positions relating to NSPs and this case in 
particular. Reporters are able to choose which speaking 
subjects are included and which are 
foregrounded/backgrounded. Politicians and their media 
officers are the most privileged, while drug educators are 
the least represented. No comments from staff or clients at 
the service involved are included in any of the texts. Also 
absent are any public health messages or descriptions of 
the benefits of NSPs.  
 
 
B  
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Larkins 2000 
 
Country: USA 
 
Research question:  
Design: Descriptive study 
with evaluation (qualitative 
study) 
Survey 
Extended interview  
14 NEP workers 
29 NEP clients 
 
Additional 48 NEP clients 
completed survey 
Needle exchange contact provided significant physical and 
modest emotional health benefits to clients. All participants 
claimed to received physical benefits beyond disease 
prevention: increased access to supplies, information and 
services was health promoting. 
C 
 
Why: Abstract 
only; USA 
 
Abstract only: 
hard to 
comment. 
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To examine the impact of 
social support on the lives 
of injection drug users 
who utilise needle 
exchange 
 
 
 
 
 
 
 
 
 
 
Appraisal of attitudes, beliefs 
and values 
 
 
 
Quality: - 
Only reported as abstract so 
no methodological details are 
reported 
 
 
Drugs professionals and IDUs 
 
 
 
 
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Lawrie 2005 
 
Country: UK 
 
Research question: 
What are the views and 
attitudes of the general 
customers towards the 
provision of needle 
exchange services in the 
community pharmacies in 
Aberdeen and Glasgow, 
Scotland 
 
 
 
 
 
 
 
 
 
 
 
 
 
Design: Semi-structured 
interview;  
Appraisal of attitudes, beliefs 
and values 
 
Quality: + 
Some details of data analysis 
are missing 
 
 
80 (non-IDU) customers in 
pharmacies in Aberdeen and 
Glasgow (Scotland) 
 
8 Pharmacies in city centre, 
suburban and rural locations. 
Only 2 of the pharmacies ran a 
NEP. 
 
General public 
 
PROGRESS data: none 
reported 
 
Purposive and quota sampling. 
Predetermined mix of age, sex, 
prescription collection or over 
the counter purchase 
customers.   
 
Although the vast majority of participants were unaware that 
a NEP was provided at their pharmacy most of them were 
supportive of pharmacies offering NEPs. 
 
Two main reasons for their support are the reduction in risk 
of finding discarded needles in public places especially by 
children and the reduction in transmission of diseases. 
 
A small minority was not supportive either because they did 
not want such services to be too visible or because it was 
seen to condone drug injecting. 
 
Age, gender, reason for attending pharmacy and pharmacy 
location did not seem to relate to customers’ views 
 
Majority of participants did not understand the concept of 
methadone services, though those who did showed more 
support for NEP than for methadone services 
 
A 
 
Why:  
Both cities used 
for the study 
have very high 
prevalence’s of 
injecting drug 
abusers and 
both are in 
need of or have 
high demand 
for Needle 
exchange 
services, for 
other parts of 
the UK with 
high prevalence 
of this same 
problem the 
results  can 
seem 
applicable 
given that 
Scotland is 
within context 
of the UK 
Evidence of 
strengths and 
weaknesses of 
the research 
were not pointed 
out by the 
authors, 
however it does 
provide some 
evidence that 
some of the 
perceived 
barriers for 
pharmacists to 
this area of 
service provision 
may not be an 
accurate 
reflection of 
actual attitudes 
held. 
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Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Lewis 1996 
 
Country: USA 
 
Research question:  
What factors influence 
pharmacists decision to 
sell syringes to injecting 
drug users without a 
prescription in Denver, 
Colorado? 
 
 
 
 
 
 
 
 
 
 
 
 
Design: Qualitative study 
Semi-structured interview  
Appraisal of attitudes, beliefs 
and values 
 
Quality: + 
Good methodological quality 
but do not report how many 
researchers analysed the 
data. 
Denver, Colorado/USA 
 
Workplace (pharmacy), social 
place (coffee shop); interviews 
took place in a convenient 
location 
 
32 pharmacists at 24 
pharmacies 
 
PROGRESS data: none 
reported 
 
 
16 pharmacists willingly sold syringes, 11 refused and 5 
were undecided. Emerging themes 
• Concerns about disease transmission and increased 
drug use 
The pro-sellers stated primary motivation to be that of 
preventing blood-borne disease transmission, they did not 
believe that providing sterile equipment would encourage 
drug use and did not believe that making sterile injection 
equipment scarce will deter IDUs from injecting whom 
instead would find other means such as picking up a 
needle off the streets or sharing. Their emphasis is on 
providing sterile injections so that IDUs don’t use 
contaminated needles. 
The non sellers concerns were on implications of selling, 
some indicated their role as one to prevent drug abuse, 
most stated their dis-interest in supporting a behaviour that 
was detrimental to a person’s health. Some suggested that 
by restricting sales IDU’s will be encouraged to seek 
substance abuse treatment instead of injecting drugs, or 
that denying syringe sales might lead to decreased drug 
injection and thus decreased potential for BBV 
transmission..  
The undecided showed equal concern about drug 
addiction and blood-borne disease transmission. There 
was acknowledgement of the public health benefits of 
sterile syringe sales and skeptism that this will increase 
injecting drug use. 
• Business concerns 
Fear of effect on business and their customers. Majority of 
Pro-sellers indicated that this was not a problem; one 
indicated that it actually helped alleviate previous 
problems encountered when there were no sales to IDUs. 
Most indicated that IDUs didn’t want too much attention on 
them and as such caused few troubles. The few reporting 
trouble indicated that the health benefits far outweighed 
the business concerns.  
No sellers had varying reasons, some was primarily 
business, others felt this was an important secondary 
motivation for not selling. The same concerns were also 
cited for the undecided sellers 
• Uncertainty about legality 
5 of the 16 pro sellers stated that the law was not a 
C 
 
Why:  
Small sample 
which makes 
findings difficult 
to generalize, 
also legal 
differences in 
the UK. 
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deterrent to sale; the no sellers who knew the law used it 
as a reinforcement on their decision not to sell. The 
Undecided indicated that the lack of prescription 
requirements by the Colorado Pharmacy Board reinforced 
their decision to sell. 
• Views on Syringe exchange programs. 
All respondents indicated their support for needle 
exchange programme, this was because they felt it will be 
more acceptable to IDUs and will be better equipped to 
provide other services than most pharmacies. Some 
indicated that this would reduce the burden on them as the 
only reliable and legal sources. Other saw NEP as more 
safe and should be coupled with substance abuse 
treatments. 
 
 
 
Study details Study design and quality Study population Main results Applicability to UK 
populations and 
settings 
Comments 
Long 2004 
 
Country: Ireland 
 
Research question: To 
examine prisoners’ views 
of drug injecting practices 
and harm reduction 
interventions in Irish 
prisons. 
 
Study carried out over 5 
weeks during 2000 
 
 
Design: Qualitative: Semi-
structured interview; 
Appraisal of attitudes, 
beliefs and values 
 
Quality: ++ 
Good quality, though it is 
unclear how sample were 
recruited  
 
 
Dublin, Ireland: 
31 male prisoners. 16 were 
injecting drug users and 15 
were non injectors. 
 
Age: median 26 (18-37) 
 
Education 
Only two respondents (6%) 
had completed second level 
education 
 
Drug use 
All of the respondents reported 
taking illicit drugs at some time 
in their lives, three quarters of 
the respondents said that they 
had taken heroin (24/31) or 
ecstasy (24/31) at least once. 
Five (16%) participants said 
that they were using heroin at 
the time of the interview. 
 
Over two thirds (21/31) of the 
participants said that they had 
spent at least 3 of the last 10 
years in prison. Three quarters 
(23/31) of the prisoners 
Two key themes are identified: injectors take risks inside 
prison that they would not if they were outside; and there 
is support among prisoners for interventions to address 
drug misuse.  
 
Opinions on the provision of needle exchange in prison 
are divided, with some support coming from both 
injectors and non-injectors, and an equal number of each 
rejecting the idea. The potential to reduce infection is 
acknowledged and concerns relate to safety and the 
possibility of increased consumption.  
 
B 
 
Why:  
 
Relevant to prison 
population only, and  
unsure about the 
similarities/differences 
between drug 
treatment /harm 
reduction provision in 
the UK and Irish 
prisons. 
 
Use may be 
limited as not 
relating to an 
existing needle 
exchange 
scheme.  
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described their crime as drug 
or alcohol related. 
 
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Matheson 1998 
 
Country: UK 
 
Research question: 
What are the views and 
experiences of illicit drug 
users on pharmacists and 
current pharmacy 
services in Scotland? 
What makes a bad or 
good pharmacy and how 
can current services be 
improved? 
 
 
 
 
 
 
 
 
 
 
 
 
Design: Descriptive study 
with evaluation (qualitative 
study) 
Semi-structured interview 
Observation 
(Passive/Participant)  
Appraisal of attitudes, beliefs 
and values 
 
Quality: ++ 
High methodological quality 
 
Aberdeen, Dundee, Edinburgh, 
Glasgow and adjacent rural 
areas/ Scotland 
 
Sex (%): 77 (62%) male, 47 
(38%) female 
 
Age - (range or mean): 16-56 
years, majority 20-35 years. 
 
 
Work place (pharmacies, Drug 
agencies (NSP) 
Cafes and pubs. 
 
Interviews conducted in a 
variety of settings in a private 
room of the work places (NEPs 
in pharmacies or drug  
agencies) and public places 
(e.g. cafes and pubs) 
depending on comfort and 
location of interviewee. 
 
124 illicit drug users interviewd 
in 23 pharmacies and 8 drug 
agencies 
 
 
People factors relating to characteristics of staff 
Most frequently mentioned feature of a good pharmacy is 
the characteristics of the pharmacists or staff at the 
pharmacy: the way they treat IDUs and their general 
attitude towards them. 
Some respondents felt staff attitude was not important. 
A higher proportion of females than males mentioned the 
importance of being treated like any other customers 
Some indicated the essence of having a good rapport and 
relationship with the staff which helped to reduce the stigma 
and any negative connotations perceived. 
Familiarity appeared to differentiate between a drug user 
and a regular customer. 
Process factors relating to pharmacy services 
Many of the respondents did not want to enter a prolonged 
conversation with the staff. 
Many expressed favouritism to other customers over them. 
A good process was seen as one which was discreet, 
flexible, strict or if advice was offered. 
Structural factor about the pharmacy 
This was the least mentioned category. The need for 
privacy was mentioned by 6 respondents to reduce 
embarrassment faced by them and other customers, 
particularly w.r.t. supervised methadone. 
A good pharmacy was seen as one which provided needle 
exchange or one for ordering toiletries, a total service would 
incorporate both dispensing methadone and providing 
needles. 
Improvements to current services 
45 expressed satisfaction with current services, others 
indicated expectations were low. 
A more flexible service 
More supervised consumption to prevent selling of 
prescription 
Mixed views on whether information should be provided at 
the pharmacies. Leaflets on drug use prevention, 
information can be provided elsewhere e.g. General 
Practitioners, drug workers. 
Having greater availability of needles and syringes through 
more exchange services. 
A 
  
Why:  
Study done in 
different 
settings (city 
and rural) of 
Scotland. 
 
not specifically 
talking about 
needle 
exchange 
programmes but 
gathers 
evidence on 
what works well 
or otherwise for 
Pharmacies 
which are also 
service 
providers for the 
programme. 
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Having more positive attitudes towards drug users.  
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Matheson 1999 
 
Country: UK 
 
Research question:  
What motivates 
Pharmacists to provide 
drug misuse services? 
What are the obstacles if 
any?  
 
Date of study:  
February – April 1996. 
 
 
 
 
 
 
 
 
 
Design: Descriptive study 
with evaluation (qualitative 
study) 
Extended interview  
Semi-structured interview  
Appraisal of attitudes, beliefs 
and values 
 
Quality: ++ 
High methodological quality 
 
Scotland 
 
45 Pharmacists. 
Interviewed at work place 
through telephone interviews 
 
A purposive sampling from 222 
pharmacists volunteering to 
take part to include a range of 
involvement, location of 
pharmacists, attitude, health 
board area and type of 
pharmacy.  
 
PROGRESS data: none 
reported 
 
 
 
 
Motivation to sell needle/syringes 
Two thirds of the participants sold or will sell needles and 
syringes and main reason for this was that they will be 
confident that IDUs will use receive clean equipment and 
thus reduce risk of sharing and spreading BB diseases and 
HIV. 
Barriers to selling needles/syringes 
Among those not willing to sell, the reason often given was 
from concerns about the negative effect on other customers 
and the encouragement of other drug users to indulge even 
more. 
Motivation to provide a Needle/Syringe exchange 
Several participants considered that this was an appropriate 
service and the reducing of injecting equipment sharing and 
communicable diseases was a motivating factor. 
Barriers to providing needle/syringe exchange services 
There was some overlap in reasons given for not providing 
NEP and not selling, issues specific to NEP were the 
perceived issues such as needle stick injuries  
Motivation to dispense controlled drugs 
It was seen as a sense of obligation to the community to 
provide such services. 
Many reported that there were difficulties in providing the 
services but financial incentives often motivated them to 
continue. 
Barriers to dispensing controlled drugs 
Majority because of geographical location which limits 
demand especially in rural areas. 
Concerns for other customers were also noted. 
Violence and theft/burglary if people knew that methadone 
was provided. 
Lack of privacy brought about by the physical limitation of 
the many pharmacies and its resulting effects on the other 
customers was also noted. 
Ethics was also noted 
Health promotion information 
All were willing to keep leaflets on drug misuse yet few did 
so. 
Some felt they had insufficient knowledge to give drug 
misuse specific advice, while some did not see it as their 
role or felt that such advice would not be welcomed. 
 
A 
 
Why:  
Context 
specific. 
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Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Miller 2001 
 
Country: Australia 
 
Research question:  
1. What is the proportion 
of needle and syringes 
disposed and discarded in 
comparison to those 
provided through needle 
syringe programmes. 
 
2. What are the users’ 
perspectives on needle 
syringe programme, 
needle disposal and what 
factors are responsible for 
discarding of these 
needles 
 
Study dates: 18/04/2000 – 
11/05/2000 
 
 
 
 
 
 
 
 
 
 
 
Design: Quantitative and 
qualitative study 
Before and after study  
Semi-structured interview  
 
 
 
Quality: + 
Some details of data analysis 
are not reported 
 
Geelong Victoria/Australia 
 
Needle syringe programme 
sites 
 
60 injecting drug users 
 
Sex (%): Male 60%, Female 
40% 
 
Age - of young people (range or 
mean): 15-51 years. Average 
28.1 
 
 
 
Results shows that from time of previous studies 1996, 
there has been a two fold increase in the both the number 
of needles distributed and returned through needle and 
syringe programmes. Most of the respondents reported 
returning needles to either a needle exchange, public 
disposal unit or disposal container. 
 
Qualitative data showed that females and younger heroin 
users were less likely to access NSPs directly, preferring to 
have an older friend (male or female) to get their needles for 
them (secondary exchange). 
 
Some respondents reported that the need to pay for 
needles and syringes after hours and at weekends when 
NSPs were closed often resulted into risky behaviour such 
as re-use of needles, needle sharing and use of discarded 
needles. Other narrative findings illustrate how the lack of 
available needles can significantly affect the Blood Borne 
Virus risk behaviour of IDUs. 
 
The presence of needle disposal bins were highly 
welcomed by the respondents who reported that there has 
been a largely reduced number of discarded needles have 
reduced in areas where needle disposal bins were placed. 
 
The issue of discarded needles was identified as a major 
concern for majority of the respondents. Some pointed out 
that disposing of a used needle signifies how tidy such a 
person, some pointed out that respect was another factor 
that could lead to persons either discarding needles 
properly or not. Others expressed how ugly and dirty a sight 
of an improperly discarded needle is to passer-bys. 
 
Interviewees pointed out that current laws surrounding 
injecting equipment and law enforcement practices where 
factors which influences discarding of needles. Some 
indicated that they got charged for possession of an opened 
syringe and as such there should be little wonder why IDU’s 
discard needles on the streets. 
C 
 
Why:  
study 
conducted in a 
regional centre 
with a relatively 
small 
population, the 
characteristics 
of the study 
coupled with 
behavioural 
pattern of users 
from such 
context will 
definitely be 
different to not 
only the UK but 
most major 
cities.  
 
Hard to 
reconcile the 
conclusion that 
a vast majority 
of the used 
needles and 
syringes are not 
been discarded 
inappropriately 
and the 
response from 
interviewee that 
current 
legislation 
promotes 
improper 
disposal of 
needles 
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Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Moore 1995 
 
Country: USA 
 
Research question: How 
feasible/possible is the 
establishment of user-self 
organizations as a means 
to reducing the spread of 
HIV among injecting drug 
users in San Francisco  
 
participant observation 
was undertaken for 3 
years 
 
 
 
 
 
 
 
 
 
 
 
Design: Ethnographic Study 
Descriptive study with 
evaluation (qualitative study) 
Extended interview  (open 
ended) 
Observation 
(Passive/Participant)  
Literature review 
 
Quality: + 
 
San Francisco/ United States 
 
an illegal multi-ethnic needle 
exchange service provider 
which is street based. 
 
20 respondents (10 clients and 
10 providers of NEPs) 
 
PROGRESS data: none 
reported 
 
1. Injecting drug users felt a sense of ownership and 
involvement in their participation in needle exchange 
services as evidenced by out-reaches, education efforts and 
sourcing of sites for the programme. 
2. The injecting drug users also provided a source of 
information and encouragement to their friends and 
associates about the needle exchange services, they were 
also a source of secondary needle exchange of syringes, 
condoms and bleach within their social networks. 
3. Through secondary distribution of sterile syringes the 
Injecting drug users were able to create informal syringe 
exchange sites and thus increasing the numbers of IDU’s 
receiving sterile equipments from the exchange. 
4. There was huge interest by many of the clients in 
becoming further involved with the needle exchange in 
different areas that can be beneficial to the services. This 
served as a means of giving back something to a 
programme that they all benefited from. 
5. There was also a sense of achievement with the 
willingness to continue helping the programme irrespective 
of the consequences. 
6. Some stressed the importance that doing drugs is a 
choice thing and if a person decides to continue doing 
drug, they should be able to have access to clean needles. 
7. The participation of clients in needle exchange services 
had resulted in changes in social norms with respect to 
needle use and hygiene. There is more awareness and a 
huge difference was been made. 
8. the responses given served to demonstrate that clients of 
the needle exchange feel and act upon a sense of both 
individual and community responsibility which prompts them 
to support injecting drug users to reduce harm associated 
injecting drug use and to support syringe exchange in it role 
as focus of harm reduction. 
9. Despite the commitment of individuals or groups, this had 
not resulted into broader based organizing on the parts of 
the IDUs in the city due to dire social living conditions faced. 
 
C  
  
Why:  
Given the 
context of the 
study in San 
Francisco 
which has 
varying 
economic and 
legal disparities 
from the UK, 
cannot 
necessarily 
generalize the 
results. There 
are stark 
differences in 
the social 
status of illicit 
drug users in 
UK and in San 
Francisco, In 
the states the 
safety net for 
unemployed 
people often 
does not cover 
basic needs 
such as 
housing, food 
and health care 
in contrast to 
UK which at 
least ensures 
that most 
people attain a 
minimal 
standard of 
living. Small 
sample size.    
 
 
 
Study details Study design and quality Study population Main results Applicability Comments 
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to UK 
populations 
and settings 
Murphy 2004 
 
Country: USA 
 
Research question:  
To examine the ability of 
an SEP to meet the HIV 
prevention needs of IDUs, 
barriers to programme 
use and the potential for 
participants to overcome 
these barriers for 
themselves and others. 
 
Date of study: Data 
collection completed 
September 1995 
 
 
 
 
 
 
 
 
 
Design: A process evaluation 
of a large needle exchange 
programme. 
Evaluation  
Extended interview  
Observation (Participant)  
 
 
 
Quality: + 
No detail reported of data 
analysis 
 
San Francisco, US 
 
Needle Exchange Programme 
 
Date of study (to/from): Data 
collection completed September 
1995 
 
244 IDUs 
 
Race/ ethnicity 
Latino    12% 
Native American 3% 
African American 31% 
Asian    3% 
White    51% 
 
Education 
<High school    30% 
High school    40% 
Some college 23% 
College or more 7% 
 
Sex (%): 39% women, 61% 
men 
Age  - (range or mean): mean = 
38 
 
Group  
Describe:  
Three groups were recruited: 
primary exchangers (n=82), 
secondary exchangers (n=82) 
and non-exchangers (n=80). 
 
There were no significant differences in race, age, gender 
and level of education between the groups.  
Three general routes of syringe distribution were identified 
between primary and secondary exchangers: exchanges 
took place between close friends and lovers; for people 
living nearby; and as part of a drug deal. Consequently 
networks varied in size.  
Barriers to attendance at the SEP included fear of public 
exposure, including being seen by the police, co-workers 
and family members. This was the most commonly cited 
barrier for both secondary and non-exchangers. The legal 
status of some participants in particular meant that they 
perceived it to be too risky to attend in case the police 
identified them.  
Other barriers included physical and mental illness, 
problems associated with location of services and 
intoxification. 
Drug lifestyles also impacted on attendance, with some 
respondents not needing to exchange, due to other sources 
of syringes (commonly, diabetics) or infrequent injecting. If 
needed, primary exchangers would then be approached. 
Secondary exchange is able to respond to all barriers to 
attendance cited, except for those related to alternative 
sources of provision. 
An analysis of HIV high-risk behaviours, reveals that 
secondary exchangers more closely resemble primary 
exchangers than non-exchangers, showing some 
awareness of harm reduction messages. 
 
C  
 
Why:   
The social and 
legal context in 
which the 
service 
operates differs 
from that in the 
UK. 
 
 
 
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Neale 1998 
 
Country: UK 
Design: Qualitative study 
examining drug users 
attitudes and behaviour  
Scotland, UK 
 
Pharmacies and drug agencies 
There was broad support for increased availability of sterile 
injecting equipment. While the situation was perceived to 
have improved, problems of accessibility persist in relation 
A  
 
Why: While 
use may be 
limited by lack of 
methodological 
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Research question: 
To examine drug users 
views on accessing and 
disposing of injecting 
equipment. 
 
Data generated as part of 
a wider study regarding 
drug users views of 
pharmacy services,  
funded by the Scottish 
Office. 
 
 
 
 
 
 
 
 
 
 
 
 
Descriptive study with 
evaluation (qualitative study) 
Semi-structured interview 
Appraisal of attitudes, beliefs 
and values 
Appraisal of knowledge, skills 
and behaviour 
 
Quality: + 
Details of sampling, data 
collection and analysis were 
limited. Data presented were 
not rich. 
124 illicit drug users 
 
White    98% 
 
Drug use 
73% of the sample had injected 
drugs and 80% of sample were 
currently receiving substitute 
drugs on prescription 
 
Sex (%): 62% male 
 
Age: range = 16-56 
 
 
 
to geographical location of services and opening hours.  
 
A need for improved publicity about services offered in 
pharmacies was highlighted, both in relation to accessing 
sterile equipment and provisions for safe disposal. 
 
Most reported that pharmacists did not discuss safe 
disposal with IDU clients. There was no consensus on to 
what extent pharmacists should provide such a service. 
 
The sample of injectors described a variety of sources of 
injecting equipment.  
 
Over half of the interviewees reported having shared a 
needle although increased knowledge and access to sterile 
equipment was reported to have resulted in less frequent 
sharing. Motivations for sharing were mostly situational. 
 
Female respondents were disproportionately more likely to 
experience negative feelings regarding using a pharmacy to 
access/dispose of injecting equipment. 
 
Secondary syringe exchange was described by some 
respondents both in relation to getting equipment to people 
who cannot physically access services, i.e. living in rural 
locations, and for those that prefer not to, i.e. through 
embarrassment. 
 
Almost all users stressed that they disposed of their needles 
safely, however a range of strategies were employed. 
 
There was no consensus among respondents regarding 
preference for accessing services at a pharmacy or 
dedicated needle exchange. NEPs were described as 
having a greater range of services and more approachable 
staff, however pharmacies were seen as sometimes more 
convenient and less stigmatising. 
 
study is UK 
based, it is 10 
years old and 
may no longer 
be relevant, 
there is also 
limited detail 
regarding 
sampling so it’s 
difficult to 
assess how 
representative 
the sample is. 
 
detail 
particularly 
related to 
sampling. 
 
 
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Phillips 2007 
 
Country: UK; USA 
 
Design: Qualitative: 
Appraisal of attitudes, beliefs 
and values 
Structured interview with 
Two samples: 
Nottingham, England; 
Northwest Ohio, USA. 
 
Large proportion reported acceptance of various 
abstinence-oriented treatments and harm reduction 
interventions. Differences existed In acceptance and 
experience of the interventions between the samples.  
A 
 
Although the 
sample is small, 
The authors 
identify efforts to 
avoid response 
bias as a 
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Research question: To 
assess the perceptions of 
drug users regarding a 
broad range of 
detoxification, relapse 
prevention, and harm 
reduction interventions.  
Not stated explicitly.  
 
Samples recruited 
between Sep 2002-July 
2003. Unclear when study 
was completed. 
 
 
 
 
open ended questions 
 
Quality: + 
Limited details given of 
methodology; considerable 
proportion of qualitative data 
reported as counts. 
 
 
UK sample: Recruited from an 
outpatient drug clinic or 
inpatient detoxification ward of 
the Nottingham Alcohol and 
Drug Team or The Health Shop, 
a publicly-supported drop-in 
center offering services to both 
drug users and sex workers. 
 
US sample: Recruited from an 
inpatient residential program for 
women 
 
Sample 1: 48 clients (35 men / 
13 women)  
Sample 2: 40 female clients. 
 
Race/ ethnicity 
Ethnicity data not collected for 
UK sample. US sample 77.5% 
White/Caucasian, 15.% 
black/African American, 5.% 
native American  and 2.5% 
other. 
 
Education 
Sample 1: 54% of sample left 
school prior to O level/GCSE, 
25%  attained O levels/GCSEs, 
20% went on to further 
education. 
Sample 2: 15% did not 
graduate from high school, 35% 
graduated from high school and 
50% went on to further 
education. 
 
Drug use 
Self described substance use 
Sample 1: 94% addicted user, 
6% regular moderate user. 
Sample 2: 80% addicted user, 
7.5% regular heavy user, 12.5% 
regular moderate user.  
 
 
 
Only 15% of US sample found safer injection facilities 
acceptable 
 
Needle exchange 
Rated as acceptable by more than two thirds of both 
samples, the English sample had much greater experience 
of it). Most frequently reported advantage was disease 
prevention. Among the UK sample the most frequently 
reported disadvantage was harm to the larger community 
(from inappropriate disposal of syringes); also encouraging 
a shift from smoking to injecting. 
 
Nottingham 
may be 
considered a 
fairly typical 
English city 
 
strength. But 
recognise that 
there were 
differences 
between the two 
samples in 
terms of 
geographic 
location, gender 
balance, drug 
histories, type of 
treatment 
setting, and 
interviewers that 
made 
comparison 
problematic. 
 
 
Study details Study design and quality Study population Main results Applicability Comments 
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to UK 
populations 
and settings 
Porter 2002 
 
Country: USA 
 
Research question: How 
do Drug Users perceive 
and use services provided 
by Needle exchange 
programmes? 
 
Data collected in1999 
 
 
 
 
Design: Qualitative: Semi-
structured interview;  
Appraisal of attitudes, beliefs 
and values; 
Appraisal of knowledge, skills 
and behaviour 
 
Quality: ++ 
High methodological quality  
 
 
Philadelphia/United States 
 
46 IDUs: 20 exchangers, 26 
non-exchangers 
 
Race/ ethnicity 
African-Americans, Whites, 
Latinos 
 
Occupation 
Both legal and illegal jobs 
(prostitution, primary drug 
dealer), Government benefit 
recipients. 
 
Gender 
Female Exchangers: 46% (12) 
Female Non-exchangers: 46% 
(9) 
Male Exchangers: 55% (14) 
Male Non-exchangers: 55% 
(11) 
 
Age: 24-64 years (Exchangers), 
25-64 (non-exchangers) 
 
Education 
High school or less 
 
Socioeconomic status 
Low socio-economic status (low 
income) 
 
Four category codes from statements made by respondents 
were created.  
1. Category 1 (active involvement): Most respondents in 
this category generally knew about NEP services and used 
full range of services including medical services delivered at 
the exchange and did not require any follow-up outside the 
site. Some exchangers assumed that the staff at the needle 
exchange were very helpful and could help in terms of 
referrals for non drug related care/ treatments. Majority of 
respondents expressed positive feelings about their 
experiences. 
2. Category 2 (Stepping stone): Majority in this category 
were aware that referrals for drug use treatment was 
provided at the NEP and viewed the exchange as a 
stepping stone or potential bridge to help for others or for 
themselves, should they decide to get help. However, the 
NEP was viewed primarily a “work truck” which functioned 
as a source of clean syringes, sterile injection supplies and 
condoms. Respondents were also aware of the other 
services such as medical and HIV testing at the NEP but 
had not used such services. Reasons given for non-use of 
exchange services were: 
- Access to a range of services through other agencies such 
as regular physicians, methadone programme etc 
 - Unwillingness to expend time needed to or wait for a 
service that was offered. 
 - Unreadiness or lack of interest in drug user treatment. 
Most of the exchangers in this category had little previous 
experience with drug user treatment programmes, were not 
currently in treatment and were heavily into street drug 
culture. 
The non exchangers in this category knew they could obtain 
clean needles from the NEP but chose to get clean needle 
from peers via secondary exchange who used NEP, there 
was no difference in knowledge about services available at 
the sits between those who used NEP (the secondary 
exchangers) and their non-exchangers indicating that 
although peers exchanging for them informed them about 
clean needles availability, they did not give them information 
about availability of services. 
3. Category 3: Vague awareness: Respondents in this 
category tended to either know about at least on specific 
services or to be unaware that the sites provided anything 
but needle exchange. 
4. Category 4: Unaware: There was the perception of NEP 
as been a “work truck” where one could get clean needles, 
C 
 
Why:  
USA: Some of 
the participants 
for the 
intervention are 
made up of 
Latinos which 
are not a very 
large group in 
the UK; most of 
them fell under 
the unaware 
category. 
 
 110 
NSP: Review of qualitative evidence – Full revised report  August 2008 
but there was no awareness of the other services provided 
there. There was also a misconception about what was 
provided as other services there. Most Latino fell under this 
category of lack of knowledge of services, most felt 
embarrassed at the prospect of been identified by friends 
and families if they were seen using the sites or its other 
services. Female non exchangers also expressed similar 
concerns about embarrassment at being identified as a drug 
injector. 
 
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Power 1996 
 
Country: UK 
 
Research question:  
How have the IDUs in 
England who are not in 
close contact with 
services been able to 
respond to risk of HIV 
infection? 
 
Date of study: between 
1991 and 1993 
 
 
 
 
 
 
 
 
Design: Descriptive study 
with evaluation (qualitative 
study) 
Survey 
Semi-structured interview  
Observation (Participant)  
Ethnographic study 
 
 
 
Quality: ++ 
Good methodological quality, 
although not specifically 
about SEP 
London, semi-rural area and 
Midlands town /UK 
 
Field sites, research centres 
(work place), semi-public 
venues (pubs and cafes) and 
private homes. 
 
70 Injecting drug users 
 
Place of residence 
London, rural area and midland 
town 
Race/ ethnicity 
Mainly white British 
Occupation 
82% unemployed 
 
Sex (%): M:F=2:1 
Age - (range or mean): 29 years 
for both sexes, 18-47 years 
range. 
 
Less than 50% indicated state 
benefits as their main source of 
income, with 33% into drug deal 
or petty crime. Most used drug 
was heroin and amphetamine 
use a distant second. There is 
also the tendency of poly-drug 
use in the group. 
 
IDUs adopted a variety of multiple strategies to avoid the 
risks associated with injecting. 
Most would either buy a needle from the pharmacy or buy 
or be given by a fellow user to ensure a consistent supply of 
needle equipment to reduce the incidence of others re-using 
their personal equipments. 
Respondents would rather buy a syringe from fellow 
colleagues who are in direct contact with SEPs thus taking 
advantage of the secondary and complementary distribution 
of such over fixed site SEPs. 
Respondents preferred to use pharmacies because of the 
distance unlike the SEP which are very far off, took too long 
and did not like the idea of carry a full bag of syringes. 
The awareness of the use of the individual risk of sharing 
needles was high and strategies employed to reduce this is 
to ensure a supply of new injecting equipment or to re-use 
their own syringes. Re-used syringes are often stored in a 
secured place at home to avoid others from using them. 
Some indicated that they re-use until they replenish their 
stock, while some stated they re-use only for a limited 
number of time. 
An extra strategy used to ensure re-used syringes are theirs 
is by marking such needles to personalize it. 
Cleaning was another strategy mostly by flushing with 
water, if sharing more rigorous methods of cleaning such as 
bleaching will be used. 
Another strategy was selecting of potential sharing partners. 
Respondent believed that no additional risk was involved if 
you shared your needle with your sex partner, some were 
prepared to share the risk of HIV infection with their intimate 
partner, syringe availability was also a factor in determining 
risk management. 
Other situations were risks were taken include drug 
A 
 
Why:  
Done in 
different 
settings in the 
UK. (rural, city 
and town) 
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intoxication and withdrawal or under the influence of drugs, 
high risk venues such street scenes were drugs are bought 
and imprisonment. 
It was common to share drug paraphernalia used in 
preparation of drugs because they felt there was no risk in 
doing so, is a practical aspect of drug preparation and forms 
part of the ritual and social etiquette of drug use and drug 
networks.    
 
 
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Rhodes 2007 
 
Country: UK 
 
Research question:  
To explore the interplay of 
public injecting 
environments, risk 
practices and social 
marginalisation 
 
Study conducted mid 
2005 
 
 
 
 
 
 
 
 
 
Design: 
Descriptive study with 
evaluation 
Semi-structured interview  
Appraisal of attitudes, beliefs 
and values 
 
Quality: + 
Limited detail provided of 
data collection methods 
 
South Wales, UK  
 
The interviews were conducted 
in six locations, This enabled 
data to be collected from urban, 
semi-rural and rural settings. 
 
49 active IDUs 
 
Age: 31 (range 18-47) 
 
Place of residence 
26% No fixed abode 
9% Living in a hostel 
 
Gender 
69% male 
 
Drug use 
80% of respondents injected 
daily, 92% identified heroin as 
most frequently injected drug. 
Recent primary source of 
injecting equipment was non-
pharmacy syringe exchange 
projects for 58%, pharmacy-
based syringe exchanges 16% 
and 22% either friends or 
sexual partners. A fifth (22%) of 
the sample reported injecting 
with a needle or syringe 
previously used by someone 
else in the last 4 weeks. 
Findings presented are primarily related to perceptions of 
public injecting and their implications for identity, including 
reoccurring themes of privacy and shame.  
Injecting in a non-public environment was the preferred 
option for respondents. Public injecting was characterised 
as a situational necessity, influenced by factors such as  
opportunity, immediacy and craving. 
The lived experience of public injecting is shown to increase 
social marginalisation, contributing to a pervasive sense of 
risk and ‘otherness’ among street injectors.  
 
Findings of potential relevance to the review:  
 
Respondents made a distinction between themselves as 
responsible, more hygienic drug users and irresponsible 
‘smackheads’, with responsible users safely disposing of 
not only their needles, but sometimes those discarded in 
public spaces as well. 
Accessing dedicated syringe exchange programmes was 
preferred to pharmacy based exchanges. Using pharmacy 
based services risked public exposure as an IDU and was 
also linked to shaming, both in being overheard when being 
served and in the way IDUs are treated by the staff, “when 
you go into the exchanges you can see they try to be alright 
but it’s not a genuine thing”. 
 
A 
 
Why: May be 
generalisable 
as study 
conducted in 
the UK, 
however non-
random 
sampling 
methods may 
bias results 
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Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Shaw 2006 
 
Country: USA 
 
Research question:  
To describe community 
opposition that emerged 
in response to a syringe 
exchange program in 
Springfield, 
Massachusetts 
 
 
 
 
 
 
 
 
 
Design: Data was gathered 
through participant-
observation, public records 
and in-depth interviews with 
local opinion leaders and 
front-line harm-reduction 
workers.  In addition, 
ethnographic interviews were 
conducted with syringe 
exchange programme 
opponents and African-
American citizens.    
 
Quality: + 
Very little detail of sampling, 
data collection or analysis 
 
Springfield, Massachusetts. 
 
We are informed that 
Springfield has significantly 
more people infected with HIV 
through injection drug use than 
is the case in both the state and 
the US as a whole.  AIDS is 
more prevalent in Springfield in 
people of colour than is the 
case for the rest of the state.   
 
The number of participants in 
the research was not made 
explicit. 
 
Local opinion leaders and front-
line harm-reduction workers 
plus syringe exchange 
programme opponents and 
African-American citizens. 
 
The paper outlines the debate of a syringe exchange 
program in Springfield.  It highlights the marginalization of 
African-Americans in the political system.  The paper shows 
the divergent views of various stakeholders and 
demonstrates how these views impact on the 
implementation of the programme. 
 
C 
 
Why:  
This is 
essentially a 
case study 
which highlights 
the problems 
going on in 
Springfield; the 
generalisability 
to the UK would 
have to be 
taken 
cautiously. 
 
 
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Singer 1995 
 
Country: USA 
 
Research question:  
What role does 
ethnography play in 
evaluation of needle 
exchange project? (to 
address the ethnographic 
gap in needle exchange 
evaluation by describing 
the role of ethnography in 
Design: Ethnographic study 
Descriptive study with 
evaluation (qualitative study) 
Survey 
Brief interview  
Observation (Participant)  
 
 
 
Quality: + 
Focus of paper is on 
methodology rather than 
Hartford/USA 
 
Injecting drug users of Hartford 
NEP 
 
Hartford NEP authorized by 
public Act 92-3 of Connecticut 
General Assembly operated by 
Community Alliance for AIDS, it 
operates as a voluntary 
organization through a mobile 
van clearly marked for 
identification. It operates 5 
The observations of outward appearances, cleanliness etc 
often reveal the overlooked heterogeneity found among 
IDUs 
With continuous use of NEP, the social interaction between 
the staffs and clients become more cordial and informal 
creating room for discussion of more personal topics such 
as emotional, health, family and money. 
NEP can come to be an important part of a client’s social 
network by providing a safe and friendly site for accessing 
needed social support. 
An important product of the relationship is the significant 
level of program recruitment by satisfied users. 
Informal conversations provide foundation for the collection 
C 
 
Why:  
? Article is 
more of 
methodology 
based 
evidence; same 
can be applied 
in the UK. 
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the evaluation of Hartford 
needle exchange project) 
What is the nature and 
effect of staff and client 
relationships 
What differences are 
there in what people 
report (structured 
interview versus informal, 
relaxed conversation or 
during observation in 
natural context. 
 
 
 
 
 
 
 
 
 
 
findings 
 
hours per day for 3 days a week 
 
PROGRESS data: none 
reported 
 
of attitudinal and life history data on IDU which provides 
detailed answers provided in structured interviews. 
Ethnography allows for collection of data on behaviour that 
can have an impact on the spread of HIV. Clients have 
been observed to carry used and un-capped needles in 
their pockets, sneakers, purses, underwear’s and in various 
containers. 
IDUs have special attitudes towards their needles and 
stylized ways of handling and referring to them. 
A fair number of needles are brought in by clients picked up 
from the streets. 
Ethnography help to identify the problems faced by the NEP 
and the revealing of effects of external factors on the ability 
of the project to reach clients e.g. police harassments, 
social environment of location of NEP which are perceived 
to be dangerous, creating opposition to local commercial 
businesses. 
Ethnography can help identify client’s values or preferences 
that influence their use and can contribute to staff training. 
Client perceived barriers to using NEP can often be picked 
up e.g. time wasting, hours of van operation 
 
 
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Snead 2003 
 
Country: USA 
 
Research question:  
To understand why and 
how IDUs engage in 
Secondary Syringe 
Exchange (SSE) to aid in 
the development of a 
large-scale peer HIV 
prevention intervention. 
 
Date of study : Data June 
to December 2000. 
 
 
 
 
 
Design: A formative 
qualitative study to inform 
development of a peer HIV 
prevention initiative. 
Semi-structured interview  
 
 
 
Quality: + 
No details on selection 
criteria for recipient sample 
 
Oakland and Richmond, 
California, US 
Syringe Exchange Programmes 
IDUs engaging in SSE as either 
provider or recipient 
 
n=47, providers = 26, recipients 
=21 
 
SEPs are located in three 
deprived neighbourhoods, 
across two cities, and operate 
for 2 hours one night a week. 
The services are now legal and 
county funded as part of a 
community based harm 
reduction centre. 
 
Sex (%): 30% women, 70% 
Secondary syringe exchange predominantly takes place 
within existing social networks, providers supplying their 
friends and family rather than strangers. In some cases new 
recipients may be introduced by a trusted friend. 
Most recipients reported having one provider; some also 
had other providers they used for backup. 
Many providers reported highly organised SSE operations, 
particularly among those who had a lot of recipients.   
Most SSE was conducted in the providers’ home. Nearly 
half of providers allowed recipients to inject in their home, in 
some cases the primary activity was drug use, in others it 
was syringe exchange. 
All providers reported distributing other harm reduction 
materials alongside syringes. None reported having 
difficulty accessing supplies from the SEP. 
Most providers cited altruistic motivations for providing 
syringes, however there was often also an expectation of 
generalised reciprocity.  
Many providers also saw their role as providing a 
community service and some displayed pride in their status 
C 
 
Why:  The 
small sample 
size and the 
different socio-
political and 
legal context. 
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men (4% also identified 
themselves as transgender) 
 
Age: provider mean age = 52 
recipient mean age = 47 
 
Race/ ethnicity 
Latino    4% 
Native American 4% 
African American 65% 
Other    4% 
White    23% 
 
Employment status 
Unemployed  67% 
Part time  24% 
Full time  9% 
 
Education 
<High school    40% 
High school    34% 
Some college 21% 
Bachelor’s degree 5% 
 
Drug use 
Majority of participants injected 
heroin exclusively, some injected 
speedballs and/or cocaine in 
addition to heroin use. 
 
as a role model. 
The findings suggest that there are many natural 
opportunities for SSE providers to educate recipients in risk 
reduction. Most providers reported sharing harm reduction 
information with recipients, particularly around safer 
injection practices. 
Recipients reported convenience of SSE and logistical 
difficulties in accessing SEP as primary motivations for 
accessing SSE. 
Most providers expressed enthusiasm for the idea of being 
trained asa  peer educator. 
Topics suggested for peer education included: safer 
injection practices; prevention, diagnosis and treatment of 
HIV and HepC; and abscess prevention and treatment. 
 
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Somlai 1999 
 
Country: USA 
 
Research question:  
To describe the use of the 
community identification 
process to produce data 
to inform the planning of 
an NEP; and to describe 
the implementation and 
operation of the resultant 
intervention.  
Design: A case study of the 
implementation of an 
intervention based upon 
social science and 
community assessment 
research. 
Descriptive study with 
evaluation (qualitative study) 
Case study  
Semi-structured interview  
Observation  
(Passive/Participant) 
Milwaukee, Wisconsin, US 
 
The following participated in the 
development of the NEP, either 
as part of the community 
identification research or as part 
of NEP task force: 
IDUs 
Outreach workers 
Researchers 
Alcohol/drug treatment 
professionals  
Physicians 
The community identification process showed different IDU 
sub cultures within the city that would require services 
tailored to their specific needs. 
In relation to NEPs, there was an ‘overwhelming’ amount of 
support from IDUs, with some hoping that it may lead to 
greater community acceptance of their drug use as a 
medical rather than criminal behaviour. However many of 
the respondents were sceptical about the amount of 
political/community support for the service. 
While possession of injecting equipment is not prohibited in 
the study area, IDUs were regularly arrested under drug 
possession laws if a syringe had a trace of illegal 
substances, it is suggested that this acts as a barrier to 
C 
 
Why: Actual 
sample size is 
unclear, focus 
is on a specific 
local area not 
designed to be 
representative, 
differences in 
legal and socio-
political 
climates in US 
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Quality: - 
Research design unclear. 
Little detail about 
methodology. 
 
and representatives from: 
Advocacy and activist groups 
Community based services 
providing for IDUs 
Religious community 
Public school systems 
Local health departments 
Local universities 
Mental health services 
AIDS organisations 
Law enforcement  
 
300 individuals were recruited 
to the study 
It is unclear whether the whole 
sample was interviewed 
 
PROGRESS data: none 
rpeorted 
access to sterile equipment. The legal purchase of syringes 
from pharmacies was also shown to be problematic. 
Key findings of the research were reflected in the features 
of the planned NEP: a mobile facility was planned to 
respond to the geographically distinct areas of IDU 
concentration; outreach workers reflecting the demographic 
diversity of the IDU population were needed as injection-
related and sexual risk behaviour were shown to be 
influenced by gender, race and age; and marketing 
messages reflected the finding that primary motivations for 
needle sharing involved economics and comfort. 
The NEP encountered less resistance to it’s establishment 
than expected, partly as a result of efforts to engage 
potential opposition in planning stages. In particular 
community groups were presented with the findings of the 
community research along with research evidence 
supporting NEPs. Neighbourhood meetings were also held 
and were considered ‘instrumental’ in obtaining community 
support. 
Concerns were expressed at community meetings about a 
fixed site NEP encouraging violent and criminal behaviour. 
A mobile facility was more acceptable. 
 
and UK  
 
 
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Spittal 2003 
 
Country: Canada 
 
Research question:  
To investigate the role of 
needle exchange 
personnel in attempting to 
provide access to sterile 
equipment and  the critical 
role that ‘point-for-point’ 
policy and ‘loaner policy’ 
may have played in the 
Vancouver epidemic 
 
Date of study (to/from): 
May 2000-March 2001 
 
 
Design: 
Ethnographic ‘ride 
along’/’walk along’ study 
Extended interview  
Observation 
(Passive/Participant)  
 
Quality: + 
Limited detail of sampling 
strategy and data analysis 
 
Vancouver, Canada 
 
Needle Exchange Programme 
Downtown Eastside area of 
Vancouver is an inner city 
neighbourhood well known for 
its public drug use scene and 
incidence of HIV and Hepatitis 
C are high. 
 
Research focused on one 
needle exchange organisation – 
Downtown Eastside Youth 
Activities Society (DEYAS) 
 
DEYAS staff members – 
exchange agents. 
 
Discrepancies between policy and practice are described. 
While one-for-one exchange is still the dominant policy, 
evidence suggests that there is a large demand for needles 
from clients with none to exchange. As a result an informal 
‘loaner’ system has developed based on agreements and 
relationships between exchange agents and their clients. 
The decision to ‘loan’ equipment is made on a client-by-
client basis and the need for clients to return the equipment 
is stressed. This system has become unofficially condoned 
and on any given mobile exchange route it is accepted 
practice that ‘loaners’ make up 5-10% of the syringes 
distributed. The findings suggest that not only is this a small 
proportion of the total volume but that often this equipment 
reaches those who are most at risk. Unofficial limits on the 
amount of ‘loaners’ distributed in one shift may result in 
some clients being refused. Observations from the fixed site 
show discarded equipment being collected and returned to 
the exchange by clients and other members of the 
community. 
B/C  
 
Why:  The strict 
Provincial 
policy context 
within which the 
service 
operates. The 
specific issues 
of the study 
area, for 
example high 
rates of HIV 
and high 
prevalence of 
cocaine 
injection.  
 
Good insight 
into grey area 
between policy 
and practice, not 
sure how far the 
results can be 
generalised 
though 
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Study details Study design and quality Study population Main results Applicability to 
UK populations 
and settings 
Comments 
Springer 1999 
 
Country: USA 
 
Research question:  
What are the perceptions 
of IDU and non IDU 
community members on 
syringe disposal 
interventions in Atlanta 
Georgia? 
 
What are the benefits and 
obstacles if any? How 
feasible are these 
disposal methods? 
 
What are the community 
members perception of 
and experiences with 
injecting drug users within 
their community  
 
Study dates: September 
1996 to March 1997 
 
 
 
 
Design: Qualitative study 
Extended interview  
Appraisal of attitudes, beliefs 
and values 
 
Quality: ++ 
High methodological quality 
 
Atlanta/USA: area of high drug 
sales and drug use. 
 
Street outreach: interviews 
conducted in 2 offices centrally 
located in the community 
32 non injecting community 
members 
26 injecting drug user 
community members 
 
Sex (%):  
Community member : 50% 
male, 50% female 
IDUs : 77% male, 23% female 
 
Age: 
Community members: 22-64 
years, mean: 40 
IDUs : 23-55 years, mean: 40 
 
Race/ ethnicity: 
Community non IDU members: 
African Americans 100% 
Community IDU members: 
African-Americans 96%, 
Caucasians 4% 
 
Occupation 
Community non IDU members:  
Legal employment 50%, non 
legal employment 50%. Not 
reported for IDUs 
 
Education: 
Community non IDU members: 
<high school graduate 41% 
High school graduate 44% 
Some college 16% 
3 disposal methods were discussed. 
Syringe exchange programme  
The injecting drug users preferred using SEPs to the other 
disposal methods and community members’ opinion about 
SEPs were generally positive.  
Both IDUs and community members believed that access 
to new syringes will be beneficial largely because it would 
reduce the reuse of syringes and thus reduce the risk of 
HIV transmission in the long run. 
IDUs major concern was the risk of getting arrested for 
possession of a syringe 
IDUs were more willing to take the risk of getting caught 
and arrested for syringe possession if they were receiving a 
new syringe for an old one disposed 
The incentive of a new syringe was not a motivating factor 
for 2 IDUs who had legal access to free syringes but both 
were still willing to dispose of their syringes at a SEP. 
Both IDUs and community members believed that the 
incentive of receiving new syringes would motivate people 
to pick up discarded syringes and return them to an SEP 
thus helping to clean the community and reduce accidental 
needlestick pricks.  
2 main disadvantages mentioned by IDU was fear of arrest 
and being identified as an IDU. 
Disadvantages mentioned by community members centred 
on moral issues of providing new syringes to IDUs, it is 
believed that stopping drugs altogether is better than giving 
new syringes. 
Syringe Collection Program 
Most of the IDUs and community members were not in 
support of this method as a means of disposal 
General concern was for fear of being arrested for 
possession of syringes which will be easily detected once 
stored in their homes in the containers. 
Another concern expressed was safety of syringes placed 
in trash cans which could injure people while emptying or 
rummaging through. 
There was concern about the impracticalities of this method 
for the homeless. 
Results show that though this method was not generally 
accepted for disposal of multiple syringes, it was a 
C 
 
Research was 
conducted in an 
area where drug 
paraphernalia 
laws exists 
which 
prevents/restricts 
people from 
using the 
disposal 
methods for fear 
of being 
arrested. In the 
UK such laws 
are less strict, for 
this reason the 
results may not 
reflect the true 
picture and may 
vary in the UK. 
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Community IDU members: 
<High school 31% 
High school 46% 
Some college 23% 
 
Social capital: 94% of non-IDUs 
have children and 53% had 
spent 10 years or more in the 
community.  69% of IDUs had 
been in prison in the last 5 
years 
reasonable alternative for disposal of individual syringes 
which is already being used by many IDUs. 
One-Way Drop Box 
Community members favoured this method much more 
than the IDUs who support this method but with caution. 
Both groups believed that this could reduce reuse by IDU 
as well as reducing risk of children being stuck by a 
discarded needle. Though there were concerns that boxes 
can be opened by children who gets curious about its 
contents, desperate people who want to sell them or by 
IDUs who need a syringe. 
Other notable disadvantage by the IDUs is the fear of being 
identified as a drug user by people other than the police 
and harassment and possibly arrest while carrying needles 
to the drop box. 
 
 
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Strenski 2000 
 
Country: USA 
 
Research question:  
What influences do 
syringe exchange 
programme have on 
injection practices 
How do they influence the 
settings in which drug 
injection occurs? 
How have shooting 
galleries evolved in 
response to SEP and 
what additional factors 
affect the use of shooting 
gallery? 
What barriers are 
experienced in SEP? 
 
 
 
 
 
 
Design: Ethnographic study 
Brief interview  
Extended interview  
Semi-structured interview  
Appraisal of attitudes, beliefs 
and values 
 
Quality: ++ 
Generally well conducted, 
though small sample size and 
predominantly male 
participants 
 
Chicago/USA 
 
Work place/Syringe exchange 
sites 
14 Injecting drug users using 
Needle exchange services 
provided by Chicago Recovery 
Alliance. 
 
Sex (%): Female IDUs: 7%(1) 
              Male IDUs: 93% (13) 
 
Age: 36-57 years, mean age 47 
 
Race/ ethnicity 
2 Caucasians, 7 African-
Americans and 4 Hispanics.  
 
Occupation 
4 had no source of income, 4 
relied on government benefit, 1 
was fully employed, 1 was 
partly employed and 4 illegal 
hustling. 
 
Impact of SEPs on Shooting Galleries 
In all 3 settings there has been a trend away from the large 
traditional cash or free shooting galleries housed in 
neighbourhood apartments to much smaller cash or taste 
galleries as a result of the presence of SEPs and personal 
reserve of sterile needles. 
Reason given for using shooting galleries prior to SEP was 
that users found it difficult to get syringes from elsewhere, 
but that is not a usual occurrence anymore. 
Sharing of needles was very popular in the shooting 
galleries, although they  aware of the risks involved with 
recycled needles, Users actually valued not sharing and 
needle re-use was partly resulting from lack of access to a 
legal supply of sterile syringes. 
Residual blood in the needles did not always serve as an 
inhibition not to re-use a needle often times when IDU had 
to make judgements about the health of others who had 
used a syringe before them. 
Withdraw symptoms of drug often times puts the IDUs in 
desperate position where the hazardous risks of sharing 
often overcomes their judgement of  making a healthy 
decision even after the AIDS epidemic, more often than not 
used syringes are now cleaned with bleach. 
Problems of dull, broken and regularly malfunctioning 
needles at the galleries had led users to get involved with 
crime following frustrations from these problems and 
C 
 
Why:  
Though the 
study was 
conducted in 3 
settings with 
variable socio-
economic 
predisposition 
which can 
reflect different 
settings here in 
the UK and 
thus give 
credibility, I 
don’t see how 
results can be 
generalized; the 
author has 
made 
conclusions 
from a small 
sample from 
less than 8% of 
actual 
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Education: 
2 high school graduates, 2 
some college, 10 less than 12 
years education. 
 
Socioeconomic status 
Low socio-economic status (low 
income) 
 
Social capital: All participants 
were career drug users (use of 
injection Heroin/cocaine twice 
daily for 20 years or more), all 
had homes and 12 had served 
jail terms  
 
unhygienic conditions at galleries. 
Acknowledgement of shooting galleries as very dangerous 
places was well recognised by respondents. 
Large free or cash galleries are not accepted by 
respondents only used in cases of desperation. 
SEPs, Increasing community policing programme and 
government intervention has lead to a decrease in number 
of large galleries. 
Networks serve as a safe alternative to free or cash 
galleries whose stability depends on nature and duration of 
relationship, health status, trouble with the law and living 
arrangements. Also scarcity and high cost of heroin has 
caused networks to be more important where principle of 
reciprocity applies re-enforcing the group as a safety net. 
Other positive outcomes of SEP are the less need to share, 
loan or sell used syringes between one another and many 
are adopting the one-shot one syringe policy.  
Risk behaviour associated with injection practices 
Routing sharing of cookers which respondents did not 
consider as sharing as long as each had their own needle. 
Backloading and the use of common cup of water to draw 
up drug mixing liquid still commonly practiced. 
Cleaning of wound site prior to injecting was not commonly 
practiced even after been preached by SEPs. 
Often times an IDU felt all other harm reduction methods 
were unnecessary so long as a sterile needle is being used. 
IDUs associated HIV only with dirty needles and not with 
other risk behaviour such as unprotected sex, sharing of 
other paraphernalia and using bleach to clean a used 
needle. 
IDUs believe that you could re-use your personal needle 
several times before exchanging so long as it’s not dull. 
Desperation often times causes reverting to risky behaviour 
even in the most careful of users.   
Barriers to SEP use 
Concerns about privacy, fear of being seen exchanging and 
been exposed as a user, this is more popular amongst 
business professionals, health workers and bus drivers who 
sends some else on their behalf.  
Problems with Law enforcement such as police 
harassments, confiscation of possessed needles and arrest. 
Personal safety issues and fear of being robbed by fellow 
addicts who don’t want to go to the sites themselves. 
 
respondents. 
Also the racial 
make-up is also 
one for 
concern???, 
gender bias of 
results 
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
Comments 
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and settings 
Strike 2002a 
 
Country: Canada 
 
Research question:  
To examine the strengths 
and challenges of four 
service delivery models: 
fixed site, mobile, satellite 
sites and home visits, 
from the points of view of 
NEP staff and managers, 
and how service delivery 
may impact on NEP HIV 
prevention efforts 
 
Date of study: November 
1998 to April 1999 
 
 
 
 
 
 
 
 
 
Design: Descriptive study 
with evaluation (qualitative 
study) 
Semi-structured interview  
Observation 
(Passive/Participant)  
 
 
Quality: + 
Some methodological details 
missing 
 
Ontario, Canada 
Needle exchange programs 
 
59 participating individuals from 
15 NEPs 
 
NEP staff and managers at all 
Ontario NEPs and government 
officials involved with the 
Ontario provincial needle 
exchange program. 
66% worked for a public health 
unit, 22% for an AIDS service 
organisation, 12% for another 
agency type. 
61% were frontline NEP staff/ 
coordinators. 
 
Fixed sites: NEPs try to ensure sites are geographically 
accessible to clients, have a non-clinical appearance and a 
friendly atmosphere. Location, adequate space and opening 
hours are seen as constraints that can negatively impact on 
client development and retention. Negative attitudes from 
non-NEP staff within parent organisations and client 
perceptions of sites as being too clinical or ‘gay-oriented’/ 
HIV-related can reduce program attendance. Fixed sites 
can also attract local opposition. 
 
Mobile NEP services: Mobile service is believed to increase 
accessibility for clients who prefer to exchange in evening 
hours, do not have a vehicle or money to travel and/ or 
cannot travel. Older NEP services tend to have agency-
owned vehicles but newer services use worker’s personal 
vehicles which can lead to additional expense and safety 
hazards for workers. Human resources shortages (e.g. 
sickness or holidays) can severely impact on operation of 
mobile services. Mobile service is viewed as insufficient for 
incorporating other harm reduction interventions. 
 
Satellite NEP site model: Perceived benefits of satellite sites 
include offsetting human resource and space costs and 
increasing accessibility: agencies who serve a different type 
of clientele, are open at different times or situated in a 
different place are invited to be satellite sites. Perceived 
problems include satellite agency staff not following NEP 
service guidelines, and refusal to act as satellite sites due to 
rejection of harm reduction principles. 
 
Home visit model: Perceived benefits include accessibility 
and credibility of the NEP. Workers who are former IDUs 
are more accepting and comfortable with this mode of 
delivery than other workers. This is a contentious issue with 
some interviewees opposing home visits for reasons of 
worker safety and intrusiveness into clients’ personal lives. 
B  
 
Why: 
Legislation and 
policy in 
Canada is 
similar to the 
UK but urban 
geography can 
be very 
different so 
issues of 
accessibility 
may not all be 
generalisable. 
 
Same study as 
Strike 2004; 
Strike 2002a 
 
 
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Strike 2002b 
 
Country: Canada 
 
Research question: To 
Design: A qualitative study 
using a modified 
ethnographic approach. 
Extended interview;  
Semi-structured interview 
Medical and Executive 
directors, Coordinators and 
workers at NEPs in Ontario, 
and 
Provincial government officials 
Exchange policies within the NEPs vary from a one-for-one 
exchange to a distribution policy. The flexibility with which 
these are applied also varies. The findings suggest that 
exchange practices are linked to the definition of needles as 
objects of ‘risk’ or ‘prevention’.  Where needles are ascribed 
B Strength- in 
depth 
examination of 
day to day 
issues within the 
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analyse the consistency 
among needle exchange 
practices, HIV prevention, 
harm reduction goals and 
potential programme 
effectiveness. 
 
 
 
 
 
 
 
 
Quality: + 
Little detail provided about 
data collection or data 
analysis framework.  The 
analysis procedure is explicit, 
however it is unclear how the 
programmes were ascribed to 
the ‘risk’ or ‘prevention’ 
categories, whether this was 
developed through attitudinal 
questions or an assessment 
of the NEPs policies. 
 
(n=59) from/ related to 15 
Needle Exchange Programmes 
in Ontario, Canada 
 
a ‘risk’ meaning by an NEP, a strict one-for-one policy is 
likely to be implemented with clients encouraged to take 
fewer needles and penalties applied to those who do not 
adhere to the rules. Two thirds of the programmes place 
more emphasis on needles as prevention objects.  
Exchange rate policies are more lenient as increased 
access to and distribution of needles is the main focus.  
Younger programmes are more likely than older 
programmes to conceptualise needles as objects of risk and 
have strict exchange policies. 
 
 
NEPs. 
Weakness- 
views of the 
NEP clients are 
not assessed 
 
 
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Strike 2004  
 
Country: Canada 
 
Research question: To 
explore how NEPs 
establish, define and 
defend their existence 
within their communities  
 
 
 
 
 
 
 
 
 
 
 
Design: Qualitative: Local 
practice report ; 
Semi-structured interview 
 
Quality: + 
Little detail given of sample 
recruitment, data collection or 
analysis. Limitations not 
discussed. 
 
 
Ontario, Canada 
 
59 Coordinators, managers and 
workers at 15 NEPs in Ontario 
Medical Officers of Health, 
Executive Directors and key 
informants from Ontario Ministry 
of Health and Long Term Care 
 
Sex (%): 56% women, 44% 
men 
 
39% of participants were 
involved with the NEP when it 
opened 
 
 
The operation of an NEP is likely to require delicate 
balancing of interests of the clients, workers, organisations 
overseeing the service and the wider community. Even as 
the number of NEPs has increased programmes still face 
difficulties finding a place, both financial and spatial, within 
the parent organisation as activities are sometimes seen as 
‘non-core’ and clients as ‘undesirable’. From the perspective 
of the clients the stigma of some parent organisations may 
affect acceptability of a service. Within communities public 
opposition is linked to concerns about dangerousness and 
contamination of the area by undesirable individuals and 
paraphernalia. Residents may not perceive that there is a 
need for a programme or may be concerned that it will 
undermine attempts to redefine the neighbourhood. 
Workers respond to the stigmatisation of their clients by 
contesting the differentness of their clients from the wider 
community. Approaches developed to contend with 
opposition are described including, the involvement of 
community partners in the planning process, keeping a low 
profile and locating to less contentious locations. 
 
B 
 
Why:  
The concepts of 
stigma, NIMBY 
and place and 
the legal basis 
of the NEP are 
comparable in 
the UK. 
 
Same study as 
Strike 2002 
(different 
outcomes, same 
people) 
 
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
Comments 
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and settings 
Strike 2005 
 
Country: Canada 
 
Research question: To 
explore syringe access 
patterns and implications 
for HIV prevention 
programming. 
From where or whom and 
in what quantities to IDUs 
obtain syringes? 
What programmatic, 
social or economic factors 
influence these 
acquisition patterns? 
What is the relationship, if 
any, with HIV risk 
behaviours? 
 
Study conducted 2000-
2001 
 
 
Design: Qualitative: 
Audit/Evaluation  
Brief interview  
Extended interview  
Semi-structured interview  
 
 
Quality: + 
Some methodological details 
of data collection and 
analysis are not reported 
 
 
Toronto, Canada 
 
Some participants 
recruited/interviewed at Syringe 
Exchange Programme, others 
from the wider drug using 
community 
 
80 IDUs were interviewed.  
Other key informants were also 
interviewed as part of the 
evaluation of the SEP.  
 
PROGRESS data: None 
reported 
 
The data suggests that IDUs are able to determine from 
where they get their injecting equipment and in what 
quantities. It is shown that some prefer the free syringes 
available from SEPs while others prefer to pay for OTC 
equipment for convenience and anonymity. Three 
behavioural patterns were identified related to syringe 
access: those who stockpile large numbers of sterile 
syringes (typically over 100), often for secondary distribution 
to friends and acquaintances as well as for personal use; 
those who plan ahead and maintain a 1-2 week supply often 
from a range of sources, based on convenience; and IDUs 
who obtain equipment as needed, either through a 
conscious decision to not be in possession of syringes (for 
example for fear of police harassment) or through a lack of 
organisation. The first two behavioural patterns are 
associated with more stable housing, relationships and drug 
using behaviours, whereas the last group were likely to 
have more chaotic lives and unstable housing.   
Syringe access is an issue for all three of these categories 
as exchange policies at some SEPs may limit the amount of 
equipment distributed and OTC sales are at the discretion 
of the pharmacist. Most stockpilers and planners are shown 
to be willing to give away, rather than sell, sterile syringes 
and some have informal peer exchanger agreements with 
the SEP. The evaluation of the peer run SEP shows 
benefits to the formal involvement of peers in the 
programme including providing a user-friendly environment, 
developing employment skills, sending a positive message 
to other IDUs and foster community development.  
 
B 
 
Why:  
The legal and 
social context 
within which 
syringes are 
acquired in the 
study area is 
similar to that in 
the UK.  
 
They compare 
their findings to 
those from 
studies in 
Montreal and 
Vancouver: the 
findings are not 
similar to the 
Vancouver 
study. They 
suggest this is 
because data on 
risk behaviour in 
this study is 
more detailed 
(strength). 
 
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Tempalski 2007 
 
Country: USA 
 
Research question:  
To determine existence, 
size, timing and sources 
of opposition, support and 
controversy regarding 
drug abuse treatment, 
outreach, syringe 
exchange and other 
Design: Descriptive study 
with evaluation (qualitative 
study) 
Semi-structured interview  
Appraisal of attitudes, beliefs 
and values 
 
Quality: + 
Limited detail of data 
collection and analysis 
 
32 metropolitan statistical areas 
in the USA 
 
workplace 
Interviews took place between 
August 2001 and February 
2004 
 
93 interviewees in 32 MSAs 
 
24 SEP directors 
14 drug treatment providers 
Respondents cited that critics to SEPs frequently used 
language regarding the immorality of drug use. 
Respondents reported that they tried to focus debate on 
questions of public health and the importance of safe 
injection. 
 
Themes were:  
1. institutional and/ or political opposition based on 
    (a) political and law enforcement issues associated with 
state drug paraphernalia laws and local syringe laws; 
   (b) harassment of drug users and resistance to services 
for drug users by local politicians and police; and 
C 
 
 
Why: The paper 
is about US 
policies which 
stigmatise 
SEPs and drug 
users. It would 
be relevant to 
the UK if similar 
policies were 
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responses to HIV/ AIDS 
among IDUs, and whether 
any of these programs 
became foci of 
controversy in the media 
or in political campaigns. 
 
 
 
 
 
 
 
13 outreach workers 
28 researchers 
14 public health administrators 
 
PROGRESS data: None 
reported 
 
   (c) state and local government (in)action or opposition; 
and 
 
2. stigmatisation of drug users and SEP resistance from 
neighbours and businesses. 
 
1a. Government structural constraints, which differ by state 
and locality, can significantly reduce the ability of IDUs to 
purchase and possess sterile syringes. Both clients and 
service providers have been arrested for carrying or 
exchanging syringes. 
 
1b. Types of harassment and prejudice by politicians and 
police mentioned by respondents included city council 
members opposing syringe exchange to maintain their 
constituents’ support, and scapegoating of drug users as a 
result of an increase in crime, leading to police cracking 
down on drug users. One respondent also described 
physical abuse of SEP workers by the police which led to 
the program shutting down. 
 
Anti-SEP advocates agree with legal policy and law 
enforcement efforts, that SEPs work against the goals of 
abstinence-based treatment programs and the ‘war on 
drugs’ by enabling drug use. 
 
1c. Political (in)action.  Fear of adopting or discussing SEPs 
because of perceived political opposition can be some of 
the biggest barriers to implementing programs in some 
localities. Political opposition can occur at difference 
government levels and can paralyse attempts by community 
members to start a SEP. In other areas respondents 
reported that government inaction created a political 
opportunity structure that enabled harm reduction activists 
to set up SEPs in some localities. 
 
2. There was wide variation reported in opposition to SEPs 
from neighbours and businesses.  Stigma and prejudice 
attached to drug users and drug use contribute to local 
arguments against SEPs in areas where SEPs are located. 
In some cases local organised resistance to SEPs came 
from religious or minority communities; other reasons for 
opposition included the belief that distributing clean needles 
encourages drug use or is morally wrong.  Resistance to 
SEPs did not exist in isolation and different players can 
generate opposition to SEPs, e.g. neighbours and 
businesses putting pressure on local politicians or client 
providers to make a program relocate, which could lead to 
fewer people accessing those services. 
adopted here 
but at the 
moment the UK 
government 
supports SEPs  
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Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Voytek 2003 
 
Country: USA 
 
Research question:  
To examine the 
motivations for people 
who provide secondary 
syringe exchange to other 
IDUs and why some IDUs 
do not use the Baltimore 
Syringe Exchange 
Programme.  
 
Date of study: 1997 
 
 
Design: 
Qualitative interviews 
exploring the motivations of 
participants 
Semi-structured  
interview 
 
Quality: + 
Short report so reporting of 
many details limited; difficult 
to assess validity 
 
Baltimore, US 
 
Needle Exchange Programme 
Providers of secondary syringe 
exchange (n=20) 
Recipients of secondary syringe 
exchange who had never used 
the BNEP in 1997 (n=10). 
 
All African American 
Sex (%): 37% female, 63% 
male 
 
 
SSE providers reported motivations centred around altruism 
and economic gain. The specific circumstances of the 
transaction often influenced whether the syringe was sold or 
given away. Influential factors included: relationship to 
recipient, current wealth, and desperation. Among those 
that regularly sold syringes a quarter reported collecting 
discarded needles from public places to exchange at BNEP. 
While recipients of SSE generally believed the NEP to be a 
valuable service, they felt it was not suitable for them for a 
range of reasons including; not convenient, location, not 
wanting to carry equipment, queues and lack of privacy. 
The most common sources of needles distributed through 
SSE were: NEP, diabetic, pharmacy, hospitals, clinics and 
street sales. 
 
C 
 
Why: 
Motivations 
reported by 
both the 
providers and 
recipients 
would be 
applicable in 
the UK 
 
Short report only 
 
Study details Study design and quality Study population Main results Applicability 
to UK 
populations 
and settings 
Comments 
Weiker 1999 
 
Country: USA 
 
Research question:  
To describe how a 
community-based 
agency’s service delivery 
philosophy can affect the 
design and 
implementation of an 
evaluation.  
 
 
 
 
 
 
 
 
Design: 
Survey 
Evaluation 
Focus group(s) 
Observation 
(Passive/Participant)  
Ethnographic interview 
 
 
Quality: - 
Data reported focused on 
evaluation methods; as such 
there was very little on 
qualitative sampling, data 
collection or analysis and 
data reported were not rich 
 
Los Angeles, US 
 
A community based needle 
exchange and harm reduction 
programme for young people. 
 
Staff and clients of Harm 
Reduction Central (drop in 
centre run by Clean Needles 
Now) 
 
N not reported 
PROGRESS data: none 
reported 
 
The focus of the article is the lessons to be learned from a 
collaborative evaluation. The benefit of incorporating harm 
reduction principles into research methods is the main 
finding. The research cannot remain separate from the 
intervention and therefore harm reduction must be 
considered at all stages of the evaluation. 
Recommendations are made as to how this can be 
achieved. 
 
Some findings from the qualitative data are also presented. 
Engagement is seen as the primary aim for CNN/HRC. The 
core intervention provided by the programme is needle 
exchange, almost 3 times as many youth using this service 
as any other activity offered. It was observed that youth who 
initially engaged with the service to use the needle 
exchange became more involved over time. Peer staff are 
also found to be important in encouraging engagement with 
many young people describing their relationship with peer 
staff as the source of their engagement. While the peer staff 
are seen as a crucial component of the service, training and 
D  
 
Why: While the 
findings related 
to the design 
and 
implementation 
of an evaluation 
are likely to be 
generalisable to 
the UK, there is 
no data 
provided 
regarding 
sample size, 
diversity and 
recruitment to 
put the findings 
from the 
qualitative data 
Lack of data 
provided about 
sample means 
this paper is of 
little use 
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supervision is time consuming. The CNN/HRC is portrayed 
by the clients as a safe, non-judgemental place to seek 
services related to drug use. 
 
in context. 
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Results of validity assessment 
 
1. Is a qualitative approach appropriate?  
• Does the research seek to understand processes or structures, or illuminate subjective experiences or meanings?  
• Could a quantitative approach better have addressed the question ? 
Appropriate/ Inappropriate/ Unsure 
 
2. Is the study clear in what it seeks to do?  
•     Is the purpose of the research discussed – aims/objectives/research question ? 
• Is there adequate reference to the literature ? 
•    Are underpinning values/assumptions/theory discussed?  
Clear/ Unclear 
 
3. How defensible is the research design?  
• Is the design appropriate to the question? 
• Are there clear accounts of the criteria used for sampling, data collection, data analysis? 
• Is the selection of cases/sampling strategy theoretically justified?  
• Is a rationale given for the choice of method?  
Defensible/ Indefensible/ Not sure 
 
4. How well was the data collection carried out?  
           • Were the data collected in a way which addressed the research question  
• Was the data collection and record keeping systematic? 
Appropriately/ Inappropriately/ Not sure 
 
5. Is the role of the researcher clearly described?  
• Has the relationship between the researcher and the participants been adequately considered? 
• Is there evidence about how the research was explained and presented to the participants? 
Clear/ Unclear/ Not sure 
 
6. Is the context clearly described?  
• Are the characteristics of the participants and settings clearly defined?  
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• Were observations made in a sufficient variety of circumstances?  
• Was context bias considered? 
Clear/ Unclear/ Not sure 
 
7. Were the methods reliable?  
• Was data collected by more than one method?  
• Is there triangulation, or justification for not triangulating?  
• Do the methods investigate what they claim to? 
Reliable/ Unreliable/ Not sure  
 
8. Is the data analysis sufficiently rigorous?  
• Is the procedure explicit – i.e. is it clear how the data was processed to arrive at the results? 
• How systematic is the analysis, is the procedure reliable/dependable?  
• Is it clear how the themes and concepts were derived from the data? 
Rigorous/ Not rigorous/ Not sure  
 
9. Is the data rich?  
• How well are the contexts of the data preserved? 
• Has the diversity of perspective and content been explored?  
• How well has the detail and depth been preserved?  
• Are responses compared and contrasted across groups/sites? 
Rich/ Poor/ Not sure  
 
10. Is the analysis reliable?  
• Did more than one researcher theme and code transcripts?  
• If so, how were differences resolved?  
• Did participants feed back on the data if possible and relevant?  
• Were negative/ discrepant results addressed or ignored? 
Reliable/ Unreliable/ Not sure  
 
11. Are the findings credible?  
• Is there a clear statement of the findings? 
• Are the findings internally coherent? 
• Are elements from the original data included?  
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• Can the data sources be traced?  
• Is the reporting clear and coherent?  
Credible/ Not credible/ Not sure 
 
12. Are the findings relevant? 
Relevant/ Irrelevant/ Not sure 
 
13. Conclusions  
• How clear are the links between data, interpretation and conclusions? 
• Are the conclusions plausible and coherent?  
• Have alternative explanations been explored and discounted?  
• Does this enhance understanding of the research topic?  
• Are the implications clearly defined? 
• Is there adequate discussion of limitations? 
Adequate/ Inadequate/ Not sure  
 
14. How clear and coherent is the reporting of ethics?  
• Have ethical issues been taken into consideration?  
• Are they adequately discussed e.g. do they address consent and anonymity?  
• Have the consequences of the research been considered i.e. raising expectations, changing behaviour etc?  
• Was the study approved by an ethics committee? 
Appropriate/ Inappropriate/ Not sure  
 128 
NSP: Review of qualitative evidence – Full revised report  August 2008 
 
Question Reference(s) 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 Rating
Barnard 1993 Appropriate Clear Not sure Appropriate Unclear Clear Reliable Not sure Rich Not 
sure 
Credible Relevant Adequate Not sure + 
Buchanan 
2003 
Appropriate Clear Defensible Appropriate Not 
sure 
Clear Reliable Not sure Rich Not 
sure 
Credible Relevant Adequate Appropriate + 
Clarke 2001 Appropriate Clear Not sure Not sure Not 
sure 
Clear Reliable Not sure Poor Not 
sure 
Not 
sure 
Relevant Adequate Appropriate + 
Cooper 2005 Appropriate Clear Defensible Not sure Unclear Clear Reliable Rigorous Rich Reliable Credible Relevant Adequate Appropriate ++ 
Downing 
2005 
Appropriate Clear Not sure Not sure Not 
sure 
Unclear Not 
sure 
Rigorous Rich Not 
sure 
Credible Relevant Adequate Appropriate + 
Finlinson 
2000 
Appropriate Clear Defensible Appropriate Clear Clear Reliable Rigorous Rich Reliable Credible Relevant Adequate Appropriate ++ 
Grund 1992 Appropriate Unclear Not sure Not sure Clear Clear Not 
sure 
Not sure Not 
sure 
Not 
sure 
Not 
sure 
Relevant Not sure Not sure + 
Hay 2001 Appropriate Clear Not sure Not sure Unclear Not 
sure 
Not 
sure 
Not sure Poor Not 
sure 
Not 
sure 
Relevant Inadequate Not sure - 
Jacob 2000 Appropriate Clear Not sure Appropriate Clear Clear Reliable Not sure Rich Not 
sure 
Credible Relevant Adequate Appropriate + 
Junge 2000 Inappropriate Clear Defensible Appropriate Clear Clear Unrelia
ble 
Not sure Not 
sure 
Not 
sure 
Credible Relevant Adequate Not sure - 
Kelley 2005 Appropriate Clear Defensible Not sure Unclear Clear Reliable Not sure Rich Not 
sure 
Credible Relevant Adequate Not sure + 
Korner 2003 Appropriate Clear Defensible Appropriate N/A Clear Not 
sure 
Rigorous Rich Not 
sure 
Credible Relevant Adequate N/A + 
Larkins 2000 Appropriate Unclear Defensible Not sure Not 
sure 
Not 
sure 
Not 
sure 
Not sure Not 
sure 
Not 
sure 
Not 
sure 
Not sure Not sure Not sure - 
Lawrie 2005 Appropriate Clear Defensible Appropriate Not 
sure 
Clear Reliable Not 
rigorous 
Rich Reliable Credible Relevant Adequate Not sure + 
Lewis 1996 Appropriate Clear Defensible Appropriate Clear Clear Not 
sure 
Rigorous Not 
sure 
Not 
sure 
Credible Relevant Adequate Appropriate + 
Long 2004 Appropriate Clear Defensible Appropriate Clear Clear Reliable Rigorous Rich Reliable Credible Relevant Adequate Appropriate ++ 
Matheson 
1998 
Appropriate Clear Defensible Appropriate Clear Clear Reliable Rigorous Rich Reliable Credible Relevant Adequate Appropriate ++ 
Matheson 
1999 
Appropriate Clear Defensible Appropriate Not 
sure 
Clear Reliable Rigorous Rich Reliable Credible Relevant Adequate Not sure ++ 
Miller 2001 Appropriate Clear  Defensible Appropriate Unclear Clear Reliable Rigorous Rich Not 
sure 
Credible Relevant Adequate Not sure + 
Moore 1995 Appropriate Clear Defensible Appropriate Clear Clear Reliable Rigorous Rich Reliable Credible Relevant Adequate Appropriate ++ 
Murphy 2004 Appropriate Unclear Defensible Appropriate Clear Not 
sure 
Not 
sure 
Not sure Rich Not 
sure 
Credible Relevant Adequate Appropriate + 
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Neale 1998 Appropriate Clear Not sure Not sure Unclear Unclear Not 
sure 
Rigorous Poor Not 
sure 
Credible Relevant Adequate Not sure + 
Phillips 2007 Not sure Clear Not sure Appropriate Not 
sure 
Clear Reliable Rigorous Not 
sure 
Reliable Credible Relevant Adequate Appropriate + 
Porter 2002 Appropriate Clear Defensible Appropriate Clear Clear Reliable Rigorous Rich Reliable Credible Relevant Adequate Not sure ++ 
Power 1996 Appropriate Clear Defensible Appropriate Clear  Clear Reliable Rigorous Rich Reliable Credible Relevant Adequate Appropriate ++ 
Rhodes 2007 Appropriate Clear Defensible Not sure Clear Not 
sure 
Reliable Rigorous Rich Reliable Credible Relevant Adequate Appropriate + 
Shaw 2006 Appropriate Clear Indefensible Not sure Unclear Unclear Not 
sure 
Not 
rigorous 
Rich Not 
sure 
Not 
sure 
Relevant Adequate Not sure + 
Singer 1995 Appropriate Clear Defensible Appropriate Clear Clear Reliable Not sure Rich Not 
sure 
Credible Relevant Adequate Appropriate + 
Somlai 1999 Appropriate Clear Indefensible Not sure Not 
sure 
Not 
sure 
Not 
sure 
Not sure Poor Not 
sure 
Not 
credible 
Relevant Not sure Inappropriate - 
Snead 2003 Appropriate Clear Not sure Appropriate Clear Clear Not 
sure 
Rigorous Rich Reliable Credible Relevant Adequate Not sure  + 
Spittal 2003 Appropriate Clear Defensible Appropriate Not 
sure 
Clear Reliable Rigorous Rich Not 
sure 
Credible Relevant Adequate Appropriate + 
Springer 
1999 
Appropriate Clear Defensible Appropriate Clear Clear Reliable Rigorous Rich Not 
sure 
Credible Relevant Adequate Not sure ++ 
Strenski 
2000 
Appropriate Clear Defensible Appropriate Clear Clear Reliable Rigorous Rich Reliable Credible Relevant Adequate Appropriate ++ 
Strike 2002a Appropriate Clear Defensible Appropriate Clear Clear Reliable Rigorous Poor Reliable Credible Relevant Adequate Appropriate + 
Strike 2002b Appropriate Clear Defensible Not sure Not 
sure 
Clear Not 
sure 
Not sure Rich Not 
sure 
Not 
sure 
Relevant Not sure Not sure + 
Strike 2004 Appropriate Clear Defensible Not sure Not 
sure 
Clear Reliable Rigorous Rich Not 
sure 
Credible Relevant Adequate Not sure + 
Strike 2005  Appropriate Clear Defensible Not sure Not 
sure 
Not 
sure 
Reliable Rigorous Rich Reliable Credible Relevant Adequate Not sure + 
Tempalski 
2007 
Appropriate Clear Defensible Not sure Clear Clear Reliable Not sure Rich Not 
sure 
Credible Relevant Adequate Not sure + 
Voytek 2003 Appropriate Clear Not sure Not sure Not 
sure 
Clear Not 
sure 
Rigorous Rich Not 
sure 
Credible Relevant Adequate Not sure + 
Weiker 1999 Appropriate Clear Not sure Not sure Clear Not 
sure 
Reliable Not sure Poor Not 
sure 
Not 
sure 
Relevant Inadequate Not sure - 
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APPENDIX D: Search Strategies 
 
Databases and search strategies 
CSA interface 
 
1. MEDLINE (171,423), ERIC (1152), ASSIA (4967), Sociological Abstracts (2944) 
from (1990-2008)  180, 486 including duplicates (English only) date searched 
31/01/2008 
((incidence or prevalence or low* or reduc* or prevent* or decreas*) within 5 (HIV or 
hepatitis or HCV or HBV or blood-borne or BBV or transmission or infection* or virus* 
or bacteria* or viral or morbidity or mortality or death* or overdose* or seroconversion 
or seroprevalence)) 
 
2. MEDLINE (385,710), ERIC (709), ASSIA (5549), Sociological Abstracts (2368) from 
(1990-2008)  394,336 including duplicates (English only) date searched 31/01/2008 
DE=HIV or DE=hepatitis C or DE=hepatitis B or DE=morbidity or DE=mortality or 
DE=blood-borne pathogen* or DE=infect* or DE=bacterial infect* or DE=virus disease* 
 
3. MEDLINE (657,456), ERIC (3183), ASSIA (16036), Sociological Abstracts (7595) 
from (1990-2008)  684,270 including duplicates (English only) date searched 
31/01/2008 
KW=HIV or KW=hepatitis C or KW=hepatitis B or KW=morbidity or KW=mortality or 
KW=blood-borne pathogen* or KW=infect* or KW=bacterial infect* or KW=virus 
disease* 
 
4. MEDLINE (22,952), ERIC (128), ASSIA (1167), Sociological Abstracts (460) from 
(1990-2008)  24,707 including duplicates (English only) date searched 31/01/2008 
((low* or reduc* or prevent* or decreas* or chang*) within 5 inject*) or ((high* or 
increas* or improve* or encourag* or promot*) within 5 safe* inject*) or (risk reduction 
behavi*r or risk reduction behavi*rs) or ((needle* or syringe* or inject* or paraphernalia 
or equipment*) within 3 (behavi*r or behavi*rs or practic* or pattern*)) or ((needle* or 
syringe* or inject*) within 3 (frequenc* or cessation)) or ((needle* or Syringe* or inject* 
or paraphernalia or equipment*) within 3 shar*) or ((needle* or Syringe* or inject* or 
paraphernalia or equipment*) within 3 (reusing or reuse* or return*)) or (DE=needle 
sharing or DE=risk-taking) 
 
5. MEDLINE (182), ERIC (6), ASSIA (25), Sociological Abstracts (14) from (1990-
2008)  227 including duplicates (English only) date 31/01/2008 
((needle* or syringe* or inject* or paraphernalia or equipment*) within 3 (exchange* or 
suppl* or provide* or distrib* or provision or access* or dispens*) within 3 (less or more 
or incidence* or prevalence* or low* or increase* or decreas* or number* or 
percentage* or proportion* or frequenc* or rate*)) 
 
6. MEDLINE (8012), ERIC (1230), ASSIA (979), Sociological Abstracts (575) from 
(1990-2008)  10798 including duplicates (English only) date 31/01/2008 
KW=(needle sharing) or KW=(risk-taking) 
 
7. Combination of #6 and new terms 
MEDLINE (24650), ERIC (6502), ASSIA (3395), Sociological Abstracts (2064) from 
(1990-2008) 36611 including duplicates (English only) date 31/01/2008 
((utili?ation or attend* or visit*) within 5 (service* or program* or facilit* or cent??? or 
site* or number* or frequenc* or percent* or proportion* or low* or more* or increase* 
or decrease*)) or (rate within 2 (relaps* or stop* or cessation)) or (inject* others) or 
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((needle* or syringe* or inject* or paraphernalia or equipment*) within 3 (exchange* or 
suppl* or provide* or distrib* or provision or access* or dispens*) within 3 (less or more 
or incidence* or prevalence* or low* or increase* or decreas* or number* or 
percentage* or proportion* or frequenc* or rate*)) or (KW=risk-taking or KW=needle 
sharing) 
 
Combination of #1 or #3 
8. MEDLINE (683,621), ERIC (3344), ASSIA (16609), Sociological Abstracts (8254) 
from (1990-2008)  711,828 including duplicates (English only) date 01/02/2008 
(KW=HIV or KW=hepatitis C or KW=hepatitis B or KW=morbidity or KW=mortality or 
KW=blood-borne pathogen* or KW=infect* or KW=bacterial infect* or KW=virus 
disease*) or ((incidence or prevalence or low* or reduc* or prevent* or decreas*) within 
5 (HIV or hepatitis or HCV or HBV or blood-borne or BBV or transmission or infection* 
or virus* or bacteria* or viral or morbidity or mortality or death* or overdose* or 
seroconversion or seroprevalence)) 
 
Combination of #4, #5, #7 or #8 
9. MEDLINE (713,068), ERIC (9716), ASSIA (19652), Sociological Abstracts (10109) 
from (1990-2008)  752,545 including duplicates (English only) date 01/02/2008 
(((needle* or syringe* or inject* or paraphernalia or equipment*) within 3 (exchange* or 
suppl* or provide* or distrib* or provision or access* or dispens*) within 3 (less or more 
or incidence* or prevalence* or low* or increase* or decreas* or number* or 
percentage* or proportion* or frequenc* or rate*)) or (((low* or reduc* or prevent* or 
decreas* or chang*) within 5 inject*) or ((high* or increas* or improve* or encourag* or 
promot*) within 5 safe* inject*) or (risk reduction behavi*r or risk reduction behavi*rs) or 
((needle* or syringe* or inject* or paraphernalia or equipment*) within 3 (behavi*r or 
behavi*rs or practic* or pattern*)) or ((needle* or syringe* or inject*) within 3 (frequenc* 
or cessation)) or ((needle* or Syringe* or inject* or paraphernalia or equipment*) within 
3 shar*) or ((needle* or Syringe* or inject* or paraphernalia or equipment*) within 3 
(reusing or reuse* or return*)) or (DE=needle sharing or DE=risk-taking))) or 
((((utili?ation or attend* or visit*) within 5 (service* or program* or facilit* or cent??? or 
site* or number* or frequenc* or percent* or proportion* or low* or more* or increase* 
or decrease*)) or (rate within 2 (relaps* or stop* or cessation)) or (inject* others) or 
((needle* or syringe* or inject* or paraphernalia or equipment*) within 3 (exchange* or 
suppl* or provide* or distrib* or provision or access* or dispens*) within 3 (less or more 
or incidence* or prevalence* or low* or increase* or decreas* or number* or 
percentage* or proportion* or frequenc* or rate*)) or (KW=risk-taking or KW=needle 
sharing)) or ((KW=HIV or KW=hepatitis C or KW=hepatitis B or KW=morbidity or 
KW=mortality or KW=blood-borne pathogen* or KW=infect* or KW=bacterial infect* or 
KW=virus disease*) or ((incidence or prevalence or low* or reduc* or prevent* or 
decreas*) within 5 (HIV or hepatitis or HCV or HBV or blood-borne or BBV or 
transmission or infection* or virus* or bacteria* or viral or morbidity or mortality or 
death* or overdose* or seroconversion or seroprevalence)))) 
 
10. MEDLINE (77403), ERIC (6695), ASSIA (1423), Sociological Abstracts (757) from 
(1990-2008)  86278 including duplicates (English only) date 01/02/2008 
((((needle* or syringe* or inject* or paraphernalia* or equipment*) within 3 (suppl* or 
access* or provision* or provid* or distribut* or dispens* or program* or service* or 
cent??? or cent?? or scheme* or area* or prison* or site* or facilities or facility or 
pharmacy or pharmacies or unit or units)) or ((needle* or syring* or inject* or 
paraphernalia* or equipment*) within 3 (steril* or equipment* or bleach* or disinfectant* 
or disinfect* or citric acid*))) or ((needle* or syringe* or inject* or paraphernalia* or 
equipment*) within 3 exchang*)) or (((NSEP or NEP or NEPs or NSP or NSPs or 
NSEPs or needle exchange scheme*) or (KW=needle-exchange program*)) or 
(KW=syringe exchange program*)) 
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11. MEDLINE (8831), ERIC (591), ASSIA (974), Sociological Abstracts (587) from 
(1990-2008)  10983 including duplicates (English only) date searched  04/02/2008 
(((((KW=dispensing machine* or KW=vending machine* or substance abuse treatment 
center* or substance abuse treatment centre*) or ((needle* or syringe* or injections* or 
paraphernalia* or equipment*) within 3 (pack? or packet* or package*))) or (shooting 
galler* or harm reduc* or KW=harm reduction)) or ((needle* or syringe* or inject* or 
paraphernalia* or equipment*) within 3 (safe* or steril*))) or (drug-use within 5 (room* 
or facility or facilities or center* or centre* or service* or program* or scheme* or site* 
or area* or place or places))) or ((needle* or syringe* or injections* or paraphernalia* or 
equipment*) within 3 (pack? or packet* or package*)) 
 
12. Combination of #10 or #11 
MEDLINE (80912), ERIC (7017), ASSIA (2126), Sociological Abstracts (1227) from 
(1990-2008) 91282 including duplicates (English only) date searched 04/02/2008 
((((((KW=dispensing machine* or KW=vending machine* or substance abuse treatment 
center* or substance abuse treatment centre*) or ((needle* or syringe* or injections* or 
paraphernalia* or equipment*) within 3 (pack? or packet* or package*))) or (shooting 
galler* or harm reduc* or KW=harm reduction)) or ((needle* or syringe* or inject* or 
paraphernalia* or equipment*) within 3 (safe* or steril*))) or (drug-use within 5 (room* 
or facility or facilities or center* or centre* or service* or program* or scheme* or site* 
or area* or place or places))) or ((needle* or syringe* or injections* or paraphernalia* or 
equipment*) within 3 (pack? or packet* or package*))) or (((((needle* or syringe* or 
inject* or paraphernalia* or equipment*) within 3 (suppl* or access* or provision* or 
provid* or distribut* or dispens* or program* or service* or cent??? or cent?? or 
scheme* or area* or prison* or site* or facilities or facility or pharmacy or pharmacies or 
unit or units)) or ((needle* or syring* or inject* or paraphernalia* or equipment*) within 3 
(steril* or equipment* or bleach* or disinfectant* or disinfect* or citric acid*))) or 
((needle* or syringe* or inject* or paraphernalia* or equipment*) within 3 exchang*)) or 
(((NSEP or NEP or NEPs or NSP or NSPs or NSEPs or needle exchange scheme*) or 
(KW=needle-exchange program*)) or (KW=syringe exchange program*))) 
 
13. MEDLINE (28697), ERIC (329), ASSIA (2373), Sociological Abstracts (1208) from 
(1990-2008)  32607 including duplicates (English only) date searched  04/02/2008 
((needle* or syring* or inject* or paraphernalia* or equipment*) within 3 (sharer* or 
sharing)) or ((opioid* or morphine or heroin or opiate or cocaine or steroid* or PIED* or 
methadone) within 3 (abuse or misuse or dependen* or use* or usage or addict* or 
inject* or intravenous*)) 
 
14. MEDLINE (254,600), ERIC (7542), ASSIA (14721), Sociological Abstracts (10611) 
from (1990-2008)  287474 including duplicates (English only) date searched  
04/02/2008 
(KW=substance abuse or KW=heroin dependence or KW=morphine dependence or 
KW=substance-related disorder* or KW=street drug* or KW=opioid-related disorder* or 
KW=cocaine-related disorder* or KW=anabolic agent* or KW=steroid* or KW=illicit 
drug* or KW=illicit substance*) or ((substance* or drug* or stimulant*) within 3 (abuse 
or misuse or dependen* or use* or usage or addict* or inject* or intravenous*)) 
 
15. Combination of #13 or #14 
MEDLINE (258,719), ERIC (7568), ASSIA (15086), Sociological Abstracts (10686) 
from (1990-2008) 292,059 including duplicates (English only) date searched 
04/02/2008 
((KW=substance abuse or KW=heroin dependence or KW=morphine dependence or 
KW=substance-related disorder* or KW=street drug* or KW=opioid-related disorder* or 
KW=cocaine-related disorder* or KW=anabolic agent* or KW=steroid* or KW=illicit 
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drug* or KW=illicit substance*) or ((substance* or drug* or stimulant*) within 3 (abuse 
or misuse or dependen* or use* or usage or addict* or inject* or intravenous*))) or 
(((needle* or syring* or inject* or paraphernalia* or equipment*) within 3 (sharer* or 
sharing)) or ((opioid* or morphine or heroin or opiate or cocaine or steroid* or PIED* or 
methadone) within 3 (abuse or misuse or dependen* or use* or usage or addict* or 
inject* or intravenous*))) 
 
16. MEDLINE (27497), ERIC (3768), ASSIA (1504), Sociological Abstracts (1658) from 
(1990-2008)  34429 including duplicates (English only) date searched  04/02/2008 
((needle exchange program* or syringe exchange or needle syringe program*) within 5 
(experience* or understand* or participat* or user* or involv* or motivat* or accept* or 
access*)) or (knowledge within 3 (attitude* or behavi*r or belief*)) 
  
17. MEDLINE (890,877), ERIC (312,954), ASSIA (129,367), Sociological Abstracts 
(142,315) from (1990-2008)  1,475,513 including duplicates (English only) date 
searched  04/02/2008 
KW=perception or KW=experience* or KW=understand* or KW=neighbourhood* or 
KW=family or KW=carer* or KW=communit* or KW=school* or KW=comission* or 
KW=network* or KW=participat* 
 
18. MEDLINE (47623), ERIC (39096), ASSIA (5771), Sociological Abstracts (7890) from 
(1990-2008)  100,380 including duplicates (English only) date searched  05/02/2008 
((percept* or effect* or accept* or access* or collabor*) within 3 (NSP* or needle 
exchange scheme* or NEP* or NSEP* opiate substitution therap*) near (communit* or 
local council* or school* or local media or national media or voluntary sector*)) or 
((percept* or effect* or accept* or access* or collabor*) near (NSP* or needle exchange 
scheme* or OST* or opiate substitution therap* or communit* or local council* or 
school* or voluntary sector*)) 
 
      Combination of #16 or #17 or#18 
19. MEDLINE (928,259), ERIC (313,745), ASSIA (130,217), Sociological Abstracts 
(143,429) from (1990-2008)  1,515,640 including duplicates (English only) date 
searched  05/02/2008 
(KW=perception or KW=experience* or KW=understand* or KW=neighbourhood* or 
KW=family or KW=carer* or KW=communit* or KW=school* or KW=comission* or 
KW=network* or KW=participat*) or ((((needle exchange program* or syringe exchange 
or needle syringe program*) within 5 (experience* or understand* or participat* or user* 
or involv* or motivat* or accept* or access*)) or (knowledge within 3 (attitude* or 
behavi*r or belief*))) or (((percept* or effect* or accept* or access* or collabor*) within 3 
(NSP* or needle exchange scheme* or NEP* or NSEP* opiate substitution therap*) 
near (communit* or local council* or school* or local media or national media or 
voluntary sector*)) or ((percept* or effect* or accept* or access* or collabor*) near 
(NSP* or needle exchange scheme* or OST* or opiate substitution therap* or 
communit* or local council* or school* or voluntary sector*)))) 
 
20. MEDLINE (859,460), ERIC (93021), ASSIA (52684), Sociological Abstracts (64440) 
from (1990-2008)  1,069,605 including duplicates (English only) date searched  
05/02/2008 
KW=phenomenon* or KW=grounded theor* or KW=constructionist* or KW=thematic 
analysis or KW=observation study or KW=survey* or KW=demonstration project* or 
KW=stakeholder* or KW=contribution or KW=consultation or KW=value* or 
KW=distribution 
 
21. Combination of #19 or #20 
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MEDLINE (1,595,473), ERIC (341,251), ASSIA (160,765), Sociological Abstracts 
(173,097) from (1990-2008)  2,270,586 including duplicates (English only) date 
searched  05/02/2008 
((KW=perception or KW=experience* or KW=understand* or KW=neighbourhood* or 
KW=family or KW=carer* or KW=communit* or KW=school* or KW=comission* or 
KW=network* or KW=participat*) or ((((needle exchange program* or syringe exchange 
or needle syringe program*) within 5 (experience* or understand* or participat* or user* 
or involv* or motivat* or accept* or access*)) or (knowledge within 3 (attitude* or 
behavi*r or belief*))) or (((percept* or effect* or accept* or access* or collabor*) within 3 
(NSP* or needle exchange scheme* or NEP* or NSEP* opiate substitution therap*) 
near (communit* or local council* or school* or local media or national media or 
voluntary sector*)) or ((percept* or effect* or accept* or access* or collabor*) near 
(NSP* or needle exchange scheme* or OST* or opiate substitution therap* or 
communit* or local council* or school* or voluntary sector*))))) or (KW=phenomenon* 
or KW=grounded theor* or KW=constructionist* or KW=thematic analysis or 
KW=observation study or KW=survey* or KW=demonstration project* or 
KW=stakeholder* or KW=contribution or KW=consultation or KW=value* or 
KW=distribution) 
 
22. Combination of #21 and #15 and #12 and #9 
MEDLINE (1355), ERIC (35), ASSIA (306), Sociological Abstracts (214) from (1990-
2008)  1910 including duplicates (English only) date searched  18/02/2008 
((((KW=substance abuse or KW=heroin dependence or KW=morphine dependence or 
KW=substance-related disorder* or KW=street drug* or KW=opioid-related disorder* or 
KW=cocaine-related disorder* or KW=anabolic agent* or KW=steroid* or KW=illicit 
drug* or KW=illicit substance*) or ((substance* or drug* or stimulant*) within 3 (abuse 
or misuse or dependen* or use* or usage or addict* or inject* or intravenous*))) or 
(((needle* or syring* or inject* or paraphernalia* or equipment*) within 3 (sharer* or 
sharing)) or ((opioid* or morphine or heroin or opiate or cocaine or steroid* or PIED* or 
methadone) within 3 (abuse or misuse or dependen* or use* or usage or addict* or 
inject* or intravenous*)))) and (((KW=perception or KW=experience* or 
KW=understand* or KW=neighbourhood* or KW=family or KW=carer* or 
KW=communit* or KW=school* or KW=comission* or KW=network* or KW=participat*) 
or ((((needle exchange program* or syringe exchange or needle syringe program*) 
within 5 (experience* or understand* or participat* or user* or involv* or motivat* or 
accept* or access*)) or (knowledge within 3 (attitude* or behavi*r or belief*))) or 
(((percept* or effect* or accept* or access* or collabor*) within 3 (NSP* or needle 
exchange scheme* or NEP* or NSEP* opiate substitution therap*) near (communit* or 
local council* or school* or local media or national media or voluntary sector*)) or 
((percept* or effect* or accept* or access* or collabor*) near (NSP* or needle exchange 
scheme* or OST* or opiate substitution therap* or communit* or local council* or 
school* or voluntary sector*))))) or (KW=phenomenon* or KW=grounded theor* or 
KW=constructionist* or KW=thematic analysis or KW=observation study or 
KW=survey* or KW=demonstration project* or KW=stakeholder* or KW=contribution or 
KW=consultation or KW=value* or KW=distribution))) and (((((needle* or syringe* or 
inject* or paraphernalia or equipment*) within 3 (exchange* or suppl* or provide* or 
distrib* or provision or access* or dispens*) within 3 (less or more or incidence* or 
prevalence* or low* or increase* or decreas* or number* or percentage* or proportion* 
or frequenc* or rate*)) or (((low* or reduc* or prevent* or decreas* or chang*) within 5 
inject*) or ((high* or increas* or improve* or encourag* or promot*) within 5 safe* 
inject*) or (risk reduction behavi*r or risk reduction behavi*rs) or ((needle* or syringe* 
or inject* or paraphernalia or equipment*) within 3 (behavi*r or behavi*rs or practic* or 
pattern*)) or ((needle* or syringe* or inject*) within 3 (frequenc* or cessation)) or 
((needle* or Syringe* or inject* or paraphernalia or equipment*) within 3 shar*) or 
((needle* or Syringe* or inject* or paraphernalia or equipment*) within 3 (reusing or 
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reuse* or return*)) or (DE=needle sharing or DE=risk-taking))) or ((((utili?ation or 
attend* or visit*) within 5 (service* or program* or facilit* or cent??? or site* or number* 
or frequenc* or percent* or proportion* or low* or more* or increase* or decrease*)) or 
(rate within 2 (relaps* or stop* or cessation)) or (inject* others) or ((needle* or syringe* 
or inject* or paraphernalia or equipment*) within 3 (exchange* or suppl* or provide* or 
distrib* or provision or access* or dispens*) within 3 (less or more or incidence* or 
prevalence* or low* or increase* or decreas* or number* or percentage* or proportion* 
or frequenc* or rate*)) or (KW=risk-taking or KW=needle sharing)) or ((KW=HIV or 
KW=hepatitis C or KW=hepatitis B or KW=morbidity or KW=mortality or KW=blood-
borne pathogen* or KW=infect* or KW=bacterial infect* or KW=virus disease*) or 
((incidence or prevalence or low* or reduc* or prevent* or decreas*) within 5 (HIV or 
hepatitis or HCV or HBV or blood-borne or BBV or transmission or infection* or virus* 
or bacteria* or viral or morbidity or mortality or death* or overdose* or seroconversion 
or seroprevalence))))) and (((((((KW=dispensing machine* or KW=vending machine* or 
substance abuse treatment center* or substance abuse treatment centre*) or ((needle* 
or syringe* or injections* or paraphernalia* or equipment*) within 3 (pack? or packet* or 
package*))) or (shooting galler* or harm reduc* or KW=harm reduction)) or ((needle* or 
syringe* or inject* or paraphernalia* or equipment*) within 3 (safe* or steril*))) or (drug-
use within 5 (room* or facility or facilities or center* or centre* or service* or program* 
or scheme* or site* or area* or place or places))) or ((needle* or syringe* or injections* 
or paraphernalia* or equipment*) within 3 (pack? or packet* or package*))) or 
(((((needle* or syringe* or inject* or paraphernalia* or equipment*) within 3 (suppl* or 
access* or provision* or provid* or distribut* or dispens* or program* or service* or 
cent??? or cent?? or scheme* or area* or prison* or site* or facilities or facility or 
pharmacy or pharmacies or unit or units)) or ((needle* or syring* or inject* or 
paraphernalia* or equipment*) within 3 (steril* or equipment* or bleach* or disinfectant* 
or disinfect* or citric acid*))) or ((needle* or syringe* or inject* or paraphernalia* or 
equipment*) within 3 exchang*)) or (((NSEP or NEP or NEPs or NSP or NSPs or 
NSEPs or needle exchange scheme*) or (KW=needle-exchange program*)) or 
(KW=syringe exchange program*))))) 
 
Web of Knowledge/SSCI 
 
1. TS=HIV or TS=hepatitis C or TS=hepatitis B or TS=morbidity or TS=mortality or 
TS=blood-borne pathogen* or TS=infect* or TS=bacterial infect* or TS=virus disease*  
Databases=SCI-EXPANDED, SSCI Time span=1990-2008 
 
2. TS=((incidence or prevalence or low* or reduc* or prevent* or decreas*) SAME 
TS=(HIV or hepatitis or HCV or HBV or blood-borne or BBV or transmission or 
infection* or virus* or bacteria* or viral or morbidity or mortality or death* or overdose* 
or seroconversion or seroprevalence))  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 
 
3. TS=((low* or reduc* or prevent* or decreas* or chang*) SAME inject*) or TS=((high* or 
increas* or improve* or encourag* or promot*) SAME safe* inject*) or TS=(risk 
reduction behavi*r or risk reduction behavi*rs) or TS=((needle* or syringe* or inject* or 
paraphernalia or equipment*) SAME TS=(behavi*r or behavi*rs or practic* or pattern*)) 
or TS=((needle* or syringe* or inject*) SAME (frequenc* or cessation)) or TS=((needle* 
or Syringe* or inject* or paraphernalia or equipment*) SAME shar*) or TS=((needle* or 
Syringe* or inject* or paraphernalia or equipment*) SAME (reusing or reuse* or 
return*))  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results 78,833 
 
4. TS=risk-taking or TS=needle sharing  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results >100000 
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5. TS=(rate SAME (relapse* or stop* or cessation))  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results 7738 
 
6. TS=inject* others  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results 2830 
 
7. TS=((utili?ation* or attendanc* or attending or visit*) SAME TS=(service* or program* 
or facility or facilities or centre* or center* or site* or number* or frequenc* or 
percentage* or proportion* or low* or more* or increas* or decreas*))  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results 51130 
 
8. TS=((needle* or syringe* or inject* or paraphernalia or equipment) SAME 
TS=(exchange* or suppl* or provide* or distrib* or provision or access* or dispens*) 
SAME TS=(less or more or incidence* or prevalence* or low* or increase* or decreas* 
or number* NOT numbering or percentage* or proportion* or frequency or rate*))  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results 4050 
 
9. #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results >100000 
 
10. TS=Needle-Exchange Program* or TS=(NSP or NEP or NSEP or NSPs or NEPs or 
NSEPs)  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results 3803 
 
11. TS=((needle* or syringe* or inject* or paraphernalia or equipment) SAME exchang*)  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results 2602 
 
12. TS=((needle* or syringe* or inject* or paraphernalia* or equipment*) SAME 
TS=(supply* or access* or provision or provid* or distribut* or dispens* or program* or 
service* or centre* or scheme* or center* or site* or facilities or facility or scheme* or 
area* or prison* or pharmacy or pharmacies or unit or units))  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results 52135 
 
13. TS=((needle* or syringe* or inject* or paraphernalia* or equipment*) SAME TS=(steril* 
or equipment* or bleach* or disinfectant* or disinfect* or citric acid*))  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results 60848 
 
14. TS=((needle* or syringe* or injection* or paraphernalia or equipment*) SAME pack*)  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results 1643 
 
15. TS=(dispensing machine* or vending machine* or "Substance Abuse Treatment 
Center*")  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results 295 
 
16. TS=(drug consumption SAME TS=(room* or facility or facilities or centre* or center* or 
service* or area* or site*))  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results 273 
 
17. TS=(drug-use SAME TS=(room* or facility or facilities or centre* or center* or service* 
or program* or scheme* or site* or area*))  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results 1643 
 
18. TS=((needle* or syringe* or inject* or paraphernalia* or equipment*) SAME TS=(safe* 
or steril*))  
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Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results 7702 
 
19. TS=(shooting galler* or harm reduc* or "harm reduction")  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results 3391 
 
20. #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results >100000 
 
21. TS=((substance* or drug* or stimulant*) SAME TS=(abuse or misuse or dependen* or 
use or usage or addict* or inject* or intravenous*))  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results >100000 
 
22. TS=((opioid* or morphine or heroin or opiate or cocaine or steroid* or PIED* or 
methadone) SAME TS=(abuse or misuse or dependen* or use or uses or usage or 
addict* or inject* or intravenous*))  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results 40283 
 
23. TS=((needle* or syringe* or inject* or paraphernalia* or equipment*) SAME sharer*)  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results 17 
 
24. TS=("Heroin Dependence" or "Morphine Dependence" or "Substance-Related 
Disorder*" or "Street Drug*" or "illicit drug*" or "Opioid-Related Disorder*" or "Cocaine-
Related Disorder*" or "anabolic agent*" or "steroid*" or "substance abuse")  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results >100000 
 
25. #21 or #22 or #23 or #24  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results >100000 
 
26. TS=(phenomenon* or grounded theor* or constructionist* or "thematic analysis" or 
"observation study" or survey* or "demonstration project*" or stakeholder* or 
contribution or consultation or value* or distribution or ethnograph* or user* or belief or 
network* or attitude* or Family or families or school* or commission* or collaboration* 
or knowledge or experience* or motivation or access or behavio$r or communit* or 
involvement or "qualitative studies" or "qualitative research" or Interview* NOT 
interviewer or perception or understanding or neighbourhood* or participat* or media) 
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results >100000 
 
27. TS=((needle exchange program* or syringe exchange or needle syringe program*) 
SAME TS=(experience* or understand* or participat* or user* or involv* or motivat* or 
accept* or access*)) or TS=(knowledge SAME TS=(attitude* or behavio*r or belief*))  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results 16065 
 
28. TS=((percept* or effect* or accept* or access* or collabor*) SAME TS=(NSP* or needle 
exchange scheme* or NEP* or NSEP* opiate substitution therap*) SAME 
TS=(communit* or local council* or school* or local media or national media or 
voluntary sector*)) or TS=((percept* or effect* or accept* or access* or collabor*) 
SAME TS=(NSP* or needle exchange scheme* or OST* or opiate substitution therap* 
or communit* or local council* or school* or voluntary sector*))  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results 62045 
 
29. #26 OR #27 OR #28  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results >100000 
 
30. #9 AND #20 AND #25  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 results 4910 
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31. #29 AND #30 AND LANGUAGE= ENGLISH  
Databases=SCI-EXPANDED, SSCI Timespan=1990-2008 limited to English 3690 
 
Web SPIRS OVID 
IBSS 
 
1. (incidence or prevalence or low* or reduc* or prevent* or decreas*) near5 (HIV or 
hepatitis or HCV or HBV or blood-borne or BBV or transmission or infection* or virus* 
or bacteria* or viral or morbidity or mortality or death* or overdose* or seroconversion 
or seroprevalence) date searched 18/02/08 results 1610  
 
2. ( (HIV) in DE )or( (Hepatitis C or Hepatitis B) in DE )or( (Morbidity or mortality) in DE ) 
Date searched 18/02/08 results 9510 
 
3. ( (Infect*) in DE )or( (Bacterial infection*) in DE )or( (virus disease*) in DE ) Date 
searched 18/02/08 results 3 
 
4. ( ((low* or reduc* or prevent* or decreas* or chang*) near5 inject*) or ((high* or increas* 
or improve* or encourag* or promot*) near5 safe* inject*) or (risk reduction behavi*r or 
risk reduction behavi*rs) or ((needle* or syringe* or inject* or paraphernalia or 
equipment*) near3 (behavi*r or behavi*rs or practic* or pattern*)) or ((needle* or 
syringe* or inject*) near3 (frequenc* or cessation)) or ((needle* or Syringe* or inject* or 
paraphernalia or equipment*) near3 shar*) or ((needle* or Syringe* or inject* or 
paraphernalia or equipment*) near3 (reusing or reuse* or return*)) )or( (needle sharing) 
in DE )or( (risk taking) in DE ) Date 18/02/08 results 236 
 
5. (needle* or syringe* or inject* or paraphernalia or equipment*) near3 (exchange* or 
suppl* or provide* or distrib* or provision or access* or dispens*) near3 (less or more or 
incidence* or prevalence* or low* or increase* or decreas* or number* or percentage* 
or proportion* or frequenc* or rate*) Date 18/02/08 results 5 
 
6. ((utili?ation or attend* or visit*) near5 (service* or program* or facilit* or cent??? or site* 
or number* or frequenc* or percent* or proportion* or low* or more* or increase* or 
decrease*)) or (rate near2 (relaps* or stop* or cessation)) or (inject* others) or 
((needle* or syringe* or inject* or paraphernalia or equipment*) near3 (exchange* or 
suppl* or provide* or distrib* or provision or access* or dispens*) near3 (less or more or 
incidence* or prevalence* or low* or increase* or decreas* or number* or percentage* 
or proportion* or frequenc* or rate*)) Date 18/02/08 results 1279 
 
7. (#1 or #2 or #3 or #4 or #5 or #6) and (LA:IBSS = ENGLISH) and (PY:IBSS = 1990-
2008) Date 19/02/08 results 9746 
((( (Infect*) in DE )or( (Bacterial infection*) in DE )or( (virus disease*) in DE )) or ((( 
(HIV) in DE )or( (Hepatitic C or Hepatitis B) in DE )or( (Morbidity or mortality) in DE )) 
or ((incidence or prevalence or low* or reduc* or prevent* or decreas*) near5 (HIV or 
hepatitis or HCV or HBV or blood-borne or BBV or transmission or infection* or virus* 
or bacteria* or viral or morbidity or mortality or death* or overdose* or seroconversion 
or seroprevalence)))) or (( ((low* or reduc* or prevent* or decreas* or chang*) near5 
inject*) or ((high* or increas* or improve* or encourag* or promot*) near5 safe* inject*) 
or (risk reduction behavi*r or risk reduction behavi*rs) or ((needle* or syringe* or inject* 
or paraphernalia or equipment*) near3 (behavi*r or behavi*rs or practic* or pattern*)) or 
((needle* or syringe* or inject*) near3 (frequenc* or cessation)) or ((needle* or Syringe* 
or inject* or paraphernalia or equipment*) near3 shar*) or ((needle* or Syringe* or 
inject* or paraphernalia or equipment*) near3 (reusing or reuse* or return*)) )or( 
(needle sharing) in DE )or( (risk taking) in DE )) 
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8. (NSEP or NEP or NEPs or NSP or NSPs or NSEPs or needle exchange scheme*) or 
((( (needle-exchange program*) in DE )or( (syringe exchange program*) in DE )) or 
(((needle* or syringe* or inject* or paraphernalia* or equipment*) near3 exchang*) or 
(((needle* or syring* or inject* or paraphernalia* or equipment*) near3 (steril* or 
equipment* or bleach* or disinfectant* or disinfect* or citric acid*)) or ((needle* or 
syringe* or inject* or paraphernalia* or equipment*) near3 (suppl* or access* or 
provision* or provid* or distribut* or dispens* or program* or service* or cent??? or 
cent?? or scheme* or area* or prison* or site* or facilities or facility or pharmacy or 
pharmacies or unit or units))))) Date 19/02/08 results 1764 
 
9. (drug consumption near5 (room* or facility or facilities or center* or centre* or service* 
or area* or site*)) or ((( (substance abuse treatment center* or substance abuse 
treatment centre*) in DE )or( (harm reduction) in DE )or( shooting galler* or harm 
reduc* or dispensing machine* or vending machine* )) or (((needle* or syringe* or 
inject* or paraphernalia* or equipment*) near3 (safe* or steril*)) or ((drug-use near5 
(room* or facility or facilities or center* or centre* or service* or program* or scheme* or 
site* or area* or place or places)) or ((needle* or syringe* or inject* or paraphernalia* or 
equipment*) near3 (pack? or packet* or package*))))) Date 19/02/08 results 227 
 
10. ((((((needle* or syring* or inject* or paraphernalia* or equipment*) near3 (sharer* or 
sharing)) or ((opioid* or morphine or heroin or opiate or cocaine or steroid* or PIED* or 
methadone) near3 (abuse or misuse or dependen* or use* or usage or addict* or 
inject* or intravenous*))) or (( (substance abuse or drug abuse) in DE )or( (heroin 
dependence or morphine dependence) in DE )or( (substance-related disorder* or 
opioid-related disorder* or cocaine-related disorder* or street drug* or anabolic agent* 
or steroid*) in DE ))) or ((substance* or drug* or stimulant*) near3 (abuse or misuse or 
dependen* or use* or usage or addict* or inject* or intravenous*))) or ((illicit drug* or 
illicit substance* or intravenous abuse) in DE)) and (LA:IBSS = ENGLISH) and 
(PY:IBSS = 1990-2008) Date 19/02/08 results 5129 
 
11. (((( (perception* or experience* or understand* or neighbourhood* or family) in DE )or( 
(Carer* or communit* or school* or comission* or network* or participat*) in DE )or( 
(attitude* or access* or accept* or knowledge or behavio?r or user* or involv* ) in DE )) 
and (LA:IBSS = ENGLISH) and (PY:IBSS = 1990-2008)) or ((((needle exchange 
program* or syringe exchange or needle syringe program*) near5 (experience* or 
understand* or participat* or user* or involv* or motivat* or accept* or access*)) or 
(knowledge near3 (attitude* or behavio?r or belief*))) and (LA:IBSS = ENGLISH) and 
(PY:IBSS = 1990-2008))) and (LA:IBSS = ENGLISH) and (PY:IBSS = 1990-2008) Date 
19/02/08 results 122662  
 
12. (((percept* or effect* or accept* or access* or collabor*) near3 (NSP* or needle 
exchange scheme* or NEP* or NSEP* opiate substitution therap*) near9 (communit* or 
local council* or school* or local media or national media or voluntary sector*)) or 
((percept* or effect* or accept* or access* or collabor*) near9 (NSP* or needle 
exchange scheme* or OST* or opiate substitution therap* or communit* or local 
council* or school* or voluntary sector*))) and (LA:IBSS = ENGLISH) and (PY:IBSS = 
1990-2008) Date 19/02/08 results 2518 
 
13. (( (phenomenon* or grounded theor* or constructionist* or thematic analysis or 
observation study) in DE )or( (survey* or demonstration project* or stakeholder*) in DE 
)or( (contribut* or consult* or value* or distribut*) in DE )) and (LA:IBSS = ENGLISH) 
and (PY:IBSS = 1990-2008) date 19/02/08 results 25679 
 
14. #11 or #12 or #13 
 140
NSP: Review of qualitative evidence – Full revised report  August 2008 
(((((( (perception* or experience* or understand* or neighbourhood* or family) in DE 
)or( (Carer* or communit* or school* or comission* or network* or participat*) in DE )or( 
(attitude* or access* or accept* or knowledge or behavio?r or user* or involv* ) in DE )) 
and (LA:IBSS = ENGLISH) and (PY:IBSS = 1990-2008)) or ((((needle exchange 
program* or syringe exchange or needle syringe program*) near5 (experience* or 
understand* or participat* or user* or involv* or motivat* or accept* or access*)) or 
(knowledge near3 (attitude* or behavio?r or belief*))) and (LA:IBSS = ENGLISH) and 
(PY:IBSS = 1990-2008))) and (LA:IBSS = ENGLISH) and (PY:IBSS = 1990-2008)) or 
((((( (phenomenon* or grounded theor* or constructionist* or thematic analysis or 
observation study) in DE )or( (survey* or demonstration project* or stakeholder*) in DE 
)or( (contribut* or consult* or value* or distribut*) in DE )) and (LA:IBSS = ENGLISH) 
and (PY:IBSS = 1990-2008)) or ((((percept* or effect* or accept* or access* or 
collabor*) near3 (NSP* or needle exchange scheme* or NEP* or NSEP* opiate 
substitution therap*) near9 (communit* or local council* or school* or local media or 
national media or voluntary sector*)) or ((percept* or effect* or accept* or access* or 
collabor*) near9 (NSP* or needle exchange scheme* or OST* or opiate substitution 
therap* or communit* or local council* or school* or voluntary sector*))) and (LA:IBSS = 
ENGLISH) and (PY:IBSS = 1990-2008))) and (LA:IBSS = ENGLISH) and (PY:IBSS = 
1990-2008))) and (LA:IBSS = ENGLISH) and (PY:IBSS = 1990-2008) Date 19/02/08 
results 144729 
 
15. #14 and #10 and (LA:IBSS = ENGLISH) and (PY:IBSS = 1990-2008) Date 19/02/08 
results 1211 
 
16. #15 and #9 
((drug consumption near5 (room* or facility or facilities or center* or centre* or service* 
or area* or site*)) or ((( (substance abuse treatment center* or substance abuse 
treatment centre*) in DE )or( (harm reduction) in DE )or( shooting galler* or harm 
reduc* or dispensing machine* or vending machine* )) or (((needle* or syringe* or 
inject* or paraphernalia* or equipment*) near3 (safe* or steril*)) or ((drug-use near5 
(room* or facility or facilities or center* or centre* or service* or program* or scheme* or 
site* or area* or place or places)) or ((needle* or syringe* or inject* or paraphernalia* or 
equipment*) near3 (pack? or packet* or package*)))))) and (#14 and #10) Date 
19/02/08 results 56. 
 
17. #15 and #8 
((NSEP or NEP or NEPs or NSP or NSPs or NSEPs or needle exchange scheme*) or 
((( (needle-exchange program*) in DE )or( (syringe exchange program*) in DE )) or 
(((needle* or syringe* or inject* or paraphernalia* or equipment*) near3 exchang*) or 
(((needle* or syring* or inject* or paraphernalia* or equipment*) near3 (steril* or 
equipment* or bleach* or disinfectant* or disinfect* or citric acid*)) or ((needle* or 
syringe* or inject* or paraphernalia* or equipment*) near3 (suppl* or access* or 
provision* or provid* or distribut* or dispens* or program* or service* or cent??? or 
cent?? or scheme* or area* or prison* or site* or facilities or facility or pharmacy or 
pharmacies or unit or units)))))) and (#14 and #10) Date 19/02/08 results 70 
 
18. #16 and #7 
(((drug consumption near5 (room* or facility or facilities or center* or centre* or service* 
or area* or site*)) or ((( (substance abuse treatment center* or substance abuse 
treatment centre*) in DE )or( (harm reduction) in DE )or( shooting galler* or harm 
reduc* or dispensing machine* or vending machine* )) or (((needle* or syringe* or 
inject* or paraphernalia* or equipment*) near3 (safe* or steril*)) or ((drug-use near5 
(room* or facility or facilities or center* or centre* or service* or program* or scheme* or 
site* or area* or place or places)) or ((needle* or syringe* or inject* or paraphernalia* or 
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equipment*) near3 (pack? or packet* or package*)))))) and (#10 and #14)) and ((#7) 
and (LA:IBSS = ENGLISH) and (PY:IBSS = 1900-2008)) Date 19/02/08 results 38 
 
19. #17 and #7 
((#7) and (LA:IBSS = ENGLISH) and (PY:IBSS = 1900-2008)) and (((NSEP or NEP or 
NEPs or NSP or NSPs or NSEPs or needle exchange scheme*) or ((( (needle-
exchange program*) in DE )or( (syringe exchange program*) in DE )) or (((needle* or 
syringe* or inject* or paraphernalia* or equipment*) near3 exchang*) or (((needle* or 
syring* or inject* or paraphernalia* or equipment*) near3 (steril* or equipment* or 
bleach* or disinfectant* or disinfect* or citric acid*)) or ((needle* or syringe* or inject* or 
paraphernalia* or equipment*) near3 (suppl* or access* or provision* or provid* or 
distribut* or dispens* or program* or service* or cent??? or cent?? or scheme* or area* 
or prison* or site* or facilities or facility or pharmacy or pharmacies or unit or units)))))) 
and (#10 and #14)) Date 19/02/08 results 58 
 
CINAHL, International Bibliography of the Social Sciences, Ovid MEDLINE(R), 
PsycINFO 
 
1     ((incidence or prevalence or low$ or reduc$ or prevent$ or decreas$) adj5 (HIV or 
hepatitis or HCV or HBV or blood-borne or blood borne or BBV or transmission or 
infection$ or virus$ or bacteria$ or viral or morbidity or mortality or death$ or overdose$ or 
seroconversion or seroprevalence)).tw. (273807) 
2     HIV/ (32582) 
3     Hepatitis C/ or Hepatitis B/ (51970) 
4     Morbidity/ or mortality/ (66411) 
5     Blood-Borne Pathogens/ or bacterial infection/ or infection/ (83712) 
6     HIV infections/ep, pc (35294) 
7     virus diseases/ or viral diseases/ (28543) 
8     ((low$ or reduc$ or prevent$ or decreas$ or chang$) adj5 inject$).tw. (27485) 
9     ((high$ or increas$ or improve$ or encourag$ or promot$) adj5 safe$ inject$).tw. (31) 
10     "Risk Reduction Behavior"/ (1937) 
11     (risk reduction behaviour$ or risk reduction behavior$).tw. (293) 
12     ((needle$ or syringe$ or inject$ or paraphernalia$ or equipment$) adj3 (behaviour$ 
or behavior$ or practic$ or pattern$)).tw. (4976) 
13     Risk-Taking/ or needle sharing/ (21889) 
14     ((needle$ or syringe$ or inject$) adj3 (frequenc$ or cessation)).tw. (1270) 
15     ((needle$ or syringe$ or inject$ or paraphernalia$ or equipment$) adj3 (sharing or 
share$1)).tw. (2693) 
16     ((needle$ or syringe$ or inject$ or paraphernalia$ or equipment$) adj3 (reusing or 
reuse$ or return$)).tw. (847) 
17     ((needle$ or syringe$ or inject$ or paraphernalia$ or equipment$) adj3 (exchange$ 
or suppl$ or provide$ or distrib$ or provision or access$ or dispens$) adj3 (less or more or 
incidence$ or prevalence$ or low$ or increas$ or decreas$ or number$1 or percentage$ or 
proportion$ or frequency$ or rate$)).tw. (417) 
18     inject$ others.tw. (13) 
19     (rate adj2 (relapse$ or stop$ or cessation)).tw. (5701) 
20     ((utilisation or utilization or attendence$ or attending or visit$) adj5 (service$ or 
program$ or facility or facilities or centre$ or center$ or site$ or number$ or frequenc$ or 
percentage$ or proportion$ or low$ or more$ or increas$ or decreas$)).tw. (55451) 
21     1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 
or 18 or 19 or 20 (615207) 
22     Needle-Exchange Programs/ (1572) 
23     (NSP or NEP or NSEP or NSPs or NEPs or NSEPs or needle exchange scheme or 
syringe exchange program$).tw. (3332) 
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24     ((needle$ or syringe$ or inject$ or paraphernalia$ or equipment$) adj3 exchang$).tw. 
(1867) 
25     ((needle$ or syringe$ or inject$ or paraphernalia$ or equipment$) adj3 (supply$ or 
access$ or provision or provid$ or distribut$ or dispens$ or program$ or service$ or 
centre$ or scheme$ or center$ or site$1 or facilities or facility or scheme$ or area$ or 
prison$ or pharmacy or pharmacies or unit or units)).tw. (22205) 
26     ((needle$ or syringe$ or inject$ or paraphernalia$ or equipment$) adj3 (steril$ or 
equipment$ or bleach$ or disinfectant$ or disinfect$1 or citric acid$)).tw. (50761) 
27     ((needle$ or syringe$ or injection$ or paraphernalia$ or equipment$) adj3 
pack$1).tw. (17) 
28     dispensing machine$.tw. (51) 
29     vending machine$.tw. (351) 
30     Substance Abuse Treatment Centers/ (2977) 
31     (drug consumption adj5 (room$ or facility or facilities or centre$ or center$ or 
service$ or area$ or site$)).tw. (67) 
32     (drug-use adj5 (room$ or facility or facilities or centre$ or center$ or service$ or 
program$ or scheme$ or site$ or area$)).tw. (1795) 
33     ((needle$ or syringe$ or inject$ or paraphernalia$ or equipment$) adj3 (safe$ or 
steril$)).tw. (4258) 
34     shooting galler$.mp. or harm reduc$.tw. [mp=ti, hw, ab, it, bt, ot, sh, gh, nm, tc, id] 
(2738) 
35     harm reduction/ (1392) 
36     22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 
(81486) 
37     Substance Abuse, Intravenous/ (10130) 
38     ((substance$1 or drug$1 or stimulant$) adj3 (abuse or misuse or dependen$ or 
use$2 or usage or addict$ or inject$ or intravenous$)).tw. (196637) 
39     ((opiod$ or morphine or heroin or opiate or cocaine or steroid$ or PIED$ or 
methadone) adj3 (abuse or misuse or dependen$ or use$2 or usage or addict$ or inject$ 
or intravenous$)).tw. (47936) 
40     Heroin Dependence/ or morphine dependence/ (9172) 
41     Substance-Related Disorders/ (63026) 
42     Street Drugs/ or anabolic agents/ (10695) 
43     Opioid-Related Disorders/ or Cocaine-Related Disorders/ (8801) 
44     steroids/ (25623) 
45     illicit drugs/ (6155) 
46     ((needle$ or syringe$ or inject$ or paraphernalia$ or equipment$) adj3 sharer$1).tw. 
(15) 
47     37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 (296639) 
48     21 and 36 and 47 (4386) 
49     ((needle exchange program* or syringe exchange or needle syringe program*) adj5 
(experience* or understand* or participat* or user* or involv* or motivat* or accept* or 
access*)).mp. or (knowledge adj3 (attitude* or behavi*r or belief*)).tw. [mp=ti, hw, ab, it, bt, 
ot, sh, gh, nm, tc, id] (21300) 
50     (((percept* or effect* or accept* or access* or collabor*) adj3 (NSP* or needle 
exchange scheme* or NEP* or NSEP* opiate substitution therap*) adj9 (communit* or local 
council* or school* or local media or national media or voluntary sector*)) or ((percept* or 
effect* or accept* or access* or collabor*) adj9 (NSP* or needle exchange scheme* or 
OST* or opiate substitution therap* or communit* or local council* or school* or voluntary 
sector*))).mp. [mp=ti, hw, ab, it, bt, ot, sh, gh, nm, tc, id] (80600) 
51     (perception or experience$ or understand$ or neighbourhood$ or family or families or 
carer$ or communit$ or school$ or comission$ or network$ or participat$).tw. (2699753) 
52     (phenomeno$ or grounded theor$ or constructionist$ or thematic analysis or 
observation study or observation studies or survey$1 or demonstration project$1 or 
stakeholder$ or contribution or consultation or value$ or distribution).tw. (2014057) 
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53     observation study/ or observation studies/ (0) 
54     qualitative studies/ (22430) 
55     grounded theory/ (5276) 
56     thematic analysis/ (10856) 
57     49 or 50 or 51 or 52 or 53 or 54 or 55 or 56 (4308836) 
58     48 and 57 (2349) 
59     limit 58 to english (2275) 
60     limit 59 to yr="1900 - 2008" (2275) 
61     from 60 keep 1-2000 (2000) 
 
 
SOCIAL CARE ONLINE 
 
1. @k=("HIV/AIDS ") or @k=("blood-borne pathogens ") or @k=("morbidity ") or 
@k=("mortality ") or @k=("bacterial infection* ") or @k=("virus disease* ") or 
@k=("hepatitis B ") or @k=("hepatitis C ") results 166 
2. @k=("risk reduction behavior ") or @k=("risk taking ") or @k=("needle sharing ") or 
@p=("risk reduction behaviour* or risk reduction behavior* ") or @p=("inject* others ") 
or @p=("rate of relapse* or rate of stop* or rate of cessation ") results 0 
3. @p=("needle* frequenc* or needle* cessation or syringe* frequenc* or syringe* 
cessation or inject* frequenc* or injection cessation ") results 0 
4. @p=("needle* shar* or syringe* shar* or inject* shar* or paraphernalia* shar* or 
equipment* shar* ") results 0 
5. @p=("needle* reusing or needle* return or syringe* reusing or syringe* return or inject* 
reusing or inject* return or paraphernalia* reusing or paraphernalia* return or 
equipment* reusing or equipment* return") results 0 
6. @p=("needle* practic* or needle* pattern* or needle* behaviour* or needle* behavior or 
syringe* pattern* or syringe* practic* or syringe* behaviour* or syringe* behavior or 
inject* practic* or inject* pattern* or inject* behaviour* or inject* behavior* or 
paraphernalia* pattern* or paraphernalia* practic* or paraphernalia behavior* or 
equipment pattern* or equipment* practic*") results 0 
7. @k=("needle exchange program* or needle syringe program* or syringe exchange 
program* or needle exchange scheme* or syringe exchange scheme* or needle 
syringe exchange program*") results 0 
8. @p=("syringe exchange ") or @p=("needle exchange ") or @p.title=("syringe exchange 
") or @p.title=("needle exchange ") or @p.title=("needle exchange program* ") or 
@p.title=("syringe exchange program* ") results 24 
9. @p=("NSP or NSPs or NSEP or NSEPs or NEP or NEPs ") results 0 
10. @p=("dispensing machine*") and @p=("vending machine*") and @k=("substance 
abuse treatment centers") results 0 
11. @p=("needle* exchang* or syring* exchang* or inject* exchang* or paraphernalia* 
exchang* or equipment* exchang* ") results 0 
12. @p=("drug consumption room* ") or @p=("drug consumption facilit* ") or @p=("drug 
consumption service* ") or @p=("drug consumption area* ") or @p=("drug 
consumption site* ") or @p=("drug consumption center* ") or @p=("drug consumption 
center* ") results 3 
13. @p=("needle pack* ") or @p=("syringe pack* ") or @p=("injection pack* ") or 
@p=("equipment pack* ") or @p=("paraphernalia pack* ") results 0 
14. @p=("needle* supply* or needle access* or needle distribut* or needle* or needle 
provid* or needle provision or needle* service* or needle* program* or needle scheme* 
or needle* center* or needle* centre* or needle pharmacy or needle pharmacies ") or 
@p=("syringe* supply* or syringe* access* or syringe* distribut* or syringe* provid* 
syringe* provision* or syringe program* or syringe* service* or syringe* scheme* or 
syringe* pharmacy or syringe* pharmacies ") or @p=("inject* supply* or inject* access* 
or inject* provid* or inject* scheme* or inject* center* or inject* distribut* ") results 0 
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15. @p=("prison* or pharmacies or pharmacy ") results 0 
16. @p=("drug-use room* or drug-use facility or drug-use facilities or drug-use center* or 
drug-use centre* or drug-use program* or drug-use service* or drug-use scheme* or 
drug-use site* or drug-use area* ") results 0 
17. @p=("shooting galler* or harm reduc* ") or @k=("harm reduction ") results 0 
18. (freetext="shooting galler*" or freetext="harm reduc*") or topic="harm reduction" or 
@p=("vending machine*") results 91 
19. @p=("needle bleach*") or @p=("needle disinfect*") or @p=("needle steril*") or 
@p=("inject* bleach*") or @p=("inject* steril*") and @p=("inject* disinfect*") or 
@p=("equipment* bleach*") or @p=("equipment* disinfect*") or @p=("syringe* 
bleach*") or @p=("syringe* disinfect*") or @p=("syringe* steril") results 0 
20. @k=("heroin dependence ") or @k=("morphine dependence ") or @k=("street drugs ") 
or @k=("steroids ") or @k=("anabolic agents ") or @k=("substance related disorder ") 
or @k=("opioid related disorder ") or @k=("cocaine related disorder ") or 
@k=("substance abuse ") or @k=("intravenous drug abuse ") or @k=("injecting drug 
abuse ") results 0 
21. (((title="heroin dependence " or title="substance abuse ") or title="cocaine related 
disorder ") or title="opioid related disorder ") or title="substance related disorder " 
results 243 
22. @p.title=("substance misuse ") or @p.title=("substance abuse ") or @p.title=("drug 
abuse ") or @p.title=("drug misuse ") or @p.title=("drug dependen* ") or @p.title=("drug 
addict* ") or @p.title=("drug inject* ") or @p.title=("stimulant inject* ") or 
@p.title=("stimulant abuse ") or @p.title=("stimulant misuse ") 673 
23. @p.title=("needle exchange program* ") or @p.title=("syringe exchange program* ") or 
@p.title=("needle exchange scheme* ") or @p.title=("needle syringe exchange 
program* ") or @p.title=("needle syringe program* ") results 5 
24. @p.title=("ethnograph* or grounded theor* or survey* or demonstration project* or 
themathic analysis or constructionist* or qualitative study or qualitative studies or 
qualitative research* ") results 0 
25. @p=("ethnograph* or grounded theor* or survey* or demonstration project* or 
themathic analysis or constructionist* or qualitative study or qualitative studies or 
qualitative research* ") results 0 
26. @k=("ethnograph* or grounded theor* or survey* or demonstration project* or 
themathic analysis or constructionist* or qualitative study or qualitative studies or 
qualitative research*") results 0 
27. @p.title=("family or families or attitude* or knowledge* or value* or experience* or 
behaviour* or behavior* or perception* or understanding ") results 0 
28. @p=("family or families or attitude* or knowledge* or value* or experience* or 
behaviour* or behavior* or perception* or understanding ") results 0 
29. @k=("family or families or attitude* or knowledge* or value* or experience* or 
behaviour* or behavior* or perception* or understanding  ") results 0 
30. @p.title=("motivation or commission* or network* or participation* or consultation* or 
user* or stakeholder* or collaboration* or contribution* ") results 0 
31. @p=("motivation or commission* or network* or participation* or consultation* or user* 
or stakeholder* or collaboration* or contribution* ") results 0 
32. @p=("shooting galler* or harm reduc* ") or @k=("harm reduction ") and 
@k=("HIV/AIDS ") or @k=("blood-borne pathogens ") or @k=("morbidity ") or 
@k=("mortality ") or @k=("bacterial infection* ") or @k=("virus disease* ") or 
@k=("hepatitis B ") or @k=("hepatitis C ") and @p.title=("needle exchange program* ") 
or @p.title=("syringe exchange program* ") or @p.title=("needle exchange scheme* ") 
or @p.title=("needle syringe exchange program* ") or @p.title=("needle syringe 
program* ") and @p.title=("substance misuse ") or @p.title=("substance abuse ") or 
@p.title=("drug abuse ") or @p.title=("drug misuse ") or @p.title=("drug dependen* ") or 
@p.title=("drug addict* ") or @p.title=("drug inject* ") or @p.title=("stimulant inject* ") or 
@p.title=("stimulant abuse ") or @p.title=("stimulant misuse ") results 0 
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WHO 05/03/08 
 
PHASE 1  
1. "substance abuse" OR "substance misuse" OR "drug abuse" OR "drug misuse" OR 
"drug dependence" OR "drug addiction" OR "drug Addict" results 20300 including 
irrelevant or similar results 
2. "heroin dependence" OR "morphine dependence" OR "methadone dependence" OR 
"street drugs" OR "illicit drugs" results 1760 
3. "opioid related disorders" OR "cocaine related disorder" OR "street drugs" OR 
"anabolic agents" OR "steroids" results 1500 
4. “methadone abuse” OR “opiate abuse” OR “PIED abuse” OR “PIED dependence” OR 
“cocaine abuse” OR “cocaine misuse” OR “stimulant usage” results 0 
5. cocaine OR opiates OR methadone OR morphine OR heroin results 3520 
6. HIV OR "hepatitis C" OR "hepatitis B" OR "virus diseases" OR "viral diseases" OR 
mortality OR morbidity results 2540 
7. "risk taking" OR "risk reduction behaviour" OR "risk reduction behavior" OR "needle 
sharing" results 2440 
8. injecting others results 3750 
9. rate of relapse OR rate of stopping OR rate of cessation OR rate of stoppage results 
107 
 
PHASE 2 
1. "needle exchange programs" OR "syringe exchange" OR NSP OR NEP OR NSEP OR 
NSPs OR NEPs OR NSEPs results 1580 
2. needle exchange OR syringe exchange OR injection exchange OR paraphernalia 
exchange results 2920 
3. needle supply OR needle distribution OR needle access OR needle facilities OR 
needle centers OR needle schemes results 921 
4. Syringe supply OR syringe access OR syringe provision Or syringe distribution OR 
syringe services OR syringe schemes OR syringe centres OR syringe centers OR 
syringe facilities OR syringe sites results 1220 
5. Injection supply OR injection units OR injection facilities OR injection facility OR 
injection pharmacy OR injection pharmacies results 1300 
6. needle sterilization OR needle sterilisation OR needle disinfection OR needle 
equipment OR syringe disinfection OR syringe bleaching OR needle bleaching OR 
syringe sterilization OR syringe sterilisation results 108 
7. injection disinfection OR injection disinfecting OR injection sterilization OR sterile 
injection OR equipment disinfection OR equipment sterilization OR equipment 
bleaching results 129 
8. needle packs OR needle packets OR injection packs OR injection packs OR 
paraphernalia packs results 527 
9. "substance abuse treatment centres" OR vending machine OR dispensing machine 
OR "harm reduction" OR harm reduction OR shooting gallery OR shooting galleries 
results 0 
10. "harm reduction" OR "substance abuse treatment centres" results 4150 
11. shooting gallery OR shooting galleries OR harm reduction results 265 
12. "shooting gallery" OR "shooting galleries" results 100 
13. “vending machine” OR “dispensing machines” OR “dispensing machines” OR “vending 
machines” results 1580 
14. drug consumption room OR drug consumption facility’s OR drug consumption centers 
OR drug consumption centres OR drug consumption site’s OR drug consumption area 
results 8030 
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15. drug use room OR drug use facilities OR drug use facility OR drug use services OR 
drug use centers OR drug use centres OR drug use schemes OR drug use sites OR 
drug use areas  results 23400 
16. “drug use room” OR “drug use facilities” OR “drug use facility” OR “drug use services” 
OR “drug use centers” OR “drug use centres” OR “drug use schemes” OR “drug use 
sites” OR “drug use areas”  results 18 
 
PHASE 3 
1. "substance abuse" OR "substance misuse" OR "drug abuse" OR "drug misuse" OR 
"drug dependence" OR "drug addiction" OR "drug Addict" and qualitative studies 
results 2080 
2. "substance abuse" OR "substance misuse" OR "drug abuse" OR "drug misuse" OR 
"drug dependence" OR "drug addiction" OR "drug Addict" and qualitative research 
results 2180 
3. "substance abuse" OR "substance misuse" OR "drug abuse" OR "drug misuse" OR 
"drug dependence" OR "drug addiction" OR "drug Addict" and "grounded theory" and 
"thematic analysis" results 11 
4. "substance abuse" OR "substance misuse" OR "drug abuse" OR "drug misuse" OR 
"drug dependence" OR "drug addiction" OR "drug Addict" and “observation studies” 
results 5 
5. "substance abuse" OR "substance misuse" OR "drug abuse" OR "drug misuse" OR 
"drug dependence" OR "drug addiction" OR "drug Addict" and evaluation results 7030 
6. "substance abuse" OR "substance misuse" OR "drug abuse" OR "drug misuse" OR 
"drug dependence" OR "drug addiction" OR "drug Addict"  and (evaluation OR 
observation studies OR "grounded theory" OR qualitative studies OR qualitative 
research OR "thematic analysis") results 5430 
7. ethnography OR ethnographic OR demonstration project OR survey OR surveys OR 
Constructionist OR constructionists results 239 
8. "substance abuse" OR "substance misuse" OR "drug abuse" OR "drug misuse" OR 
"drug dependence" OR "drug addiction" OR "drug Addict" AND  demonstration project  
results 280  
9. "substance abuse" OR "substance misuse" OR "drug abuse" OR "drug misuse" OR 
"drug dependence" OR "drug addiction" OR "drug Addict" AND survey results 6647 
10. "substance abuse" OR "substance misuse" OR "drug abuse" OR "drug misuse" OR 
"drug dependence" OR "drug addiction" OR "drug Addict" and ("ethnography" OR 
ethnographic) results 297 
11. "substance abuse" OR "substance misuse" OR "drug abuse" OR "drug misuse" OR 
"drug dependence" OR "drug addiction" OR "drug Addict" and (constructionist OR 
constructionists) results 5  
12. "substance abuse" OR "substance misuse" OR "drug abuse" OR "drug misuse" OR 
"drug dependence" OR "drug addiction" OR "drug Addict" AND (ethnography OR 
ethnographic OR “demonstration project” OR survey OR surveys OR Constructionist 
OR constructionists) results 6740 
13. "substance abuse" OR "substance misuse" OR "drug abuse" OR "drug misuse" OR 
"drug dependence" OR "drug addiction" OR "drug Addict" and (carers OR family OR 
families) results 7460 
14. "substance abuse" OR "substance misuse" OR "drug abuse" OR "drug misuse" OR 
"drug dependence" OR "drug addiction" OR "drug Addict" and (attitude OR knowledge 
OR belief OR perception OR behaviour OR values) results 8400 
15. "substance abuse" OR "substance misuse" OR "drug abuse" OR "drug misuse" OR 
"drug dependence" OR "drug addiction" OR "drug Addict" and (experience OR 
understanding) results 7000 
16. carers OR family OR families OR attitude OR knowledge OR belief OR perception OR 
behaviour OR values OR experience OR understanding results 166000 
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17. "substance abuse" OR "substance misuse" OR "drug abuse" OR "drug misuse" OR 
"drug dependence" OR "drug addiction" OR "drug Addict" and (carers OR family OR 
families OR attitude OR knowledge OR belief OR perception OR behaviour OR values 
OR experience OR understanding) results 9670 
18. "heroin dependence" OR "morphine dependence" OR "methadone dependence" OR 
"street drugs" OR "illicit drugs" and (evaluation OR observation studies OR "grounded 
theory" OR qualitative studies OR qualitative research OR "thematic analysis") results 
912 
19.  "heroin dependence" OR "morphine dependence" OR "methadone dependence" OR 
"street drugs" OR "illicit drugs" and (carers OR family OR families OR attitude OR 
knowledge OR belief OR perception OR behaviour OR values OR experience OR 
understanding) results 1480 
20. motivation OR commissioning OR commission OR network OR network OR 
participation OR stakeholder OR user OR consultation OR collaboration OR 
contribution results 175000 
21. "substance abuse" OR "substance misuse" OR "drug abuse" OR "drug misuse" OR 
"drug dependence" OR "drug addiction" OR "drug Addict" and (motivation OR 
commissioning OR commission OR network OR network OR participation OR 
stakeholder OR user OR consultation OR collaboration OR contribution) results 9360 
22. "heroin dependence" OR "morphine dependence" OR "methadone dependence" OR 
"street drugs" OR "illicit drugs" and (motivation OR commissioning OR commission OR 
network OR network OR participation OR stakeholder OR user OR consultation OR 
collaboration OR contribution) results 1440 
23. "opioid related disorders" OR "cocaine related disorder" OR "street drugs" OR 
"anabolic agents" OR "steroids” and (evaluation OR observation studies OR "grounded 
theory" OR qualitative studies OR qualitative research OR "thematic analysis") results 
862 
24. "opioid related disorders" OR "cocaine related disorder" OR "street drugs" OR 
"anabolic agents" OR "steroids" and (carers OR family OR families OR attitude OR 
knowledge OR belief OR perception OR behaviour OR values OR experience OR 
understanding results 1210 
25. "opioid related disorders" OR "cocaine related disorder" OR "street drugs" OR 
"anabolic agents" OR "steroids” and (motivation OR commissioning OR commission 
OR network OR network OR participation OR stakeholder OR user OR consultation 
OR collaboration OR contribution) results 1310 
26. HIV OR "hepatitis C" OR "hepatitis B" OR "virus diseases" OR "viral diseases" OR 
mortality OR morbidity and (evaluation OR "observation studies" OR "grounded theory" 
OR qualitative studies OR qualitative research OR "thematic analysis") results 0 
27. HIV OR "hepatitis C" OR "hepatitis B" OR "virus diseases" OR "viral diseases" OR 
mortality OR morbidity and (ethnography OR ethnographic OR “demonstration project” 
OR survey OR surveys OR Constructionist OR constructionists) results 0 
28. "risk taking" OR "risk reduction behaviour" OR "risk reduction behavior" OR "needle 
sharing" and (evaluation OR observation studies OR "grounded theory" OR qualitative 
studies OR qualitative research OR "thematic analysis") results 1550 
29. "risk taking" OR "risk reduction behaviour" OR "risk reduction behavior" OR "needle 
sharing" and (ethnography OR ethnographic OR “demonstration project” OR survey 
OR surveys OR Constructionist OR constructionists) results 1650 
30. "risk taking" OR "risk reduction behaviour" OR "risk reduction behavior" OR "needle 
sharing" and (carers OR family OR families OR attitude OR knowledge OR belief OR 
perception OR behaviour OR values OR experience OR understanding) results 2420 
31. injecting others and (evaluation OR "observation studies" OR "grounded theory" OR 
qualitative studies OR qualitative research OR "thematic analysis") results 0 
32. "needle exchange programs" OR "syringe exchange" OR NSP OR NEP OR NSEP OR 
NSPs OR NEPs OR NSEPs and (evaluation OR "observation studies" OR "grounded 
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theory" OR qualitative studies OR qualitative research OR "thematic analysis") results 
879 
33. "needle exchange programs" OR "syringe exchange" OR NSP OR NEP OR NSEP OR 
NSPs OR NEPs OR NSEPs AND (ethnography OR ethnographic OR “demonstration 
project” OR survey OR surveys OR Constructionist OR constructionists) results 959 
34. "needle exchange programs" OR "syringe exchange" OR NSP OR NEP OR NSEP OR 
NSPs OR NEPs OR NSEPs and (carers OR family OR families OR attitude OR 
knowledge OR belief OR perception OR behaviour OR values OR experience OR 
understanding) results 1320 
35. "needle exchange programs" OR "syringe exchange" OR NSP OR NEP OR NSEP OR 
NSPs OR NEPs OR NSEPs and (motivation OR commissioning OR commission OR 
network OR network OR participation OR stakeholder OR user OR consultation OR 
collaboration OR contribution) results 1350 
36. needle supply OR needle distribution OR needle access OR needle facilities OR 
needle centers OR needle schemes OR needle exchange                           OR syringe 
exchange OR injection exchange OR paraphernalia exchange and (carers OR family 
OR families OR attitude OR knowledge                           OR belief OR perception OR 
behaviour OR values OR experience OR understanding) results 2790 
37. needle supply OR needle distribution OR needle access OR needle facilities OR 
needle centers OR needle schemes OR needle exchange                           OR syringe 
exchange OR injection exchange OR paraphernalia exchange and (motivation OR 
commissioning OR commission OR network                           OR network OR 
participation OR stakeholder OR user OR consultation OR collaboration OR 
contribution) results 2740 
38. needle supply OR needle distribution OR needle access OR needle facilities OR 
needle centers OR needle schemes OR needle exchange                           OR syringe 
exchange OR injection exchange OR paraphernalia exchange and (evaluation OR 
observation studies OR results 2270 
39. Syringe supply OR syringe access OR syringe provision Or syringe distribution OR 
syringe services OR syringe schemes OR syringe                           centres OR syringe 
centers OR syringe facilities OR syringe sites OR Injection supply OR injection units 
OR injection facilities                           OR injection facility OR injection pharmacy OR 
injection pharmacies and (carers OR family OR families OR attitude OR knowledge               
OR belief OR perception OR behaviour OR values OR experience OR understanding) 
results 352 
40. Syringe supply OR syringe access OR syringe provision Or syringe distribution OR 
syringe services OR syringe schemes OR syringe                           centres OR syringe 
centers OR syringe facilities OR syringe sites OR Injection supply OR injection units 
OR injection facilities                           OR injection facility OR injection pharmacy OR 
injection pharmacies AND (ethnography OR ethnographic OR demonstration project               
OR survey OR surveys OR Constructionist OR constructionists) results 134 
41. Syringe supply OR syringe access OR syringe provision Or syringe distribution OR 
syringe services OR syringe schemes OR syringe centres OR syringe centers OR 
syringe facilities OR syringe sites OR Injection supply OR injection units OR injection 
facilities OR injection facility OR injection pharmacy OR injection pharmacies and 
(evaluation OR observation studies OR qualitative studies OR qualitative research OR 
"thematic analysis" OR "grounded theory") results 323 
42. needle sterilization OR needle sterilisation OR needle disinfection OR needle 
equipment OR syringe disinfection OR syringe bleaching OR needle bleaching OR 
syringe sterilization OR syringe sterilisation OR injection disinfection OR injection 
disinfecting OR injection sterilization OR sterile injection OR equipment disinfection OR 
equipment sterilization OR equipment bleaching OR needle packs OR needle packets 
OR injection packs OR injection packs OR paraphernalia packs and (carers OR family 
OR families OR attitude OR knowledge OR belief OR perception OR behaviour OR 
values OR experience OR understanding) results 312 
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43. needle sterilization OR needle sterilisation OR needle disinfection OR needle 
equipment OR syringe disinfection OR syringe                           bleaching OR needle 
bleaching OR syringe sterilization OR syringe sterilisation OR injection disinfection OR 
injection disinfecting                           OR injection sterilization OR sterile injection OR 
equipment disinfection OR equipment sterilization OR equipment bleaching OR needle 
packs OR needle packets OR injection packs OR injection packs OR paraphernalia 
packs and (motivation OR commissioning                           OR commission OR network 
OR network OR participation OR stakeholder OR user OR consultation OR 
collaboration OR contribution) results 252 
44. "harm reduction" OR "substance abuse treatment centres" OR "shooting gallery" OR 
"shooting galleries" OR "vending machine” OR “dispensing machines” OR “dispensing 
machines” OR “vending machines” OR “drug use room” OR “drug use facilities” OR 
“drug use facility” OR “drug use services” OR “drug use centers” OR “drug use centres” 
OR “drug use schemes” OR “drug use sites” OR “drug use areas” and (evaluation OR 
observation studies OR "grounded theory" OR qualitative studies OR qualitative 
research OR "thematic analysis") results 2380 
45. "harm reduction" OR "substance abuse treatment centres" OR "shooting gallery" OR 
"shooting galleries" OR "vending machine” OR “dispensing machines” OR “dispensing 
machines” OR “vending machines” OR “drug use room” OR “drug use facilities” OR 
“drug use facility” OR “drug use services” OR “drug use centers” OR “drug use centres” 
OR “drug use schemes” OR “drug use sites” OR “drug use areas” and (carers OR 
family OR families OR attitude OR knowledge OR belief OR perception OR behaviour 
OR values OR experience OR understanding) results 3750 
46. "harm reduction" OR "substance abuse treatment centres" OR "shooting gallery" OR 
"shooting galleries" OR "vending machine” OR “dispensing machines” OR “dispensing 
machines” OR “vending machines” OR “drug use room” OR “drug use facilities” OR 
“drug use facility” OR “drug use services” OR “drug use centers” OR “drug use centres” 
OR “drug use schemes” OR “drug use sites” OR “drug use areas” and (ethnography 
OR ethnographic OR demonstration project OR survey OR surveys OR Constructionist 
OR constructionists) results 542 
47. "harm reduction" OR "substance abuse treatment centres" OR "shooting gallery" OR 
"shooting galleries" OR "vending machine” OR “dispensing machines” OR “dispensing 
machines” OR “vending machines” OR “drug use room” OR “drug use facilities” OR 
“drug use facility” OR “drug use services” OR “drug use centers” OR “drug use centres” 
OR “drug use schemes” OR “drug use sites” OR “drug use areas” and (motivation OR 
commissioning OR commission OR network OR network OR participation OR 
stakeholder OR user OR consultation OR collaboration OR contribution) results 2630 
48. drug consumption rooms OR drug consumption facility’s OR drug consumption centers 
OR drug consumption centres OR drug consumption site’s OR drug consumption 
areas OR drug use room OR drug use facilities OR drug use facility OR drug use 
services OR drug use centers OR drug use centres OR drug use schemes OR drug 
use sites OR drug use areas and (carers OR family OR families OR attitude OR 
knowledge OR belief OR perception OR behaviour OR values OR experience OR 
understanding) results 0 
49. drug consumption rooms OR drug consumption facility’s OR drug consumption centers 
OR drug consumption centres OR drug consumption site’s OR drug consumption 
areas OR drug use room OR drug use facilities OR drug use facility OR drug use 
services OR drug use centers OR drug use centres OR drug use schemes OR drug 
use sites OR drug use areas and (motivation OR commissioning OR commission OR 
network OR network OR participation OR stakeholder OR user OR consultation OR 
collaboration OR contribution) results 0 
50. “drug use room” OR “drug use facilities” OR “drug use facility” OR “drug use services” 
OR “drug use centers” OR “drug use centres” OR “drug use schemes” OR “drug use 
sites” OR “drug use areas” AND (ethnography OR ethnographic OR “demonstration 
project” OR survey OR surveys OR Constructionist OR constructionists) results 0 
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51. “drug use room” OR “drug use facilities” OR “drug use facility” OR “drug use services” 
OR “drug use centers” OR “drug use centres” OR “drug use schemes” OR “drug use 
sites” OR “drug use areas” and (carers OR family OR families OR attitude OR 
knowledge OR belief OR perception OR behaviour OR values OR experience OR 
understanding) results 514 
 
JOSEPH ROWNTREE 5/03/08 
PHASE 1  
10. "substance abuse" OR "substance misuse" OR "drug abuse" OR "drug misuse" OR 
"drug dependence" OR "drug addiction" OR "drug Addict" results 156 
11. "heroin dependence" OR "morphine dependence" OR "methadone dependence" OR 
"street drugs" OR "illicit drugs" results 45 
12. "opioid related disorders" OR "cocaine related disorder" OR "street drugs" OR "illicit 
drugs" OR "anabolic agents" OR "steroids" results 17 
13. methadone abuse OR opiate abuse OR PIED abuse OR PIED dependence OR 
cocaine abuse OR cocaine misuse OR stimulant usage results 12 
14. cocaine OR opiates OR methadone OR morphine OR heroin results 83 
15. HIV OR "hepatitis C" OR "hepatitis B" OR "virus diseases" OR "viral diseases" OR 
mortality OR morbidity results 132 
16. "risk taking" OR "risk reduction behaviour" OR "risk reduction behavior" OR "needle 
sharing" results 68 
17. injecting others results 32 
18. rate of relapse OR rate of stopping OR rate of cessation OR rate of stoppage results 1 
 
PHASE 2 
17. "needle exchange programs" OR "syringe exchange" OR NSP OR NEP OR NSEP OR 
NSPs OR NEPs OR NSEPs results 7 
18. needle exchange OR syringe exchange OR injection exchange OR paraphernalia 
exchange results 8 
19. needle supply OR needle distribution OR needle access OR needle facilities OR 
needle centers OR needle schemes results 11 
20. Syringe supply OR syringe access OR syringe provision Or syringe distribution OR 
syringe services OR syringe schemes OR syringe centres OR syringe centers OR 
syringe facilities OR syringe sites results 6 
21. Injection supply OR injection units OR injection facilities OR injection facility OR 
injection pharmacy OR injection pharmacies results 5 
22. Injection supply OR injection units OR injection facilities OR injection facility results 18 
23. needle sterilization OR needle sterilisation OR needle disinfection OR needle 
equipment OR syringe disinfection OR syringe bleaching OR needle bleaching OR 
syringe sterilization OR syringe sterilisation results 0 
24. injection disinfection OR injection disinfecting OR injection sterilization OR sterile 
injection OR equipment disinfection OR equipment sterilization OR equipment 
bleaching results 0 
25. injection sterilization OR sterile injection results 4 
26. needle packs OR needle packets OR injection packs OR injection packs OR 
paraphernalia packs results 1 
27. "substance abuse treatment centres" OR vending machine OR dispensing machine 
OR "harm reduction" OR harm reduction OR shooting gallery OR shooting galleries 
results 0 
28. "harm reduction" OR "substance abuse treatment centres" results 43 
29. shooting gallery OR shooting galleries results 4 
30. vending machine OR dispensing machines OR vending machines results 3 
31. drug consumption room OR drug consumption facilities OR drug consumption centers 
OR drug consumption centres OR drug consumption sites OR drug consumption area 
results 58 
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32. drug use room OR drug use facilities OR drug use facility OR drug use services OR 
drug use centers OR drug use centres OR drug use schemes OR drug use sites OR 
drug use areas  results 254 
 
PHASE 3 
52. "substance abuse" OR "substance misuse" OR "drug abuse" OR "drug misuse" OR 
"drug dependence" OR "drug addiction" OR "drug Addict" and qualitative studies and 
qualitative research results 54 
53. "substance abuse" OR "substance misuse" OR "drug abuse" OR "drug misuse" OR 
"drug dependence" OR "drug addiction" OR "drug Addict" and "grounded theory" and 
"thematic analysis" results 1 
54. "substance abuse" OR "substance misuse" OR "drug abuse" OR "drug misuse" OR 
"drug dependence" OR "drug addiction" OR "drug Addict" and observation studies 
results 35 
55. "substance abuse" OR "substance misuse" OR "drug abuse" OR "drug misuse" OR 
"drug dependence" OR "drug addiction" OR "drug Addict" and evaluation results 96 
56. "substance abuse" OR "substance misuse" OR "drug abuse" OR "drug misuse" OR 
"drug dependence" OR "drug addiction" OR "drug Addict"  and evaluation OR 
observation studies OR "grounded theory" OR qualitative studies OR qualitative 
research OR "thematic analysis" results 71 
57. "substance abuse" OR "substance misuse" OR "drug abuse" OR "drug misuse" OR 
"drug dependence" OR "drug addiction" OR "drug Addict" AND (ethnography OR 
ethnographic OR “demonstration project” OR survey OR surveys OR Constructionist 
OR constructionists) results 105 
58. "heroin dependence" OR "morphine dependence" OR "methadone dependence" OR 
"street drugs" OR "illicit drugs" and (evaluation OR observation studies OR "grounded 
theory" OR qualitative studies OR qualitative research OR "thematic analysis") results 
14 
59. "heroin dependence" OR "morphine dependence" OR "methadone dependence" OR 
"street drugs" OR "illicit drugs" and (carers OR family OR families OR attitude OR 
knowledge OR belief OR perception OR behaviour OR values OR experience OR 
understanding) results 44 
60. "substance abuse" OR "substance misuse" OR "drug abuse" OR "drug misuse" OR 
"drug dependence" OR "drug addiction" OR "drug Addict" and (motivation OR 
commissioning OR commission OR network OR network OR participation OR 
stakeholder OR user OR consultation OR collaboration OR contribution) results 146  
61. "heroin dependence" OR "morphine dependence" OR "methadone dependence" OR 
"street drugs" OR "illicit drugs" and (motivation OR commissioning OR commission OR 
network OR network OR participation OR stakeholder OR user OR consultation OR 
collaboration OR contribution) results 41  
62. "opioid related disorders" OR "cocaine related disorder" OR "street drugs" OR 
"anabolic agents" OR "steroids” and (evaluation OR observation studies OR "grounded 
theory" OR qualitative studies OR qualitative research OR "thematic analysis") results 
1  
63. "opioid related disorders" OR "cocaine related disorder" OR "street drugs" OR 
"anabolic agents" OR "steroids" and (carers OR family OR families OR attitude OR 
knowledge OR belief OR perception OR behaviour OR values OR experience OR 
understanding) results 3  
64. "opioid related disorders" OR "cocaine related disorder" OR "street drugs" OR 
"anabolic agents" OR "steroids” and (motivation OR commissioning OR commission 
OR network OR network OR participation OR stakeholder OR user OR consultation 
OR collaboration OR contribution) results 2 
65. HIV OR "hepatitis C" OR "hepatitis B" OR "virus diseases" OR "viral diseases" OR 
mortality OR morbidity and (evaluation OR "observation studies" OR "grounded theory" 
OR qualitative studies OR qualitative research OR "thematic analysis") results 63 
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66. HIV OR "hepatitis C" OR "hepatitis B" OR "virus diseases" OR "viral diseases" OR 
mortality OR morbidity and (ethnography OR ethnographic OR “demonstration project" 
OR survey OR surveys OR Constructionist OR constructionists) results 106 
67. "risk taking" OR "risk reduction behaviour" OR "risk reduction behavior" OR "needle 
sharing" and (evaluation OR observation studies OR "grounded theory" OR qualitative 
studies OR qualitative research OR "thematic analysis") results 20 
68. "risk taking" OR "risk reduction behaviour" OR "risk reduction behavior" OR "needle 
sharing" and (ethnography OR ethnographic OR “demonstration project” OR survey 
OR surveys OR Constructionist OR constructionists) results 40 
69. "risk taking" OR "risk reduction behaviour" OR "risk reduction behavior" OR "needle 
sharing" and (carers OR family OR families OR attitude OR knowledge OR belief OR 
perception OR behaviour OR values OR experience OR understanding) results 68 
70. "needle exchange programs" OR "syringe exchange" OR NPS OR NEP OR NSEP OR 
NSPs OR NSEPs and (evaluation OR "observation studies" OR "grounded theory" OR 
qualitative studies OR qualitative research OR "thematic analysis") results 4 
71. "needle exchange programs" OR "syringe exchange" OR NSP OR NEP OR NSEP OR 
NSPs OR NEPs OR NSEPs AND (ethnography OR ethnographic OR “demonstration 
project” OR survey OR surveys OR Constructionist OR constructionists) results 7 
72. "needle exchange programs" OR "syringe exchange" OR NSP OR NEP OR NSEP OR 
NSPs OR NEPs OR NSEPs and (carers OR family OR families OR attitude OR 
knowledge OR belief OR perception OR behaviour OR values OR experience OR 
understanding) results 8 
73. needle supply OR needle distribution OR needle access OR needle facilities OR 
needle centers OR needle schemes OR needle exchange                           OR syringe 
exchange OR injection exchange OR paraphernalia exchange and (carers OR family 
OR families OR attitude OR knowledge                           OR belief OR perception OR 
behaviour OR values OR experience OR understanding) results 8 
74. needle supply OR needle distribution OR needle access OR needle facilities OR 
needle centers OR needle schemes OR needle exchange                           OR syringe 
exchange OR injection exchange OR paraphernalia exchange and (motivation OR 
commissioning OR commission OR network                           OR network OR 
participation OR stakeholder OR user OR consultation OR collaboration OR 
contribution) results 8 
75. Syringe supply OR syringe access OR syringe provision OR syringe distribution OR 
syringe services OR syringe schemes OR syringe centres OR syringe centers OR 
syringe facilities OR syringe sites OR Injection supply OR injection units OR injection 
facilities OR injection facility OR injection pharmacy OR injection pharmacies and 
(carers OR family OR families OR attitude OR knowledge OR belief OR perception OR 
behaviour OR values OR experience OR understanding) 
76. drug use room OR drug use facilities OR drug use facility OR drug use services OR 
drug use centers OR drug use centres OR drug use schemes OR drug use sites OR 
drug use areas and (family OR carers OR attitudes OR knowledge) results 330 
77. “drug use room” OR “drug use facilities” OR “drug use facility” OR “drug use services” 
OR “drug use centers” OR “drug use centres” OR “drug use schemes” OR “drug use 
sites” OR “drug use areas” AND (ethnography OR ethnographic OR “demonstration 
project”) results 0 
78. “drug use room” OR “drug use facilities” OR “drug use facility” OR “drug use services” 
OR “drug use centers” OR “drug use centres” OR “drug use schemes” OR “drug use 
sites” OR “drug use areas” AND (OR survey OR surveys OR Constructionist OR 
constructionists) results 0 
79. drug consumption room OR drug consumption facility’s OR drug consumption centers 
OR drug consumption centres OR drug consumption site’s OR drug consumption area 
and (carers OR family OR families OR attitude OR knowledge OR belief OR perception 
OR behaviour OR values OR experience OR understanding) results 30 
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80. drug consumption room OR drug consumption facility’s OR drug consumption centers 
OR drug consumption centres OR drug consumption site’s OR drug consumption area 
and (motivation OR commissioning OR commission OR network OR network OR 
participation OR stakeholder OR user OR consultation OR collaboration OR 
contribution) results 30 
81. "harm reduction" OR "substance abuse treatment centres" and (motivation OR 
commissioning OR commission OR network OR network OR participation OR 
stakeholder OR user OR consultation OR collaboration OR contribution) results 38 
82. "harm reduction" OR "substance abuse treatment centres" and (evaluation OR 
observation studies OR "grounded theory" OR qualitative studies OR qualitative 
research OR "thematic analysis") results 7 
83. "harm reduction" OR "substance abuse treatment centres" and (carers OR family OR 
families OR attitude OR knowledge OR belief OR perception OR behaviour OR values 
OR experience OR understanding) results 40 
 
KING’S FUND 2/03/08 
 
1. subject "heroin dependence or morphine dependence or substance related disorder or 
street drugs" OR subject "opioid related disorder or cocaine related disorder or illicit 
drugs or anabolic agents or steroids" OR subject "Substance abuse or intravenous 
abuse" search found 149 titles. 
2. words or phrase "(opioid$ or morphine or heroin or opiate or cocaine or steroid$ or 
PIED$ or methadone) ADJ abuse or misuses or dependen$ or use$2 or usage or 
addict$ or inject$ or intravenous$" OR words or phrase "(Substance$1 or drug$1 or 
stimulant$) ADJ addict$ or use$2 or dependen$" OR words or phrase "(Substance$1 
or drug$1 or stimulant$) ADJ inject$ or intravenous$ or abuse or misuse" search found 
14022 titles. 
3.  words or phrase "(needle$ or syringe$ or inject$ or paraphernalia or equipment$) ADJ 
safe$ or steril$" OR words or phrase "(needle$ or syringe$ or injection$ or 
paraphernalia or equipment$) ADJ pack$1" search found 28 titles. 
4. words or phrase "shooting galler$ or harm reduc$ or dispencing machine$ or vending 
machine$" OR subject "harm reduction or substance abuse treatment center$ or 
needle exchange programme$" OR words or phrase "NSP or NEP or NSEP or NSPs 
or NEPs or NSEPs" OR words or phrase "(needle$ or Syringe$ or inject$ or 
paraphernalia or equipment$) ADJ exchange$" search found 95 titles. 
5. drug-use ADJ (room$ or facility or facilities or centre$ or center$ or service$ or 
program$ or scheme$ or site$ or area$) no results. 
6. drug consumption ADJ (room$ or facilities or facility or centre$ or center$ or service$ 
or area$ or site$) no results 
7. words or phrase "(needle$ or syringe$ or inject$ or paraphernalia or equipment) adj 
steril$ or equipment or bleach$ or disinfectant$ or disinfect$1 or citric acid$" OR words 
or phrase "(needle$ or syringe$ or inject$ or paraphernalia or equipment) adj supply$ 
or access$ or provision or provid$ or distribut$ or dispens$ or program$ or service$ or 
centre$ or scheme$ or center$ or site$1 or facilities or facility or scheme$ or area$" 
search found 51150 titles. 
8. words or phrase "(needle$ or syringe$ or inject$ or paraphernalia or equipment) adj 
prison$ or pharmacy or pharmacies or unit or units" search found 4882 titles. 
9. words or phrase "risk reduction behavio?r" OR subject "risk reduction behavio?r or risk 
taking or needle sharing" OR subject "HIV or hepatitis C or hepatitis B or mortality or 
morbidity or bacterial infection or viral diseases or virus diseases or infection or blood-
borne pathogens" search found 1917 titles. 
10. words or phrase "(needle$ or syringe$ or inject$ or paraphernalia or equipment) adj 
reusing or reuse$ or return$" OR words or phrase "(needle$ or syringe$ or inject$ or 
paraphernalia or equipment) adj sharing or share$1" OR words or phrase "(needle$ or 
syringe$ or inject$) adj frequenc$ or cessation" OR words or phrase "inject$ others" 
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OR words or phrase "rate of adj (relapse$ or stop$ or cessation)" search found 2226 
titles. 
11. (high$ or increas$ or improve$ or encourag$ or promot$) adj safe$ inject$. No results 
12. (low$ or reduc$ or prevent$ or decreas$ or chang$) adj inject$ no results. 
13. subject "qualitative studies or qualitative research or grounded theor$ or thematic 
analysis or observation stud$2" OR words or phrase "knowledge or attitude or belief or 
motivation or value$ or access or involvement or participation or patient interview$ or 
opinion or network$" OR words or phrase "demonstration project or perception or 
experience$ or understanding or family or families or carer$ or evaluation or 
ethnograph$" search found 27954 titles. 
14. words or phrase "constructionist$ or commission$ or distribution or motivation or 
access or user$ or stakeholder$" OR words or phrase "collaboration or consultation or 
behavio?r or contribution or school$ or media" search found 22113 titles. 
15. #1 and #14  
words or phrase "constructionist$ or commission$ or distribution or motivation or 
access or user$ or stakeholder$" OR words or phrase "collaboration or consultation or 
behavio?r or contribution or school$ or media" AND subject "heroin dependence or 
morphine dependence or substance related disorder or street drugs OR opioid related 
disorder or cocaine related disorder or illicit drugs or anabolic agents or steroids OR 
Substance abuse or intravenous abuse" search found 15884 titles. 
16. #1 and #13  
words or phrase "knowledge or attitude or belief or motivation or value$ or access or 
involvement or participation or patient interview$ or opinion or network$" AND subject 
"heroin dependence or morphine dependence or substance related disorder or street 
drugs OR opioid related disorder or cocaine related disorder or illicit drugs or anabolic 
agents or steroids OR Substance abuse or intravenous abuse" search found 34 titles. 
words or phrase "demonstration project or perception or experience$ or understanding 
or family or families or carer$ or evaluation or ethnograph$" AND subject "heroin 
dependence or morphine dependence or substance related disorder or street drugs Or 
opioid related disorder or cocaine related disorder or illicit drugs or anabolic agents or 
steriods OR Substance abuse or intravenous abuse" search found 21 titles. 
17. #1 and #10  
words or phrase "(needle$ or syringe$ or inject$ or paraphernalia or equipment) adj 
reusing or reuse$ or return$ OR (needle$ or syringe$ or inject$ or paraphernalia or 
equipment) adj sharing or share$1" OR words or phrase "(needle$ or syringe$ or 
inject$) adj frequenc$ or cessation" OR words or phrase "inject$ others" OR words or 
phrase "rate of adj (relapse$ or stop$ or cessation)" AND subject "heroin dependence 
or morphine dependence or substance related disorder or street drugs OR opioid 
related disorder or cocaine related disorder or illicit drugs or anabolic agents or steriods 
OR Substance abuse or intravenous abuse" search found 2 titles. 
18. #1 and #9 
subject "risk reduction behavio?r or risk taking or needle sharing OR HIV or hepatitis C 
or hepatitis B or mortality or morbidity" AND subject "heroin dependence or morphine 
dependence or substance related disorder or street drugs OR opioid related disorder 
or cocaine related disorder or illicit drugs or anabolic agents or steriods OR Substance 
abuse or intravenous abuse" search found 5 titles. 
subject "bacterial infection or viral diseases or virus diseases or infection or blood-
borne pathogens" AND subject "heroin dependence or morphine dependence or 
substance related disorder or street drugs OR opioid related disorder or cocaine 
related disorder or illicit drugs or anabolic agents or steriods OR Substance abuse or 
intravenous abuse" OR words or phrase "risk reduction behavio?r" search found 9 
titles. 
19. #1 and #8  
words or phrase "(needle$ or syringe$ or inject$ or paraphernalia or equipment) adj 
prison$ or pharmacy or pharmacies or unit or units" AND subject "heroin dependence 
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or morphine dependence or substance related disorder or street drugs OR opioid 
related disorder or cocaine related disorder or illicit drugs or anabolic agents or steriods 
OR Substance abuse or intravenous abuse" search found 3 titles. 
20. #1 and #7 
words or phrase "(needle$ or syringe$ or inject$ or paraphernalia or equipment) adj 
steril$ or equipment or bleach$ or disinfectant$ or disinfect$1 or citric acid$" OR words 
or phrase "(needle$ or syringe$ or inject$ or paraphernalia or equipment) adj supply$ 
or access$ or provision or provid$ or distribut$ or dispens$ or program$ or service$ or 
centre$ or scheme$ or center$ or site$1 or facilities or facility or scheme$ or area$" 
AND subject "heroin dependence or morphine dependence or substance related 
disorder or street drugs OR opioid related disorder or cocaine related disorder or illicit 
drugs or anabolic agents or steroids OR Substance abuse or intravenous abuse" 
search found 112 titles. 
21. #1 and #4 
subject "heroin dependence or morphine dependence or substance related disorder or 
street drugs OR opioid related disorder or cocaine related disorder or illicit drugs or 
anabolic agents or steroids OR Substance abuse or intravenous abuse" AND words or 
phrase "NSP or NEP or NSEP or NSPs or NEPs or NSEPs OR (needle$ or Syringe$ 
or inject$ or paraphernalia or equipment$) ADJ exchange$" search found 1 title. 
subject "heroin dependence or morphine dependence or substance related disorder or 
street drugs OR opioid related disorder or cocaine related disorder or illicit drugs or 
anabolic agents or steroids OR Substance abuse or intravenous abuse" AND subject 
"harm reduction or substance abuse treatment center$ or needle exchange 
programme$" OR words or phrase "shooting galler$ or harm reduc$ or dispencing 
machine$ or vending machine$" search found 71 titles. 
22. #1 and #3 no results found. 
23. #2 and #3 
words or phrase "(needle$ or syringe$ or inject$ or paraphernalia or equipment$) ADJ 
safe$ or steril$ OR (needle$ or syringe$ or injection$ or paraphernalia or equipment$) 
ADJ pack$1" AND words or phrase "(opioid$ or morphine or heroin or opiate or 
cocaine or steroid$ or PIED$ or methadone) ADJ abuse or misuses or dependen$ or 
use$2 or usage or addict$ or inject$ or intravenous$" search found 8 titles. 
words or phrase "(needle$ or syringe$ or inject$ or paraphernalia or equipment$) ADJ 
safe$ or steril$ OR (needle$ or syringe$ or injection$ or paraphernalia or equipment$) 
ADJ pack$1" AND words or phrase "(Substance$1 or drug$1 or stimulant$) ADJ 
addict$ or use$2 or dependen$ OR (Substance$1 or drug$1 or stimulant$) ADJ inject$ 
or intravenous$ or abuse or misuse" search found 8 titles. 
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